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Almost all cells of a metazoan organism share the same genetic information but can differ
highly in their function and phenotype. The transition from the same genotype to different
phenotypes is mostly achieved by epigenetic mechanisms, including DNA base modifica-
tions. The most prominent and best studied DNA modification is 5-methylcytosine (5mC),
which was implicated in transcriptional repression. The levels of 5mC are maintained on
the newly synthesized DNA strand, to ensure its faithful inheritance during mitotic cell
division. Oxidation of the 5mC by Tet dioxygenases, to 5-hydroxymethylcytosine (5hmC)
and even further, can drastically change the epigenetic information transported by this
modification and hence modulate gene expression and the overall phenotype of a cell.
However, the exact regulation of Tet proteins and the putative cell cycle dependent inheri-
tance of their oxidative products still is under investigation. In the present work, I therefore
characterized the subnuclear distribution of different Tet proteins throughout the cell cycle
and especially during S-phase and potential implications for cellular homoeostasis. I identi-
fied the recruitment of the short isoform of Tet1 (Tet1s), which is found to be overexpressed
in different cancers, to sites of ongoing DNA replication in pericentric heterochromatin,
which is rich in 5mC. I furthermore found that Tet1s localization during S-phase and also
its catalytic activity is highly dependent on a conserved lysine residue. Moreover, I could
show that Tet1 physically interacts with the E3 ubiquitin-ligase Uhrf1 and that the observed
localization of Tet1s to sites of ongoing DNA replication in pericentric heterochromatin
requires the presence of Uhrf1. Finally, I found that a breast cancer cell line that was
shown to overexpress Tet1s, exhibits significantly changed 5mC and 5hmC levels, globally
as well as in situ, in comparison to non-transformed breast epithelial cells.
In summary, my findings contribute to the understanding of how the epigenetic information





Nahezu alle Zellen eines metazoen Organismus besitzen die gleiche genetische Informa-
tion, können sich jedoch in ihrer Funktion und ihrem Phänotyp stark unterscheiden. Der
Übergang vom gleichen Genotyp zu verschiedenen Phänotypen wird hauptsächlich durch
epigenetische Mechanismen, einschließlich verschiedener DNA-Basenmodifikationen er-
reicht. Die bekannteste und am besten untersuchte DNA-Modifikation ist 5-Methylcytosin
(5mC), das an der Transkriptionsrepression beteiligt ist. Das 5mC-Muster wird während
der S-Phase auf den neu synthetisierten DNA-Strang kopiert, um sicherzustellen, dass
es während der mitotischen Zellteilung korrekt vererbt wid. Die Oxidation der 5mC-
Methylgruppe durch Tet-Dioxygenasen zu 5-Hydroxymethylcytosin (5hmC) und darüber
hinaus, kann die durch diese Modifikation transportierten epigenetischen Informationen
drastisch verändern und somit die Genexpression und den Gesamtmetabolismus einer
Zelle modulieren. Die genaue Regulation von Tet-Proteinen und die Zellzyklus-abhängige
Aufrechterhaltung ihrer oxidativen Produkte wirft jedoch noch viele Fragen auf.
In der vorliegenden Arbeit habe ich daher die subnukleäre Verteilung verschiedener
Tet-Proteine während des Zellzyklus und insbesondere während der S-Phase, sowie
potenzielle Implikationen für die zelluläre Homöostase charakterisiert. Ich identifizierte
die Rekrutierung der kurzen Isoform von Tet1 (Tet1s), die in verschiedenen Krebsarten
überexprimiert wird, während der laufenden DNA-Replikation in perizentrischem Hete-
rochromatin. Weiterhin fand ich, dass die Lokalisierung von Tet1 während der S-Phase
und auch seine gerichtete katalytische Aktivität stark von einem konservierten Lysinrest
abhängen. Außerdem konnte ich zeigen, dass Tet1 physisch mit der E3-Ubiquitin-Ligase
Uhrf1 interagiert und dass die beobachtete Lokalisierung von Tet1s während der laufenden
DNA-Replikation in perizentrischem Heterochromatin, die Anwesenheit von Uhrf1 erfordert.
Schließlich konnte ich zeigen, dass eine Brustkrebszelllinie, die Tet1s überexprimiert,
signifikant veränderte Level von 5mC und 5hmC sowohl global als auch textit in situ, im
Vergleich zu nicht transformierten Brust-Epithelzellen, aufweist.
Zusammenfassend tragen meine Erkenntnisse zum generellen Verständnis bei, wie die
epigenetischen Information jeder Zelle durch die Regulation der Tet-Proteinlokalisierung




2.1 Information content of DNA and the impact of epigenetics
2.1.1 DNA – A linguistic perspective
Being presented with a naked stretch of eukaryotic, genomic DNA is similar to being pre-
sented with a piece of text that lacks all basic syntactic features like the simple separation
of words by spaces. To simplify this analogy, transcriptional activity outside of genic regions
is neglected and only a short genic stretch of DNA is observed in close detail.
A first layer of syntax is the correct order of cis-acting regulatory elements within any given
genic region, like the promoter or the TATA-box and the open reading frame, associated
with these elements. The distinction of the different, specialized components of this region
is mainly achieved by defined sequence features. Consequently, all constituents of a genic
region harbour conserved consensus sequences that clearly define them as promoter and
transcription start sites or flank intronic and exonic regions, respectively.
If the regulatory elements and the promoter are bound by the transcription initiation com-
plex and a RNA polymerase starts transcribing, a semantic meaning arises from this
stretch of DNA. This eventually results in a protein product or a non-coding RNA and is
comparable to reading out loud a text without paying attention to the actual combined
meaning of words as long as basic grammatical rules are followed. If not only grammatical
rules but also the meaningful combination of words is considered, pragmatic information is
transported to the listener. (Figure 1)
In metazoans, almost all cells of an organism are genetically identical but still give rise
to different cell types and consequently various, specialized tissues. Hence, a pragmatic
mode of regulation for the information content of DNA is needed to control the precise,
contextual correct activation of transcription in individual cells.
This pragmatic layer of DNA information interpretation is mainly achieved by epigenetic
mechanisms and chromatin modifications, which finetune the interplay of syntactic and
semantic DNA information content.
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Figure 1: Illustration of the linguistic view of a genic DNA region. A non-structured DNA sequence that
stretches across a genic region can be subdivided into regulatory elements and an open reading frame,
according to the respective sequence features and is thereby given a logical syntax (on the righthand side).
This is similar to the descriptive list on the lefthand side, whose syntax arises from the addition of spaces
and bullet points. The combined interpretation of the regulatory elements and the open reading frame results
in the transcription of this piece of DNA and is thereby given a semantic relevance in the form of (pre)mRNA
and its product. The levels of a newly translated protein or a resulting non-coding RNA can differ highly
between different cells, even within the same tissue. This heterogeneity shapes the individual phenotype of




The term epigenetics was originally introduced by Conrad Hal Waddington to describe how
phenotypical differences arise from genetic mutations. He used it, to bring together the
fields of genetics and organismic development, then called epigenesis (Waddington, 1942).
This definition would start to change with a discovery, made shortly after Waddington dis-
cussed his ideas on epigenetics and already five years before the initial description of the
DNA double-helix structure (Watson and Crick, 1953). In 1948, Rollin Hotchkiss described
a fifth peak on a paper chromatogram from thymus deoxyribonucleic acids, in addition to
the four canonical DNA bases. He termed this novel mammalian DNA base "epicytosine",
unknowingly anticipating the modern definition of epigenetics and additional layer of in-
formation that epigenetic chromatin modifications add to the genetic information of every
eukaryotic cell (Hotchkiss, 1948). A sixth DNA base, named 5-hydroxymethylcytosine
(5hmC), was identified in different vertebrate tissues like frog and mouse brain already
in 1972 (Penn et al., 1972). However, epicytosine or 5-methylcytosine (5mC), how it was
later known, remained the only non-canonical mammalian DNA base that was studied to a
larger extent for a long time.
5mC helped explaining how different cellular phenotypes can arise from the same nu-
cleotide sequence. Consistently, it has meanwhile been established that the complex
interplay of DNA modifications, different histone variants and their modifications as well
as non-coding RNAs and nucleosomal arrangements and the thereby modulated binding
of transcription factors serves as a hereditary transgenerational mechanism to regulate a
plethora of cellular processes in higher eukaryotic organisms (Figure 2). The combinatorial
effect of different epigenetic modifications furthermore defines the two main chromatin
types, euchromatin and heterochromatin. Euchromatin is comparatively less condensed,
gene-rich and characterized by high transcriptional activity. Heterochromatin, on the other
hand, is generally considered to be transcriptionally inactive and can be further subdi-
vided into two different classes, constitutive and facultative heterochromatin. The latter
can become transcriptionally active in response to certain cellular signals. Constitutive
heterochromatin, in contrast, is mainly composed of repetitive DNA sequences and stays
transcriptionally inert in normal somatic cells (Joffe, Leonhardt, and Solovei, 2010).
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Figure 2: Overview over the different epigenetic mechanisms that regulate DNA metabolism. The
epigenetic make-up of higher eukaryotic cells comprises many different chromatin modifications. Amongst
them are covalent DNA- and histone modifications, but also various histone variants as well different non-
coding RNAs and also nucleosomal arrangements. Mammalian DNA modifications comprise predominantly
cytosine methylation and different oxidised forms thereof. Many post-translational histone tail modifications,
like ubiquitination (Ub), SUMOylation (SUMO) and acetylation (Ac) are found exclusively on lysine residues.
Methylation of histones (Me), however, is found on lysines and also on arginines and histone phosphorylation
(P) is observed on threonines and serines. Besides the histone modifications, different histone variants
that can vary between celltypes and even within the cell cycle, have been described to modulate important
cellular processes. Non-coding RNAs act in diverse function to fine-tune transcriptional activity, for example
by coating, to be silenced, DNA. These processes concomitantly affect nucleosome remodelling and thereby
affect chromatin structure and consequently DNA metabolism.
2.1.3 Epigenetic mechanisms & chromatin modifications
Chromatin topology is highly dynamic and undergoes constant changes that correlate with
its transcriptional activity, which in turn is highly dependent on epigenetic mechanisms
and chromatin modifications (Hübner and Spector, 2010). The basic unit of chromatin
organization is an approximately 146 base pair long stretch of DNA wrapped around a
histone octamer, which consists of two copies of each of the core histones H2A, H2B,
H3 and H4 that together form the so-called nucleosome (Luger et al., 1997; Luger and
Richmond, 1998). The drum-shaped nucleosome particles are further compacted via
the binding of the linker histone H1, which sits between neighbouring nucleosomes and
stabilizes the DNA that is wrapped around them (Hergeth and Schneider, 2015). The
amino-terminal histone tails, which protrude from the core, are essential for the biological
function of the nucleosome, as many post-translational modifications (PTMs) are deposited
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here (Kouzarides, 2007). The most abundant histone modifications comprise lysine and
arginine methylation, lysine acetylation, phosphorylation of serines or threonines, as well
as ubiquitination and SUMOylation of lysines within the histone tails. Of the different
groups of post-translational histone modifications, all of them have been implicated in
transcriptional regulation, while some were shown to also regulate DNA repair or DNA
replication.
Histone tail modifications can modulate chromatin structure, for example, by neutralizing the
positive charge of lysine via the addition of acetyl groups, thereby opening up the chromatin.
Histone hyperacetylation is therefore a characteristic feature of transcriptionally active
euchromatic domains and mostly absent in heterochromatin. Methylation of histones,
on the other hand, is found in transcriptionally active as well as silenced chromatin
regions. While trimethylation of lysines 9, 20 and 27 in histone H3 (H3K9/20/27me3) is
associated with heterochromatin, trimethylation of lysines 4, 36 and 79 (H3K4/36/79me3)
is predominantly found in euchromatic domains (Karlic et al., 2010). Each single histone
tail modification can serve as a recruitment platform for further chromatin factors and hence
downstream epigenetic processes (Bannister and Kouzarides, 2011). Although, conserved
nucleosome modification patterns have been described in the context of promoters and
different upstream regulatory elements (Wang et al., 2008), the exact modification pattern
of neighbouring nucleosomes can be highly diverse and is not mutually exclusive, resulting
in the so-called histone code (Strahl and Allis, 2000; Jenuwein and Allis, 2001).
Besides their modification status, variants of the four core histones play an important
role in various cellular processes and can be highly dynamic throughout the cell cycle
(Boyarchuk, Montes de Oca, and Almouzni, 2011). Histone H2A and its variant H2A.Z, for
example, are deposited in pericentric heterochromatin in discrete waves throughout the
cell cycle and thereby contribute to the faithful progression of S-phase and G1, respectively
(Boyarchuk et al., 2014). Different histone variants and their modifications also serve
as recognition sites as well as substrates for chromatin remodelling complexes like the
SWI/SNF (SWItch/Sucrose Non-Fermentable) or the Mi-2/NuRD (Nucleosome Remodeling
Deacetylase) complexes. These chromatin remodelling complexes consist of multiple
different proteins, amongst them ATPases, which modulate nucleosomal repositioning,
but also a plethora of epigenetic reader and writer proteins (Clapier et al., 2017). The
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Mi-2/NuRD-complex, for example, comprises histone deacetylases HDAC1 and HDAC2
as well as methyl-CpG binding domain protein (Mbd) family members Mbd2 and Mbd3
(Wade et al., 1999), which together enable it to read chromatin signatures and finetune
transcriptional activity. Besides this, the NuRD complex was also shown to bind the cell
cycle independent histone variant H3.3, which is enriched in actively transcribed chromatin,
thereby promoting gene activity (Kraushaar et al., 2018) and to associate with the Tet1
dioxygenase (Shi et al., 2013). While being crucial regulators of chromatin structure and
function, many chromatin remodelling complexes were found to be themselves regulated
by non-coding RNAs (ncRNAs) that often arise from non-protein coding DNA sequences
and are therefore not translated (Palazzo and Lee, 2015). Accordingly, it could be shown
that the SWI/SNF member Brg1/BAF can be removed from its chromatin binding sites
by the long-ncRNA Mhrt to prevent nucleosome remodelling (Han et al., 2014). Other
ncRNAs, like PARTICLE or HOTAIR, have furthermore been implicated in regulating
post-translational histone modifications, like lysine methylation, by acting as scaffolds
for the assembly of distinct protein complexes for subsequent H3K27 methylation and
H3K4 demethylation (Tsai et al., 2010; O’Leary et al., 2017). Finally, similar to acting as a
scaffold for histone modifying enzymes, ncRNAs like PARTICLE were shown to modulate
the activity of the maintenance DNA methyltransferase Dnmt1 and thereby affect global
DNA methylation levels (O’Leary et al., 2017).
2.2 DNA methylation and the Dnmt protein family
Methylation of the fifth carbon atom of cytosine is found in the DNA of many prokaryotic
and with only a few exceptions eukaryotic organisms. It represents one of the most
abundant and most conserved epigenetic modifications and regulates gene expression
by silencing promoter regions and facilitating the compaction of chromatin (Lande-Diner
et al., 2007; Smith and Meissner, 2013). Mammalian DNA methylation occurs predomi-
nantly in the context of symmetric CpG dinucleotides and in the human genome between
60-80% of the about 28 million CpG sites, hence around 5% of all cytosines are methy-
lated (Smith and Meissner, 2013). However, up to 200 base-pair long stretches of these
dinucleotides, so-called CpG-islands (CGI), are often found in the context of promoters
and transcription start sites (TSS), where they are sparsely methylated (Bird, 1986; Smith
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and Meissner, 2013). The remaining fraction of long CpG stretches in the genome is
usually hypermethylated in healthy, somatic cells and plays an important role in processes
like X chromosome inactivation and genomic imprinting but also in cancerogenesis and
neurodegeneration, where aberrant DNA methylation patterns are frequently observed
(Bird, 2002; Klutstein et al., 2016; Sanchez-Mut et al., 2016). Consequently, repetitive
and transposable elements within the human genome, like retroviruses or LINE1 and Alu
elements are normally highly methylated to prevent their reactivation or in general their
transcription (Jones, 2012). Moreover, DNA methylation contributes to the integrity of
heterochromatin by serving as a binding platform for various proteins that can recognize
and bind 5mC, like the members of the Mbd (methyl-CpG binding domain)-protein family
(Ludwig, Zhang, and Cardoso, 2016). By modulating chromatin structure, 5mC has a
direct effect on DNA transcription fidelity and can thereby affect alternative splicing. Con-
sistently, DNA methylation and accompanying nucleosome occupancy in exons results
in decreased binding of the architectural protein CTCF (CCCTC-binding factor), which
in turn leads to exclusion of weak upstream exons (Shukla et al., 2011; Marina et al., 2015).
DNA cytosine methylation is catalysed by members of the DNA (cytosine-5)-methyltransferase
(Dnmt) protein family that all share a highly conserved C-terminal catalytic domain. De-
spite this homology, of the six protein family members, only Dnmt1, Dnmt3A, Dnmt3B
and Dnmt3C were shown to catalytically act on DNA (Jurkowska, Jurkowski, and Jeltsch,
2011; Barau et al., 2016) (Figure 3A). While the Dnmt3-like protein Dnmt3L serves as a
catalytically inactive regulatory factor (Chedin, Lieber, and Hsieh, 2002), Dnmt2 or Trdmt1
targets RNA and methylates different tRNAs, thereby protecting them from ribonuclease
cleavage (Goll et al., 2006; Schaefer et al., 2010).
All catalytically active Dnmts belong to the class I of methyltransferases and act on non-
methylated cytosines in DNA or RNA by flipping its substrate out of the sugar-phosphate
backbone (Song et al., 2012) (Figure 3B). This enables them, to transfer a methyl group
from the methyl donor molecule S-adenosyl-L-methionine (SAM) to the cytosine residue,




Figure 3: The Dnmt Methyltransferase protein family. (A) Domain organizations of human Dnmt1, Dnmt2,
Dnmt3A, Dnmt3B, Dnmt3C and Dnmt3L including the DMAP (DMAP1 interacting site), PBD (PCNA binding
domain), TS (Replication Foci Targeting Sequence), CxxC (CxxC Zinc-finger domain), BAH (Bromeo-adjacent
homology), MT (methyltransferase domain). (B) Crystal structure of mouse DNMT1 (731-1602) bound to
hemimethylated CpG DNA in complex with 5-methylcytosine (red), flipped out of the double helix and a 12
bp long stretch of double stranded DNA (golden and silver) at a resolution of 2.6 Å (PDB: 4DA4) (Song
et al., 2012). Zinc atom is displayed as grey sphere. The structural model was prepared with Cn3D (Wang
et al., 2000). (C) Illustration of the methylation reaction of Dnmt family proteins. The catalytic center of Dnmt
proteins covalently bind cytosine and the methylgroup is transferred from the cofactor S-adenosyl-methionine
to the C5 carbon atom of cytosine, leaving 5mC and demethylated S-adenosyl-homocysteine.
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2.2.1 Dnmt3 de novo DNA methyltransferases
DNA cytosine methylation is initially established during embryogenesis and gametogenesis
by the de novo DNA methyltransferases Dnmt3A and Dnmt3B, which both show a strong
affinity for unmethylated DNA (Jurkowska, Jurkowski, and Jeltsch, 2011). In accordance
with this, these two de novo DNA methyltransferases are highly expressed in embryonic
stem cells and germ cells, but are down-regulated upon differentiation and in general
in somatic tissues. However, Dnmt3A and Dnmt3B are not redundant in their biological
function and relevance. While depletion of Dnmt3A results in embryonic lethality, Dnmt3B
deficient mice die a couple of weeks after birth (Okano et al., 1999; Ueda, 2006).
A third protein that resembles Dnmt3A and Dnmt3B structurally but is catalytically inert,
Dnmt3L, was found to stimulate the catalytic activity of Dnmt3A and Dnmt3B (Chedin,
Lieber, and Hsieh, 2002), for example by interacting with non-modified lysine 4 in the
histone H3 tail (H3K4) and subsequently recruiting Dnmt3a for de novo methylation (Ooi
et al., 2007). The modification status of H3K4 furthermore regulates an autoinhibitory
conformational change of Dnmt3A, which is further regulated by its interplay with the
essential 5mC binding protein MeCP2 (Rajavelu et al., 2018). In rodents, a third catalytically
active de novo DNA methyltransferase, Dnmt3C, was described recently and shown to
protect genome integrity of male germ cells by targeting the promoters of transposable
elements and thereby silencing them (Barau et al., 2016).
2.2.2 Dnmt1 maintenance methyltransferase
After DNA methylation patterns have been established by Dnmt3A and Dnmt3B they need
to be maintained during the cell cycle to conserve the thereby transported epigenetic
information. The mitotic inheritance of DNA methylation patterns is facilitated by the
maintenance DNA methyltransferase Dnmt1. Its activity during DNA replication in S-
phase prevents the enrichment of hemimethylated CpG sites and eventual loss of DNA
methylation, due to the semi-conservative nature of DNA replication. In contrast to the
comparatively short N-terminal domain of Dnmt3A and Dnmt3B, Dnmt1 harbours a long
N-terminus with a multitude of additional regulatory domains. The importance of the
N-terminal domains of Dnmt1 is underlined by the impaired catalytic activity of its C-
terminal catalytic domain alone (Margot et al., 2000). Furthermore its high preference
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for hemimethylated DNA (Song et al., 2011) and the localization to sites of ongoing DNA
replication (Leonhardt et al., 1992) is important for the role of Dnmt1 in DNA methylation
maintenance during mitotic cell division. While Dnmt1 shows only a diffuse nuclear
localization pattern during G1 and most parts of G2, a clear colocalization with the DNA
replication machinery is observed throughout S-phase and in the transition from S-phase
to G2 (Easwaran et al., 2004). Furthermore, in contrast to Dnmt3A or Dnmt3B, Dnmt1 was
shown to be recruited to DNA damage sites and hence plays a crucial role in maintaining
epigenetic information not only during DNA replication, but also on newly synthesized DNA
after successful repair (Mortusewicz et al., 2005).
The catalytic activity of Dnmt1 is regulated by the concerted action of interacting proteins
and the thereby modulated regulation of autoinhibitory conformational changes. Structural
data and mutagenesis studies hint to a blocking of the catalytic pocket by the N-terminal
CxxC- and TS-domains (Song et al., 2011). Moreover, protein stability and therefore
catalytic activity are regulated by ubiquitination and deubiquitination via Uhrf1 and Usp7,
respectively. Besides regulating Dnmt1 protein stability, Uhrf1 plays a crucial role for Dnmt1
mediated DNA methylation maintenance, by stimulating its catalytic activity through direct
protein-protein interactions and by binding and modifying the chromatin that surrounds
hemimodified CpG sites (Bashtrykov et al., 2013; Qin et al., 2015).
2.3 The Uhrf protein family
Uhrf1 is the founding member of the Uhrf protein family and essential for the correct
function of Dnmt1 during DNA methylation maintenance by multiple, different interactions
with Dnmt1, methylated cytosine as well as histones in the vicinity of hemimethylated DNA
(Arita et al., 2008; Avvakumov et al., 2008; Hashimoto et al., 2008; Qin et al., 2015). Uhrf1
was first discovered by two independent studies that set out to identify proteins that are
recruited during S-phase or harbour a CCAAT-box binding motif, respectively (Fujimori
et al., 1998; Hopfner et al., 2000). The human proteins Uhrf1 or ICBP90 (inverted CCAAT
Box-binding Protein of 90 kDa) and the later identified Uhrf2 or NIRF (Np95/ICBP90 Ring
Finger) show high sequence homology to their respective mouse orthologs Np95 (Nuclear
protein of 95 kDa; mUhrf1) and Np97 (Nuclear protein of 97 kDa; mUhrf2), as they all
share the same functional domains. At the very N-terminus resides the UBL (Ubiquitin-like)
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Figure 4: Uhrf1 and Uhrf2 are multidomain proteins with modules for DNA and histone interactions.
(A) Domain organizations of human Uhrf1 and Uhrf2, including the ubiquitin-like (UBL) domain, histone
modifications binding tandem tudor domain (TTD) and plant homeodomain (PHD), as well as the DNA
interacting SET and RING associated (SRA) domain and the really interesting new gene (RING) domain,
which harbours an E3-ligase activity. (B) crystal structure of the human Uhrf1 UBL domain at 2 Å (PDB:
2FAZ) (C) Crystal structure of the human Uhrf1 TTD domain in complex with trimethylated lysine 9 (red) of
the histone H3 tail peptide at a resolution of 2.96 Å (PDB: 4GY5_A) (Cheng et al., 2013) (D) Crystal structure
of the human Uhrf1 PHD domain in complex with trimethylated lysine 4 (red) of the histone H3 tail petide
(black) at a resolution of 1.9501 Å (PDB: 3SOW_A) (Rajakumara et al., 2011). (E) Crystal structure of the
SRA domain of human Uhrf1 in complex with 5-methylcytosine (red), flipped out of the double helix and
a 12 bp long stretch of double stranded DNA (golden and silver) at a resolution of 2.2 Å (PDB: 3CLZ_A)
(Avvakumov et al., 2008) (F) Crystal structure of the RING domain of human Uhrf1 at a resolution of 1.74 Å
(PDB: 3FL2_A); Zinc atoms are displayed as light spheres, alpha helices are displayed as barrel shaped
arrows, beta sheets are displayed as flattened arrows. All structural models were prepared with Cn3D (Wang
et al., 2000).
domain followed by the histone binding tandem tudor domain (TTD) and plant home-
odomain (PHD), the DNA-interacting SRA (SET and RING Associated) domain and the
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E3-ligase activity mediating RING (Really Interesting New Gene) domain (Figure 4A).
The UBL domain shows 35% sequence homology with ubiquitin, as well as the typical
ubiquitin alpha/beta fold and was proposed to interact with the proteasome and target
ubiquitinated proteins for degradation. Recently, the UBL domain was shown to stimulate
the activity of the C-terminal, E3-ligase activity mediating, RING domain (Foster et al.,
2018). In line with these findings, it was demonstrated that hUhrf2 rescues primary neurons
from cytotoxic polyglutamine aggregates by targeting them for proteasomal degradation
(Iwata et al., 2009).
As previously mentioned, the regulation of Dnmt1 activity, is one of the most important
biological functions of Uhrf1. Consistently, it was shown that the UBL domain of Uhrf1
directly interacts with the TS domain of Dnmt1, not only by targeting it for methylation
maintenance but also by allosterically stimulating its catalytic activity (Li et al., 2018).
Furthermore, it was shown that overexpression of Uhrf1 enhances ubiquitination levels
of Dnmt1 in vivo (Qin, Leonhardt, and Spada, 2011) and also of histone H3, with a high
preference over the other histones (Citterio, Papait, and Nicassio, 2004; Karagianni et al.,
2008). This dual ubiquitination was meanwhile linked to the regulation of Dnmt1 in DNA
methylation maintenance during DNA replication (Qin et al., 2015). In addition, Uhrf pro-
teins were shown to be involved in cell cycle control by ubiquitinating PCNP in vivo and in
vitro (Mori et al., 2004).
The PHD domain is thought to be involved in gene activation and silencing via binding to
different histone modifications. Consequently it has been shown that H3K4me3, a hallmark
of transcriptionally active chromatin, is recognized and bound by the PHD domain with high
specificity and can even be distinguished from the dimethylated variant of H3K4 (Wysocka
et al., 2006; Li et al., 2006; Pena et al., 2009). It was furthermore shown that the PHD
domain can bind H3R2me2, a characteristic modification of active promoters (Rajakumara
et al., 2011; Yuan et al., 2012). In this regard, the TTD domain was found to recognize
the methylation state of H3K9 and H3R2 and facilitate binding to this residues together
with the PHD domain (Arita et al., 2012; Cheng et al., 2013). The TTD domain was
furthermore shown to bind H3K9me3 but not histone H3 tail acetylations (Rottach et al.,
2010). Recently, the TTD of Uhrf1 was found to recognize a H3K9me3-mimic peptide in
ligase1, which targets it for methylation maintenance during DNA replication of pericentric
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heterochromatin (Ferry et al., 2017). The SRA (SET and RING associated) domain has
in mammals only been described in Uhrf1 and Uhrf2. In plants, however, it is found in a
variety of histone methyltransferases involved in epigenetic silencing (Baumbusch et al.,
2001). The SRA domain was shown to bind 5mC and also 5hmC (Frauer et al., 2011b;
Unoki, Nishidate, and Nakamura, 2004). It is able to flip methylated cytosine out of the
DNA helix at hemimethylated sites and shows a up to 10 fold higher affinity for hemimethy-
lated DNA compared to fully methylated DNA (Sharif et al., 2007; Bostick et al., 2007;
Hashimoto et al., 2008). Furthermore, the SRA domain of Uhrf1 was shown to stimulate
the methylation activity of Dnmt1, most likely by allosterically removing the TS domain
from the catalytic pocket and thereby allowing for DNA-binding and consequently, catalytic
activity (Berkyurek et al., 2014).
Albeit the highly similar domain structures of Uhrf1 and Uhrf2, their respective expression
patterns and biological functions are far from redundant (Bronner et al., 2007). While Uhrf1
was found do bind to 5mC and 5hmC with similar affinities (Frauer et al., 2011b), Uhrf2
was implicated in only recognizing and binding to 5hmC (Spruijt et al., 2013a). Although,
Uhrf1 and also Uhrf2 were found to interact with Dnmt1, Dnmt3A and Dnmt3B and also
the protein methyltransferase G9a in general, a S-phase dependent Dnmt1 interaction was
only shown for Uhrf1 (Zhang et al., 2011). Accordingly, one of the most important functions
of Uhrf1 in cellular homeostasis, the targeting of Dnmt1 for methylation maintenance, can
not be rescued by Uhrf2 in an Uhrf1 depleted background (Pichler et al., 2011). This was
explained with conformational constraints of Uhrf2 that arise from a different chromatin
modification readout, compared to Uhrf1, and subsequent failure to ubiquitinate lysines in
the histone H3 tail (Vaughan et al., 2018). In stark contrast to the important role of Uhrf1
in DNA methylation maintenance, it was found that cancer-associated overexpression
of Uhrf1 and also Uhrf2 is correlated with ubiquitination and subsequent proteasomal
degradation of Dnmt3A and consequently global DNA hypomethylation (Jia et al., 2016).
2.4 5mC oxidation and the Tet protein family
The already in 1972 described sixth mammalian DNA base 5-hydroxymethylcytosine was
rediscovered in 2009, when it was found to be abundant in mouse brain and there especially
in Purkinje neurons and granule cells (Kriaucionis and Heintz, 2009). A simultaneously
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published study investigated homologous proteins of the trypanosomal thymine dioxyge-
nases JBP1 and JBP2 (J-binding protein 1/2). Here, three mammalian JBP paralogs,
Tet1, Tet2 and Tet3 were identified and Tet1 was shown to convert 5mC to 5hmC in an
Fe(II)- and 2-oxoglutarate (2OG) dependent manner (Tahiliani et al., 2009). The name
Tet1 (Ten-eleven-translocation) was derived from its role as a t(10;11)(q22;q23) chromo-
somal translocation partner of the histone methyltransferase MLL/KMT2A (Mixed lineage
leukemia/lysine methyltransferase 2A) in acute myeloid leukemia. This translocation results
in a fusion protein that harbours the N-terminus of MLL and a C-terminal part of Tet1 (Ono,
Taki, and Taketani, 2002; Lorsbach et al., 2003).
The picture of Tet catalytic activity was completed by studies that found 5hmC to be fur-
ther oxidised to 5-formylcytosine (5fC) and 5-carboxylcytosine (5caC) in a Tet-dependent
manner (Ito et al., 2011; Pfaffeneder et al., 2011). The oxidised forms of 5mC can serve
as substrates for different proteins that are involved in base excision repair (BER), like
Tdg or the Neil glycosylases (Maiti and Drohat, 2011; Müller et al., 2014). Hence, it was
initially assumed that 5hmC, 5fC and 5caC are primarily intermediates in a base excision
repair mediated 5mC removal and accompanied loss of DNA methylation. In this line, the
finding that Tet proteins can also oxidise thymine to 5-hydroxymethyluracil (5hmU) was in
part attributed to mismatch induced DNA repair and an accompanied increase in 5mC
removal (Pfaffeneder et al., 2014) (Figure 5C). However, 5hmC and 5fC have meanwhile
been identified to be stable DNA base modifications, whose levels fluctuate throughout
the cell cycle and peak in late S-phase and G2, similar to the dynamics that are observed
for 5mC in normal proliferating cells (Bachman et al., 2014; Bachman et al., 2015). In
addition, 5caC was assigned an important signalling function in adult neurons where it
regulates neurodegeneration (Jin et al., 2016). Besides their signalling functions, the 5mC
oxidation products have been implicated in altering the mechanical properties of the DNA
double-helix. While 5mC stiffens the DNA strand, its oxidised forms, especially 5hmC and
5fC, can markedly increase DNA flexibility (Ngo et al., 2016).
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Figure 5: The Tet dioxygenase protein family. (A) Domain organizations of the long isoforms of human
Tet1, Tet2 and Tet3. Shown are the N-terminal zinc-finger domain (CxxC), the cystein-rich domain (CRD)
and the double stranded beta-helix (DSBH) which is interrupted by a low complexity insert and harbours
the Fe(II)- and 2-oxoglutarate binding sites. (B) Crystal structure of human Tet2 bound to a 12 base pair
long stretch of methylated DNA at a resolution of 2.03 Å (PDB 4NM6) (Hu et al., 2013). The CRD is shown
as faint red tube worms and the DSBH as faint yellow tube worms. The bound DNA is depicted as blue
and brown stick representation helix with the methylated cytosine flipped out of the double helix shown in
green. Zinc and iron atoms are shown as grey and red spheres, respectively. The 2-oxoglutarate analog,
N-oxalylglycine is shown in stick representation. The structural model was visualized with Cn3D (Wang et al.,
2000). (C) Overview of the different cytosine modifications and the involved proteins. Cytosine is initially
methylated by DNA methyltransferases (Dnmt) and is then oxidised by Tet proteins to 5hmC, 5fC and 5caC
in an iterative manner, 2-OG and Fe(II)-dependent manner. 5mC or 5hmC can be deaminated by Apobec
(apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like)deaminases and 5hmC additionally by
Aid (Activation-induced deaminase), creating thymidine (T) or 5-hydroxymethyluracil (5hmU), respectively.
5fC and 5caC as well as 5hmU and mismatched T are recognized and excised by different glycosylases
involved in the base excision repair (BER) pathway, like Mbd4 (Methyl-CpG binding domain protein 4), Neil
glycosylases, Smug1 (Single-strand selective monofunctional uracil DNA glycosylase) or Tdg (Thymine DNA
glycosylase), eventually creating non-modified cytosine. The oxidised forms of 5mC can however transport
epigenetic information and are not necessarily removed immediately.
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2.4.1 The Tet dioxygenase family
All three members of the Tet protein family share high sequence similarities in their C-
terminal catalytic domain, which is sufficient for their respective catalytic activity. This
catalytic domain comprises the cysteine-rich domain (CRD) and the split double-stranded
beta helix domain (DSBH) which harbours the Fe(II) and 2-oxoglutarate cofactor binding
sites and is interrupted by a low-complexity insert (Figure 5A). Structural studies have
shown that the CRD and the DSBH form a compact catalytic core, in which a conserved
sequence motif within the CRD stabilizes the substrate-containing DNA double helix, while
5mC or its oxidised derivatives are flipped out of the DNA double helix (Hu et al., 2013)
(Figure 5B). Besides this, two recent studies identified monoubiquitination of a conserved
lysine residue within the CRD of all three Tet proteins by the CRL4(VprBP) E3-ligase
complex to modulate their catalytic activity and chromatin association (Yu et al., 2013;
Nakagawa et al., 2015).
A structural feature that separates the three Tet proteins from one another is their N-
terminal CxxC domain. Although the zinc-finger domains of Tet1 and Tet3 as well as
the Tet2 associated IDAX/CXXC4, belong to the same subgroup of CxxC-domains (Xu
et al., 2018), they differ highly in their respective binding affinities and substrates. Tet2
lost its zinc-finger during evolution in a chromosomal inversion and it is now encoded by
the genomically adjacent IDAX/CXXC4, which negatively regulates Tet2 expression and
modulates its catalytic activity (Ko et al., 2013). Tet1 and Tet3, in contrast, both kept their
respective zinc-finger domains and the CxxC domain of Tet3 was shown to preferentially
bind 5caC whereby it regulates the expression of lysosomal proteins in postmitotic neurons
(Jin et al., 2016). However, Tet1 CxxC domain was found to mostly bind non-modified DNA
(Frauer et al., 2011a), which was implicated in the prevention of DNA methylation spreading
into unmethylated, euchromatic regions (Jin et al., 2014). Besides this, the Tet1 CxxC
was furthermore implicated in transcriptional fine tuning by facilitating Tet1 association
with transcriptional start sites within CpG rich promoters and genic sequences. In line
with these findings that assign Tet1 a role in transcriptional regulation, it was also found
to interact with the Sin3a co-repressor complex and the polycomb repressive complex 2
(PRC2) in embryonic stem cells (Williams et al., 2011; Neri et al., 2013).
While three different isoforms of Tet2 and also Tet3 have been characterized to date
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(Langemeijer et al., 2009; Jin et al., 2016), a N-terminally truncated Tet1 isoform, which
also lacks the CxxC domain, was described just recently and attributed a role in mouse
development, but also in cancerogenesis (Zhang et al., 2016b; Good et al., 2017).
Despite their high similarities in catalytic activity, major differences between the three
Tet protein family members are observed in their respective expression levels throughout
different tissues and developmental stages and hence their physiological roles. While Tet3
is predominantly expressed during early embryogenesis but also in post-mitotic neurons,
Tet1 and Tet2 are found to be more ubiquitously expressed across different tissues from
embryonic stem cells to somatic cells (Santiago et al., 2014).
Although Tet proteins were found to be degraded in an ubiquitination-independent pathway
via calpain proteases (Wang and Zhang, 2014), it was recently discovered that the cellular
presence of viral protein R (Vpr) after HIV infection modulates the ubiquitination pattern
of a conserved lysine residue within the CRD of Tet2. While the monoubiquitination of
said lysine positively stimulates the chromatin association of Tet2 and also the activity of
Tet1 and Tet3 (Nakagawa et al., 2015), Vpr presence results in a polyubiquitination of said
lysine and consequently proteasomal degradation (Lv et al., 2018). This leads to increased
HIV-1 replication through de-repression of interleukin 6 that is targetd by HDAC1/2 via Tet2
recruitment in non-infected cells.
Additionally, the activity of Tet proteins is not restricted to DNA. While already the first
study to describe 5hmC in mammalian DNA hinted to its occurrence in RNA from crude
rat tissue preparations (Penn et al., 1972), further evidence for this was found recently.
Accordingly, mammalian Tet proteins were shown to act not only on DNA but also to oxidise
5mC in RNA and it was demonstrated that ectopic overexpression of either of the three
Tet proteins leads to a 5hmC increase in RNA (Fu et al., 2014). It was furthermore found
that ascorbic acid, which is known to enhance Tet activity, can increase the levels of 5hmC
and also 5fC not only in DNA but also in RNA (Zhang et al., 2016a). In line with these
findings, recent studies identified a Tet homologue in Drosophila melanogaster, called dTet,
whose knockout resulted in impaired brain development and late pupal lethality (Delatte
et al., 2016; Wang et al., 2018). Despite the almost complete absence of 5mC or 5hmC in
Drosophila DNA (Capuano et al., 2014), a 5hmC enrichment in polyadenylated mRNA and
accompanied positive effect on translation was demonstrated (Delatte et al., 2016).
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2.5 Cytosine modifications in development and diseases
The loss of de novo DNA methyltransferases Dnmt3A and Dnmt3B or the maintenance
methyltransferase Dnmt1 and the accompanying embryonic and early postnatal lethality in
mice highlights the importance of cytosine methylation for normal development in mammals
(Li, Bestor, and Jaenisch, 1992; Okano et al., 1999; Ueda, 2006). However, not only DNA
methylation but also its removal in the right context is crucial during mammalian devel-
opment. Before the discovery of the Tet proteins and their catalytic activity, loss of DNA
methylation was considered a purely passive process, resulting from prevention of DNA
methylation maintenance by Dnmt1. Consistently, decreasing Dnmt1 levels or disruption
of its interaction with PCNA and Uhrf1 were shown to result in hypomethylation and even
death of corresponding mouse models (Gaudet et al., 2003; Hervouet et al., 2010). Loss
of methylation in the maternal pronucleus was initially attributed to replication depended
dilution effects, since Dnmt1 is retained in the cytoplasm during early embryogenesis
(Cardoso and Leonhardt, 1999). Meanwhile it could be shown that retention of Dnmt1 and
accompanied replication dependent dilution effects, but also Tet3 mediated 5mC oxidation
concomitantly contribute to the loss of DNA methylation in the maternal, but also the
paternal pronucleus (Shen et al., 2014).
After the removal of 5mC during fertilization, DNA methylation marks have to be set
again by Dnmt3A and Dnmt3B to ensure faithful embryonic development. While Dnmt3A
was shown to play an important role in setting parental imprints (Okano et al., 1999),
Dnmt3B was linked to the correct methylation pattern of pericentric DNA regions and
hence chromosome structure (Kaneda et al., 2004). Accordingly, mutations of Dnmt3B,
whose loss results in embryonic death, were linked to the ICF (Immunodeficiency, Cen-
tromere instability, Facial abnormalities) syndrome. This disease is, on a molecular level,
characterized by hypomethylation of the normally highly methylated pericentric repeats in
human chromosomes 1, 9 and 16 (Xu et al., 1999).
Similar to the lethality observed in embryos lacking Dnmt3B, failure to maintain the DNA
methylome by Dnmt1 also results in non-viable embryos (Li, Bestor, and Jaenisch, 1992).
Mutations in the TS domain of Dnmt1, repeatedly found in the autosomal neurodegenera-
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tive disease HSN1E (hereditary sensory and autonomic neuropathy with dementia and
hearing loss type 1E) abrogate the interaction with its facilitating factor Uhrf1 and thereby
DNA methylation maintenance (Smets et al., 2017). Furthermore, mutations or aberrant
expression patterns of Uhrf1 are often associated with cancer phenotypes and a constant
overexpression of Uhrf1 is described in many malignant neoplasms. Even though, Uhrf1
plays an important role in DNA methylation maintenance and the accompanied silencing
of repetitive and retrotransposable elements (Bostick et al., 2007), a recurring loss of DNA
methylation in LINE1 is observed in cancer cells that overexpress Uhrf1 (Nakamura et al.,
2016; Hong et al., 2018). The overexpression of Uhrf1 and also its homolog Uhrf2 in
cancer cells and the accompanied decrease of DNA methylation levels was attributed to
the E3-ligase targeting and subsequent proteasomal degradation of Dnmt3A (Jia et al.,
2016). Similar to cancer cells, a loss of DNA methylation and accompanied reactivation
of retroviral elements is observed in neural stem cells upon loss of Uhrf1 which results in
impaired neonatal neurodegeneration (Ramesh et al., 2016).
Despite their different roles during earliest embryonic development and gametogenesis,
where mostly Tet3 plays a role, all three Tet family members are expressed throughout
neurogenesis and in the adult brain, where the highest 5hmC levels are detected in com-
parison to other tissues. 5hmC is in general the most abundant 5mC oxidation product
with an abundance of around 0.5% of all cytosines in cells of the central nervous system
and around 0.05% of all cytosines in different internal organs (Globisch et al., 2010). 5fC
and 5caC, on the other hand, are found with up to 100-fold lower levels than 5hmC and
often fall below the detection limit (Bachman et al., 2015).
Tet3 is highly expressed in preimplantation embryos but rapidly downregulated with pro-
gressing embryonic development (Gu et al., 2011). In contrast to Tet1 and Tet2, whose
individual or combined loss has no direct effects on embryonic development and manifests
only during advanced postnatal development, loss of Tet3 is lethal in neonatal mice (Gu
et al., 2011; Dawlaty et al., 2011). Despite the dispensable biological role for Tet1 and Tet2
in early embryonic development, their loss can have severe effects in postnatal organisms.
Hematopoietic stem cells, for instance, were found to frequently give rise to myeloid and
lymphoid abnormalities upon loss of Tet1 but mostly Tet2 (Ko et al., 2011; Li et al., 2011).
Tet1, on the other hand, was also assigned an important role in the maintenance of neural
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progenitor cells (Zhang et al., 2013) and its loss was found to impair the expression of
activity-regulated genes and synaptic plasticity (Rudenko et al., 2013).
Table 1: Phenotypes of cytosine modifier knockout mice
Phenotypes of cytosine modifier knockout mice
Dnmt3A null mice Postnatal growth retardation and dysplasia (Okano et al., 1999)
neonatal mortality
Dnmt3B null mice Not viable (Okano et al., 1999; Ueda, 2006)
Dnmt3C null mice Hypogonadism and aberrant retrotransposon expression (Barau et al., 2016)
Dnmt3L null mice Early embryonic lethality in females (Hata et al., 2002)
and sterile males
Dnmt1 null mice Not viable (Li, Bestor, and Jaenisch, 1992)
Tet1 null mice Mostly normal embryonic and postnatal development (Dawlaty et al., 2014)
abnormal long-term depression (Rudenko et al., 2013)
Tet2 null mice Increased development of myeloid malignancies (Ko et al., 2011; Li et al., 2011)
and early life mortality
Tet3 null mice Normal embryonic development (Gu et al., 2011; Tsukada, Akiyama, and Nakayama, 2015)
but neonatal mortality
Uhrf1 null mice Embryonic growth retardation and ultimately lethality (Sharif et al., 2007)
Global genomic hypomethylation (Bostick et al., 2007)
Development to expanded blastocyst stage (Maenohara et al., 2017)
severely impaired upon maternal KO
Uhrf2 null mice Viable but increased risk of spontaneous seizures (Liu et al., 2017)
2.6 DNA replication and epigenome maintenance
As just discussed, epigenetic DNA modifications can severely impact mammalian embry-
onic and also postnatal development, which makes the faithful propagation of epigenetic
modifications during mitotic cell division a crucial step in the cell cycle. To ensure the
correct inheritance of epigenetic modifications to a daughter cell, epigenome replication is
tightly coupled to the replication of DNA itself.
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Genome duplication in eukaryotic and especially mammalian cells before mitotic cell di-
vision is a temporally and spatially tightly orchestrated process. The foundation for DNA
replication during S-phase is laid already during late mitosis and in G1 phase, when the
MCM2-7 helicase complex is loaded onto DNA at origins of replication. These origins
are distributed throughout the whole nucleus, which ensures replication of the entire
genome. Upon being licensed and starting replication, an origin becomes inactive to avoid
re-replication of DNA (Blow and Dutta, 2005). The transition from MCM2-7 chromatin
loading to origin licensing and eventually firing as well as the prevention of re-licensing
in S-phase is tightly regulated by cyclin-dependent kinases (CDK) (Satyanarayana and
Kaldis, 2009). Upon initiation of DNA replication from an origin, replication forks move away
bidirectionally from the origin. A plethora of proteins concomitantly ensures the progression
of the replication fork and faithful DNA duplication. Amongst them are helicases, different
DNA polymerases, DNA single strand binding proteins and the processivity factor PCNA
(Proliferating cell nuclear antigen) that serves as a loading platform for proteins associated
with DNA replication, but also epigenetic inheritance (Chagin, Stear, and Cardoso, 2010;
Moldovan, Pfander, and Jentsch, 2007).
In somatic cells, S-phase progression follows the gene-density and GC-content of the
underlying DNA (Costantini and Bernardi, 2008). In early S-phase, gene-rich and transcrip-
tionally active euchromatin is replicated, while in mid S-phase, replication of facultative
heterochromatin takes place. Facultative heterochromatin comprises silenced genic re-
gions and can be highly variable between different cells. Constitutive heterochromatin
is highly methylated and replicated in late S-phase in somatic cells. It comprises many
repetitive sequences like tandem satellite repeats and furthermore fulfils structural tasks
(Saksouk, Simboeck, and Déjardin, 2015). Large heterochromatic clusters, so-called
chromocenters, are observed in DNA-stainings of murine cells, which are characterized by
large focal patterns during DNA replication (Figure 6).
However, not only the DNA but also associated proteins and chromatin modifications
have to be duplicated. The most prominent DNA-associated proteins are the core histones,
which make up the nucleosome, hence the fundamental structure of chromatin organiza-
tion. It is by now well established that the replicated nascent DNA strands receive newly
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Figure 6: Progression of DNA replication in somatic cells. Shown are maximum Z-projections of a
C2C12 mouse myoblasts that was transiently transfected with mRFP-PCNA and subjected to live-cell
time lapse microscopy. In early S-phase, euchromatic DNA is replicated, which is characterized by a
homogeneous distribution of PCNA foci. Facultative heterochromatin is replicated in mid S-phase, which
shows PCNA patterns in the nuclear and nucleolar periphery. Furthermore, in female cells, like the shown
tetraploid mouse myoblasts, the two inactive X-chromsomes are replicated in mid S-phase and are visible as
large, synchronously replicating structures. During late S-phase, constitutive heterochromatin which forms
large clusters in murine cells, so-called chromocenters, is replicated. Scale bar = 5 µm.
synthesized and recycled parental histones in equal amounts (Campos, Stafford, and
Reinberg, 2014) ensuring the correct inheritance of post-translational histone modifications.
For this purpose, histones H3 and H4, which contain a majority of the regulatory PTMs
(Rando, 2007), from the parental DNA strand are divided symmetrically by the replicative
helicase MCM2 with a minor bias for the leading strand over the lagging strand (Petryk
et al., 2018).
Besides histones and DNA itself, also DNA base modifications have to be duplicated, as
all known mammalian DNA modifications are added post-synthetically.
2.6.1 Maintaining the DNA methylome
Considerable efforts were undertaken to unravel the cell cycle dependent inheritance of
the repressive DNA modification 5mC. The most important players in maintaining 5mC are
the just introduced maintenance DNA methyltransferase Dnmt1 and its facilitating factor
Uhrf1. Although, Dnmt1 harbours an N-terminal PCNA binding domain, association with
the replication machinery via PCNA, was shown to be dispensable for DNA methylation
maintenance (Spada et al., 2007). Due to an autoinhibitory conformation, Dnmt1 needs a
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Figure 7: Molecular mechanism of DNA methylation maintenance. (A) Schematic, simplified overview of
a DNA replication fork and a detailed view of newly synthesized piece of DNA, harbouring a hemimethylated
CpG adjacent to a nucleosome. (B) Dnmt1 access to the unmethylated cytosine is prevented by its
autoinhibitory conformation. Uhrf1 recognizes and binds the opposing methylated cytosine via its SRA
domain. (C) Binding to methylated cytosine in a hemimethylated CpG-context triggers a conformational
change of Uhrf1, which in turn binds H3K9me3. (D) Interaction with the histone H3 tail activates the
E3 ubiquitin-ligase function of Uhrf1 and it deposits monoubiquitination marks on lysines 18 and 23 in
histone H3, via the interplay of its UBL and RING domain. (E) Histone H3K18/K23 monoubiquitination and




regulatory cofactor to stimulate its enzymatic activity, which is facilitated by Uhrf1 (Bashtrykov
et al., 2013).
Uhrf1 is initially recruited to chromatin by recognizing hemimethylated DNA via its SRA
domain. This binding triggers a conformational change, enabling it to bind H3K9me3 in the
vicinity of hemimethylated DNA through its tandem tudor domain (Liu et al., 2013b; Fang
et al., 2016). The thereby mediated binding to the histone H3 tail activates the E3-ligase
activity of Uhrf1 and results in monoubiquitination of lysines 18 and 23 in the histone H3 tail
(Qin et al., 2015; Harrison et al., 2016; Foster et al., 2018). These monoubiquitinations are
in turn bound by the TS domain of Dnmt1 and crucial for its maintenance methytransferase
activity (Qin et al., 2015). The protein-protein interaction of chromatin bound Uhrf1 and
Dnmt1, via the Uhrf1 SRA- and UBL-domains, results in a conformational change in Dnmt1
and its recruitment. The TS domain of Dnmt1 allosterically blocks the catalytic center,
rendering Dnmt1 inactive. This blocking is reversed by Uhrf1 binding to Dnmt1, which
promotes its maintenance methyltransferase activity (Bashtrykov et al., 2013; Li et al.,
2018) (Figure 7).
Although, it has been found that Uhrf1-recruitment for replication coupled methylation main-
tenance depends also on its binding to a trimethylated H3K9me3-mimicking peptide within
ligase1, complete loss of ligase1 did not affect DNA methylation maintenance, suggesting
a backup mechanism for this interaction (Ferry et al., 2017).
As briefly outlined here, extensive efforts have been undertaken to elucidate the exact
mechanism, how 5mC is inherited during mitotic cell division and the picture of this crucial
biological mechanism becomes ever more complex. In contrast to this, the maintenance
of the oxidative derivatives of 5mC remains elusive, although it was shown that 5hmC
and 5fC are largely stable throughout the cell cycle and follow similar kinetics as 5mC
(Bachman et al., 2014; Bachman et al., 2015).
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3 Aim of the study
Although the proteins of the Tet dioxygenase family have been the subject of extensive
research over the past years, the mechanisms by which they are recruited in the course of
5mC oxidation is still poorly understood. Furthermore, it remains elusive how Tet proteins
maintain the 5mC oxidation products that were shown to be more than mere intermediates
in the active removal of DNA methylation and to furthermore follow the cell cycle dynamics
of 5mC.
With regard to these findings, I addressed the question of a potential role for the Tet
proteins in DNA replication-coupled 5mC oxidation product maintenance and therefore
addressed the following points:
i) The localization of the different Tet proteins during ongoing DNA replication
ii) Potential interactions with proteins that are implicated in (epi)genome replication
iii) Potential physiological consequences of a Tet recruitment in DNA replication
Figure 8: Aim of the study. The mechanism how DNA methylation is maintained throughout the cell cycle
in proliferating cells is well established. The maintenance DNA methyltransferase Dnmt1 is recruited to sites
of-going DNA replication predominantly by interactions with the multidomain protein Uhrf1 but also, with
the clamp loader protein PCNA. Dnmt1 interaction with these two proteins ensures faithful inheritance of
the DNA methylome in proliferating cells (Section 2.6). The members of the Tet dioxygenase family on the
other hand, are known to oxidise 5mC to 5hmC, 5fC and 5caC in an iterative manner. The exact mechanism,
how Tet proteins are recruited for catalytic activity or how the levels of these predominantly stable DNA
modifications are maintained remains, however, elusive. The aim of this study was therefore, to characterize
the cell cycle localization of Tet proteins, interactions with other proteins that are involved in (epi)genome
maintenance and physiological consequences of a putative cell cycle dependent Tet recruitment.
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4 Material and Methods
4.1 Expression plasmids
All mammalian expression vectors were obtained by using standard restriction enzyme-
and PCR-based molecular cloning techniques, if not stated otherwise. All oligonucleotides
that were used in the cloning procedures are given in table 1.
Plasmids encoding human EGFP- and mRFP-tagged PCNA have been described in previ-
ous publications (Leonhardt et al., 2000; Sporbert et al., 2005). To create miRFP-PCNA,
the sequence of miRFP670 was amplified from pmiRFP670-N1 (Addgene plasmid # 79987)
(Shcherbakova et al., 2016)and used to replace the mRFP sequence in pENmRFPCNAL2
(Sporbert et al., 2005) using BsrGI and AgeI restriction endonucleases sites.
EGFP- or mcherry-tagged catalytically active and inactive mouse Tet1CD constructs as
well as mcherry-tagged catalytic domains of Tet2 and Tet3 and the three full-length proteins
have been described before (Frauer et al., 2011a; Liu et al., 2013a; Müller et al., 2014;
Ludwig et al., 2017; Zhang et al., 2017c).
The EGFP-tagged short isoform of Tet1 was generated by amplifying the respective cod-
ing sequence from EGFP-Tet1 (Frauer et al., 2011a) and replacing the full-length Tet1
sequence with the Tet1s sequence by restriction with AsiSI and NotI. Mcherry-tagged
Tet1s was generated by replacing the coding-sequence of Uhrf1 from mcherry-Uhrf1 (Qin,
Leonhardt, and Spada, 2011)with the Tet1s sequence by AsiSI and NotI restriction.
EGFP-tagged Tet1-CRD and Tet1-DSBH were generated by amplifying the respective
domains from full-length Tet1 and replacing the EGFP-Tet1 (Frauer et al., 2011a) sequence
by AsiSI and NotI restriction.
EGFP-Tet1∆1-389 and EGFP-Tet1∆566-833 were obtained by overlap-extension PCR
and the thereby generated products were used to replace the Tdg-coding sequence in
EGFP-TDG (Müller et al., 2014) with AsiSI and NotI restriction.
To obtain a EGFP-tagged peptide encoding the putative Tet1-PBD, oligo-cloning was per-
formed and MCMT-PBD in an EGFP-N2 backbone (Mortusewicz et al., 2005)was replaced
by restriction with XmaI and EcoRI.
The CRD of EGFP-Tet1s or EGFP-Tet1 was deleted by overlap-extension PCR(Ho et al.,
1989) and the obtained amplicon was used to replace the Tet1 coding sequence in EGFP-
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Tet1 (Frauer et al., 2011a).
Lysine 852 in Tet1s was mutated to either arginine or glutamate using a slightly modified
protocol of a previously described sequence and ligation independent cloning(SLIC) ap-
proach (Jeong et al., 2012). In brief, two overlapping DNA fragments that contained the
desired mutations in their respective complementary 5’ and 3’ regions were generated
by PCR, using the Tet1s coding sequence as template. The Tet1 coding sequence was
excised from EGFP-Tet1 (Frauer et al., 2011a) with AsiSI and NotI and the remainder used
as backbone. 100 ng of the backbone were mixed with the two amplicons in a ratio of 1:2:2
and a T4 polymerase reaction with 0.6 units of T4 polymerase was set up in a volume of 10
µL. The reaction was incubated at room temperature for 2.5 minutes and further incubated
on ice for 10 minutes before being transformed into chemically competent Top10 cells.
EGFP-tagged Tet1CD harbouring the just described K to R or K to E mutations within the
CRD was generated by PCR amplifying the respective Tet1CD coding sequence from the
corresponding Tet1s vectors. The amplicons were than used to replace the Tet1 coding
sequence from EGFP-Tet1 (Frauer et al., 2011a).
Full-length mouse Uhrf1 fused to EGFP or mcherry and mouse EGFP-Uhrf2 constructs
have been described before (Qin, Leonhardt, and Spada, 2011; Pichler et al., 2011). Single
domain deletion constructs or single domains of Uhrf1 fused to EGFP were described in
previous studies (Rottach et al., 2010; Pichler et al., 2011; Qin et al., 2015).
Mcherry-tagged VprBP was cloned from murine ESC cDNA by overlap extension PCR (Ho
et al., 1989) and the obtained PCR fragment used to replace the Uhrf1 sequence from
mcherry-Uhrf1 (Qin, Leonhardt, and Spada, 2011) with AsiSI and NotI restriction.
A major satellite repeat recognizing polydactyl zinc-finger fused to EGFP or a EGFP-
recognizing nanobody was described in previous publications (Lindhout et al., 2007;
Casas-Delucchi et al., 2012b).
30
4 MATERIAL AND METHODS
4.1.1 List of oligonucleotides
Table 2: List of oligonucleotides used for plasmid generation
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4.2 Cell culture and transfection
All mammalian cells were cultured in a humidified atmosphere under 5% CO2 at 37
◦C. Cells were split every two to three days in the case of somatic cells and embry-
onic stem cells were split every two days with daily medium changes. All media were
supplemented with 1x Penicillin-Streptomycin (Sigma-Aldrich Chemie GmbH, Steinheim,
Germany, Cat.No.: P4333) and 1x L-glutamine (Sigma-Aldrich Chemie GmbH, Steinheim,
Germany, Cat.No.: G7513).
4.2.1 Cell lines
C2C12 mouse myoblasts (Blau et al., 1985)were cultured as described previously (Ludwig
et al., 2017) in DMEM (Sigma-Aldrich Chemie GmbH, Steinheim, Germany; Cat.No.:
D6429) containing 20% FCS.
Mouse embryonic fibroblasts (MEF) deficient for Dnmt1 and p53 (MEF-PM, Dnmt1-/-,
p53-/-), deficient for p53 (MEF-P, p53-/-), deficient for SUV39 (MEF-D15, SUV39H1-/-,
SUV39H2-/-) and corresponding wildtype cells were cultured under previously described
conditions in DMEM containing 15% or 10% FCS, respectively (Lande-Diner et al., 2007;
Peters et al., 2001).
MCF10a non-tumorigenic mammary gland cells were cultured in DMEM/F12 (Sigma-
Aldrich Chemie GmbH, Steinheim, Germany; Cat.No.: D8900) supplemented with final
concentrations of 5% horse serum (Sigma-Aldrich Chemie GmbH, Steinheim, Germany;
Cat.No.: H0146), 20 ng/mL EGF (Sigma-Aldrich Chemie GmbH, Steinheim, Germany;
Cat.No.: E9644), 0.5 mg/mL hydrocortisone (Sigma-Aldrich Chemie GmbH, Steinheim,
Germany; Cat.No.: H0888), 100 ng/mL cholera toxin (Sigma-Aldrich Chemie GmbH, Stein-
heim, Germany; Cat.No.: C8052) and 10 µg/mL insulin (Sigma-Aldrich Chemie GmbH,
Steinheim, Germany; Cat.No.: I2643) and MCF7 breast cancer cells were cultured in
DMEM (Sigma-Aldrich Chemie GmbH, Steinheim, Germany; Cat.No.: D6429) containing
10% FCS.
Mouse embryonic stem cells E14 and stem cells deficient for Uhrf1 (Uhrf1-/-) (Sharif et al.,
2007) and ligase1 (Lig1-/-) (Ferry et al., 2017) were cultured under feeder-free, 2i/LIF
conditionsin culture dishes that were coated with gelatin (0.2%; Sigma-Aldrich Chemie
GmbH, Steinheim, Germany, Cat.No.: G2500). DMEM (Sigma-Aldrich Chemie GmbH,
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Steinheim, Germany; Cat.No.: D6429) for embryonic stem cell culture contained 16% FCS
and was, in addition to L-glutamine and Pen/Strep, supplemented with 1x non-essential
amino acids (Sigma-Aldrich Chemie GmbH, Steinheim, Germany; Cat.No.: M7145), 0.1
mM β-mercaptoethanol (Carl Roth, Karlsruhe, Germany, Cat.No.: 4227), 0.1 µM PD
0325901 (Axon Medchem BV, Groningen, The Netherlands, Cat.No.: Axon 1408), 0.3
µM CHiR 99021 (Axon Medchem BV, Groningen, The Netherlands, Cat.No.: Axon 1386),
1,000 U/ml LIF (Enzo Life Sciences GmbH, Lörrach, Germany, Cat.No.: ALX-201-242).
HEK-293 cells (Invitrogen; catalog # 620-07, Paisley PA49RF, UK) were cultured in DMEM
(Sigma-Aldrich Chemie GmbH, Steinheim, Germany; Cat.No.: D6429) containing 10%
FCS.
4.2.2 Transfection
C2C12, MEF, MCF7 and MCF10a cells were transfected by electroporation with the AMAXA
Nucleofector II system (Lonza, Cologne, Germany), using a self-made buffer (5 mM KCl, 15
mM MgCl2, 120 mM Na2HPO4/NaH2PO4 pH 7.2, 50 mM Mannitol) with default programs
B032, A024, P020 or T024, respectively.
Mouse embryonic stem cells were transfected with the Neon nucleofection system (Thermo
Fisher Scientific, Waltham, MA, USA; Cat.No.: MPK5000), according to the manufacturer’s
protocol.
HEK-293 cells were transfected with polyethylenimine (PEI) pH 7.0 (Sigma-Aldrich Chemie
GmbH, Steinheim, Germany; Cat.No.: 408727) as previously described (Agarwal et al.,
2007).
4.3 Immunofluorescence staining of cells
For immunofluorescent staining of modified nucleotides, Tet1 or replication associated
proteins, all cells were seeded on gelatine-coated glass coverslips and fixed in 3.7%
formaldehyde (Sigma-Aldrich Chemie GmbH, Steinheim, Germany, Cat.No.: F8775) in 1x
PBS for 10 minutes. After three washing steps with PBS-T (1x PBS, 0.01% Tween-20),
cells were permeabilized with 0.5% Triton X-100 in 1x PBS for 20 minutes, incubated in
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ice-cold 88% methanol for 5 minutes and washed again.
In the case of immunostainings of modified nucleotides, cells were incubated with 10 µg
/mL RNaseA in 1x PBS for 30 minutes at 37 ◦C. After three more washing steps, cells were
blocked with 1% BSA in 1x PBS at 37 ◦C for 30 minutes. The primary antibody solution
contained final concentration of 0.5% BSA, 1x DNaseI reaction buffer (60 mM Tris/HCl
pH 8.1, 0.66 mM MgCl2, 1 mM β-mercapthoethanol) and 0.1 U/µL DNaseI (Sigma-Aldrich
Chemie GmbH, Steinheim, Germany, Cat.No.: D5025). Antibodies against 5hmC (Active
Motif, La Hulpe, Belgium, Cat.No.: 39769) and 5mC (mouse monoclonal clone 32E2,
Manuscript in preparation: Weichmann F. et al., "Generation and validation of monoclonal
antibodies specific to modified nucleotides"), were each used in a dilution of 1:200. The
primary antibody mix was incubated at 37 ◦C for 70 minutes and afterwards washed three
times with PBS-TE (PBS-T + 100 mM EDTA).
Cells that were immunostained against Tet1, PCNA and ligase1 were blocked in 1% BSA
for 30 minutes after fixation and incubated with primary antibodies diluted in 1% BSA for 60
minutes at room temperature. As antibodies, α-Tet1 clone 5D8 (Bauer et al., 2015), αPCNA
clone PC10 (Agilent Technologies, Inc. / DAKO, Santa Clara, USA, Cat.No.: M0879) and
αLigaseI (rabbit, polyclonal against N-terminal amino acids 1-23, Ab-S977) were used in
dilutions of 1:2, 1:100 and 1:250, respectively. After incubation with the primary antibodies,
cells were washed three times with PBS-T.
For the detection of the primary antibodies, cells were incubated with following secondary
antibodies diluted in 1% BSA, Alexa Fluor 488-conjugated goat α-rabbit IgG (H+L) (1:500;
ThermoFisher Scientific, Invitrogen, Carlsbad CA, USA, Cat.No.: A-11008), Alexa Fluor
488-conjugated goat α-mouse IgG(H+L) (1:250; ThermoFisher Scientific, Invitrogen, Carls-
bad CA, USA, Cat.No.: A-11001), Alexa Fluor 594-conjugated goat α-rabbit IgG (H+L)
(1:250; ThermoFisher Scientific, Invitrogen, Carlsbad CA, USA, Cat.No.: R37117), Cy5-
conjugated donkey α-mouse IgG(H+L) (1:250; The Jackson Laboratory, Bar Harbor, ME,
USA, Cat.No.: 715-715-150).
After an incubation of 45 minutes at room temperature, cells were washed three times with
PBS-T, counterstained with 10 µg/ml DAPI (4’,6- diamidin-2-phenylindol, Sigma-Aldrich
Chemie GmbH, Steinheim, Germany, Cat.No.: D9542) and mounted in Mowiol (Sigma-
Aldrich Chemie GmbH, Steinheim, Germany, Cat.No.: 81381).
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4.4 Microscopy and image analysis
4.4.1 Live cell time-lapse microscopy
Live cell time-lapse experiments were performed with a Nikon Ti-E microscope equipped
with a UltraVIEW VoX spinning disk confocal unit (PerkinElmer, UK), controlled by Volocity
6.3 (PerkinElmer, UK), and a live cell chamber (ACU control, Olympus), at 37 ◦C, with 5%
CO2 and 60% air humidity. Z-stacks were acquired with a 60x/1.49 NA CFI Apochromat
TIRF oil immersion objective (voxel size: 0.12 x 0.12 x 0.5-1 µm; Nikon, Tokyo, Japan) or a
100x/1.49 NA CFI Apochromat TIRF oil immersion objective (voxel size, 0.071 x 0.071 x
0.5-1 µm; Nikon, Tokyo, Japan) and a cooled 14-bit CCD camera (Hamamatsu Photonics
K.K., Hamamatsu City, Japan, Cat.No.: C9100-50). Z-stack images were analysed Using
Volocity 6.3 (PerkinElmer, UK) and [ImageJ].
4.4.2 Protein accumulation analysis
Heterochromatin accumulation ability of ectopically overexpressed fluorescently-tagged
proteins, during ongoing DNA replication, was assesed by transfecting cells with the
respective plasmids. 8-12 hours post transfection, confocal Z-stacks (voxel size, 0.12 x
0.12 x 0.5 µm) were acquired using the aforementioned Nikon-Ti-E setup. Z-stacks were
analysed using ImageJ. For this purpose, three circular regions with a radius of 4 pixels, in
the nucleoplasm and in chromocenters, marked by PCNA, were measured in maximum
intensity Z-projections images. The ratio of the averaged mean signal intensities of the
protein of interest in PCNA marked replication sites and in the nucleoplasm was plotted
using RStudio (Version 1.1.447).
4.4.3 High content screening microscopy
Endogenous 5mC and 5hmC levels and levels of ectopically expressed EGFP-tagged
proteins were measured with the Operetta high-content screening system (Perkin Elmer,
UK) in wide-field mode, equipped with a Xenon fibre-optic light source and a 20x/0.45 NA
long working distance or a 40x/0.95 NA objective. For excitation and emission, following
filtercombinations were used, 360-400 nm and 410-480 nm for DAPI or AMCA, 460-490
nm and 500-550 nm for EGFP as well as 560-580 nm and 590-640 nm for TexasRed.
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Fluorescence intensity levels were quantified with the Harmony software (Version 3.5.1,
PerkinElmer, UK) (Figure 9).
For the analysis of cells that were transfected with EGFP or EGFP fusion encoding plasmids
and stained against 5hmC and counterstained with DAPI, cell nuclei were first identified
according to their EGFP fluorescence and evaluated for morphological properties like
roundness and size. These parameters as well as the mean and sum nuclear fluorescence
intensities of DAPI, EGFP and Alexa 594-labelled 5hmC were calculated in cells that fit
these morphological criteria. Measurement results were further processed with RStudio
(Version 1.1.447). For further analysis, sum nuclear 5hmC levels were divided by the sum
nuclear DAPI intensity, to compensate for potential cell cycle dependent 5hmC fluctuations.
The normalized 5hmC values were grouped according to the mean EGFP intensities of the
respective cells and cells with mean EGFP levels below 50 were considered as background.
The before normalized 5hmC levels of the background-expressing cells were averaged
and the 5hmC values of cells above background level, divided by this average. Cells
above EGFP background expression levels were then grouped according to their mean
EGFP fluorescence levels in low (50-100 AU), mid (100-500 AU), and high (500-1000 AU)
expressing groups and plotted with RStudio (Version 1.1.447).
The nuclei of MCF10a and MCF7 cells that were simultaneously stained for 5mC and
5hmC and counterstained with DAPI, were identified by their DAPI-staining and further
grouped according to morphological criteria. The mean and sum nuclear fluorescence
intensities of DAPI, Alexa-488 labelled 5mC and Alexa-594 labelled 5hmC were calculated
in cells that matched this criteria. Exported measurement results were further analysed
and plotted with RStudio (Version 1.1.447). For this purpose, the sum nuclear Alexa-488
and Alexa-594 levels of cells that were only stained with the secondary antibodies, were
averaged to obtain a background fluorescence value. The sum nuclear fluorescence
values of 5mC and 5hmC in cells that were incubated with primary and secondary antibody
were each normalized to the respective average background fluorescence and further
normalized to the DAPI fluorescence intensity and the normalized values plotted.
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Figure 9: Workflow of the Harmony-based nuclear 5hmC quantification. To quantify sum nuclear 5hmC
levels in C2C12 mouse myoblasts that ectopically overexpressed different fluorescently tagged Tet variants,
cells were imaged in wide-field mode and analysed with the Harmony software. Cell nuclei in the input image
were segmented according to their EGFP fluorescence and further categorized according to morphological
properties. Sum and mean nuclear fluorescence intensities were calculated in all three channels and further
processed with RStudio (Version 1.1.447). Sum nuclear 5hmC levels were normalized to sum nuclear DAPI
levels. The normalized 5hmC levels of cells wih a mean nuclear EGFP intensity below 50 were averaged
and considered as background values. Cells that were normalized to the background 5hmC intensity were
grouped according to their mean nuclear EGFP fluorescence intensity into low (50-100 AU), mid (100-500
AU) and high (500-1000 AU) and plotted.
4.4.4 In situ DNA modification quantification
To quantify 5hmC levels in chromocenters and the nucleoplasm, C2C12 cells were trans-
fected with EGFP-tagged Tet1-variants or EGFP alone and immunostained against 5hmC
and counterstained with DAPI. Confocal Z-stacks with a Z-step length of 0.5 µm were
acquired with the before described Nikon Ti-E spinningdisk setup. Images were anal-
ysed with a self-written semiautomated macro routine for ImageJ (Figure 19A). In brief,
maximum Z-projections were generated and binary nuclear masks were created of the
respective 16-bit images, based on the DAPI signal. For this, images were thresholded
with the triangle method and grey values above 3000 were considered for the mask. A
second binary mask for the chromocenters was created with the triangle threshold method
for all pixels with intensities above 7000. Based on these two masks a third mask for the
nucleoplasm was calculated and the respective mean 5hmC levels were measured and
plotted with RStudio (Version 1.1.447).
To address the endogenous levels of 5mC and 5hmC in heterochromatic domains of
MCF10a or MCF7 cells, cells were immunostained against 5mC and 5hmC and counter-
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stained with DAPI. Cells were imaged with the before described confocal spinningdisk
setup and analysed with ImageJ. For this, maximum Z-projections were generated and
circular ROIs with a radius of 5 pixel were created around DAPI-dense regions and the
respective mean fluorescence intensities measured. Mean fluorescence intensities were
normalised to the DAPI intensity and plotted with RStudio (Version 1.1.447).
4.5 Statistical analysis
Statistical significance was tested with a paired two-samples Wilcoxon test with RStudio
(Version 1.1.447). P-values below 0.005 were assumed to be statistically significant. All
p-values are given in the figure legends or respective plots directly. Boxplots represent the
median with the box depicting the 25–75 percentile and the lines and circles denote the
95% confidence interval and outliers, respectively.
4.6 Western blotting and co-immunoprecipitation
Cell pellets for western blotting and co-immunoprecipitation were obtained by harvesting
cells by centrifugation for 5 minutes at 500 xg and 4 ◦C. For general western blotting, cell
lysates were prepared by resuspending the cell pellet in lysis buffer and (20 mM Tris-HCl
pH 8, 150 mM NaCl, 0.5 mM EDTA, 0.5 % NP-40) supplemented with Pepstatin A (1 µM
final concentration; Sigma-Aldrich Chemie GmbH, Steinheim, Germany, Cat.No.: P5318),
PMSF (10 µM final concentration, Sigma-Aldrich Chemie GmbH, Steinheim, Germany,
Cat.No.: 78830), AEBSF (1 mM final concentration, AppliChem, Darmstadt, Germany,
Cat.No.: A1421,0100). Cells were disrupted by syringe treatment with 21 G needles and
incubated on ice for 30 minutes with repeated vortexing in-between. Cell lysates were
cleared by centrifugation for 15 minutes at 13000 xg and 4 ◦C and the supernatant resolved
by SDS-PAGE and subjected to western blotting analysis.
Co-immunoprecipitation experiments were essentially performed as described before
(Becker et al., 2016). In brief, HEK-293 cells were PEI-transfected with EGFP and mRFP-
or mcherry-fusion protein encoding plasmids and harvested approximately 36 hours later
by centrifugation for 5 minutes at 500 xg and 4 ◦C. The cells were washed with ice-cold
washing buffer (20 mM Tris-HCl pH 8, 150mM NaCl, 0.5 mM EDTA) and centrifuged
again for 5 minutes at 500 xg and 4 ◦C. The resulting cell pellet was resuspended in 200
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µL lysis buffer and cells were disrupted and the cell lysate cleared as described earlier.
15% percent of the cell lysate was used as input control and the rest was incubated with
equilibrated GFP- or RFP-trap beads (Chromotek GmbH, Planegg-Martinsried, Germany)
on a rotator for 90 minutes at 4 ◦C. Afterwards, beads were washed 3 times with 300
µL washing buffer. Input and bound fraction were separated on 6% SDS-PA gels and
transferred to a nitrocellulose membrane (Bio-Rad Laboratories, Hercules, CA, USA,
Cat.No.: 1620112).
Membranes were blocked with 5% milk in 1x PBS-T (0.1% Tween). For the detection
of EGFP- or mRFP- and mcherry-tagged proteins, rat monoclonal anti-GFP clone 3H9
(ChromoTek GmbH, Planegg-Martinsried, Germany, Cat.No.: 3h9) and rat monoclonal anti-
RFP clone 5F8 (Rottach et al., 2008); (ChromoTek GmbH, Planegg-Martinsried, Germany,
Cat.No.: 5f8) were used as primary antibodies. Tet1 was detected with monoclonal rat 5D8
(1:2, (Bauer et al., 2015)). Primary antibodies were diluted in blocking buffer and incubated
for 2 hours at room temperature. After washing three times with 1x PBS supplemented with
0.1 Tween-20, a horseradish peroxidase conjugated goat anti-rat IgG secondary antibody
(1:5000; The Jackson Laboratory, Bar Harbor, ME, USA, Cat.No.: 112-035-068) was
incubated in blocking buffer for 1 hour at room temperature. The secondary antibody was
visualized with ECL Plus Western Blotting Substrate (ThermoFisher Scientific, Waltham,





5.1 The short isoform of Tet1 localizes to pericentric heterochro-
matin during ongoing DNA replication
5.1.1 Tet1 and its short isoform show different S-phase localizations
Methylated cytosine serves as a substrate for the dioxygenases of the Tet protein family,
which can oxidise this repressive DNA modification and thereby change and diversify the
information content of the epigenome. The Tet catalytic activity thus modulates crucial
cellular processes like transcription, DNA replication or repair and in turn affects embryonic
as well as postnatal organismic development but also plays a role in tumorigenesis. Despite
extensive efforts to unravel the regulation of Tet proteins, the mechanism how cellular
levels of 5hmC and its oxidative derivatives are maintained in proliferating cells, remains
elusive. Tet1, the founding member of the Tet dioxygenase family, has previously been
implicated in maintaining euchromatic 5hmC levels in differentiated cells, throughout the
cell cycle and to thereby prevent DNA methylation spreading to euchromatin (Jin et al.,
2014). However, also this study failed to present a mechanism on how this maintenance is
achieved. Recently, a short isoform of Tet1 was described to be expressed in somatic cells
upon differentiation, while expression of full-length Tet1 is mainly restricted to embryonic
stem cells and early embryogenesis (Zhang et al., 2016b). Said short isoform was found
to arise from an alternate promoter and to lack a major part of its N-terminus, including the
CxxC-domain, which targets the full-length Tet1 protein to non-modified DNA (Frauer et al.,
2011a). The short isoform of Tet1 was furthermore shown to be overexpressed in various
cancers, which correlates with poor patient survival (Good et al., 2017). In line with the
finding that Tet1 can act as a maintenance dioxygenase, the Tet-mediated 5mC oxidation
products 5hmC and 5fC were found to be stable throughout the cell cycle in proliferating
cells with almost similar cell cycle-dependent dynamics as described for 5mC (Bachman
et al., 2014; Bachman et al., 2015).
Based on the question, how the oxidative derivatives of 5mC are maintained throughout
the cell cycle, I first addressed the cellular localization of full-length Tet1 and its cancer-
associated, N-terminally truncated, short isoform during ongoing DNA replication in somatic
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cells. For this purpose I transfected C2C12 mouse myoblasts with plasmids encoding
EGFP-tagged fusion proteins of full-length Tet1 and its short isoform, hereafter called Tet1s,
(Figure 10A) together with mRFP-tagged PCNA, as a marker for cell cycle progression and,
in particular, S-phase substages and active replication sites. C2C12 cells were chosen, as
their S-phase and its spatio-temporal progression have been studied extensively and are
well characterized (Casas-Delucchi et al., 2011). In their undifferentiated state, C2C12 cells
moreover express comparatively low to undetectable levels of Mbd proteins like MeCP2
(Brero et al., 2005), which we could previously show to counteract Tet catalytic activity by
restricting its access to DNA (Ludwig et al., 2017). Besides the low levels of Mbd proteins,
undifferentiated C2C12 cells also show low expression of all three Tet proteins, which
makes them a suitable model for ectopic Tet overexpression experiments (Zhong et al.,
2017). To avoid secondary effects from prolonged Tet1 overexpression and 5mC oxidation,
cells were subjected to live cell time-lapse microscopy eight to ten hours after transfection.
For time-lapse imaging, cells in early S-phase, defined by a homogeneously distributed
focal PCNA pattern, were chosen and confocal Z-stacks acquired every 20 minutes over
the course of several hours.
While full-length Tet1 showed no noteworthy accumulation during either of the S-phase
substages or in G2, a clear localization between Tet1s and PCNA could be observed
at sites of ongoing DNA replication in pericentric heterochromatin during late S-phase
(Figure 10B). This observation led me to quantify the relative accumulation of Tet1 and
Tet1s during late S-phase. For this purpose, C2C12 cells were again co-transfected with
either of the two EGFP-tagged Tet1 variants, together with mRFP-tagged PCNA and
imaged live approximately eight hours post transfection. Live-cell imaging was chosen,
because the observed localization of Tet1s during late S-phase was lost upon fixation,
although different fixation protocols were tested. Cells that showed a late S-phase PCNA
pattern, characterized by strong focal accumulations, were imaged. For the analysis of
Tet1 or Tet1s accumulation, maximum intensity Z-projections were generated and three
nuclear areas in PCNA marked, replicating pericentric heterochromatin (PHC) domains
and in the nucleoplasm outside of DNA replication foci, were chosen. The fluorescence
intensity signals of the three respective spots were averaged and the ratio of the mean
Tet1 fluorescence signals inside and outside of PCNA foci was calculated. In this way, a
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significant accumulation of Tet1s at sites of late S-phase, in comparison to full-length Tet1
was found (Figure 10C).
Figure 10: The short isoform of Tet associates with pericentric heterochromatin during DNA repli-
cation and increases 5hmC levels. (A) Gene structure of the human Tet1 locus. Exons 1 and 3 are
non-coding and each harbour a distinct transcription start site, of which each is targeted by a different
promoter. Translation of full-length Tet1 and its short isoform starts in exon 2 and 4, respectively (Good et al.,
2017). (B) Confocal mid Z-planes of C2C12 mouse myoblasts that were transfected with mRFP-PCNA and
EGFP-Tet1 or EGFP-Tet1s and subjected to time-lapse live cell microscopy eight hours post transfection.
Cells that showed an early S-phase pattern were chosen and followed over time with time intervals of 20
minutes. While no noteworthy accumulation or PCNA colocalization was observed for Tet1, Tet1s showed a
clear colocalization with PCNA during ongoing replication in pericentric heterochromatin in late S-phase. (C)
To analyse the accumulation of Tet1 and Tet1s at PCNA marked replication sites, C2C12 cells were trans-
fected with EGFP-tagged Tet1 or Tet1s and mRFP-PCNA and imaged live eight hours post transfection. For
the quantification of the Tet1 or Tet1s accumulation at late replication PHC, maximum intensity Z-projections
were generated and the mean fluorescence intensities of three nuclear areas inside and outside of sites of
ongoing DNA replication were measured. The respective values were averaged and the mean fluorescence
intensities of Tet1 in PCNA foci divided by the mean fluorescence in nucleoplasmic regions. (n-numbers:
Tet1: 10, Tet1s: 13). (D) Ectopic overexpression of Tet1s significantly increases 5hmC levels in C2C12 cells.
C2C12 mouse myoblasts were transfected with EGFP-Tet1, EGFP-Tet1s or EGFP alone and 24 hours later
fixed and immunostained against 5hmC. Fluorescence intensity levels of overexpressed proteins and 5hmC
were measured with a wide-field high content screening microscopy system. Sum nuclear 5hmC levels
were normalized to the sum nuclear DAPI intensity and grouped according to their respective mean EGFP
fluorescence (low: 50-100 AU, mid:100-500 AU, high: 500-1000 AU; n-numbers: GFP=6255, Tet1=3169,
Tet1s=5960). Experiments were performed at least in triplicate and statistical significance was tested with a
paired two-samples Wilcoxon test, using R-studio version 1.1.447. Scale bars = 5 µm.
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Prompted by the finding that Tet1s localized to pericentric heterochromatin during ongoing
DNA replication, I was furthermore interested, to see how global 5hmC levels changed
upon overepression of either Tet1 or Tet1s. To answer this question, I transfected C2C12
mouse myoblasts with either EGFP-tagged Tet1 or Tet1s or EGFP as a control and fixed
the cells 24 hours after transfection and performed immunofluorescence staining against
5hmC. Stained cells were imaged with a wide-field high content screening microscope
system and sum and mean nuclear fluorescence intensities quantified with the respective
analysis software (Figure 9). For further analysis, sum 5hmC levels were normalized to
the sum nuclear DAPI intensity as a proxz for DNA content. EGFP levels, were normalized
to the average of the lowest expressing cells and than grouped in low, mid and high
expressing cells, according to their mean nuclear EGFP fluorescence levels. Interest-
ingly, Tet1s overexpression led to significant 5hmC increases in all groups compared to
the EGFP-control, but also Tet1-transfected cells. In contrast, full-length Tet1 failed to
markedly increase 5hmC levels in low- and mid-expressing cells and, with exception for
the high-expressing group, showed no significantly higher 5hmC levels as the respective
EGFP-control groups (Figure 10D).
5.1.2 The CxxC domain of Tet1 prevents its S-phase localization
A domain, distinguishing Tet1 from its short isoform is the N-terminal zinc-finger that is
lacking in Tet1s (Figure 10A). Besides the CxxC-domain one more regulatory domain in
the very N-terminus was recently identified and termed BC (before CxxC) domain (Zhang
et al., 2016b). The CxxC- and the BC-domain were implicated in concomitantly facilitating
chromatin binding of full-length Tet1 and their combined deletion was shown to result in
markedly decreased chromatin loading (Zhang et al., 2016b). These findings prompted
me to investigate the accumulation of different N-terminal deletion mutants of Tet1 and
also its CxxC-domain alone, during late S-phase. Hence, I transfected C2C12 cells with
mRFP-PCNA and EGFP-Tet1∆1-389 that lacks the BC-domain, EGFP-Tet1∆566-833 that
lacks the CxxC-domain or EGFP-Tet1-CxxC (Figure 11A). Cells in late S-phase were
imaged live eight to ten hours post transfection and the relative accumulation in PCNA
foci of late S-phase cells quantified as described before. While the CxxC domain of Tet1
44
5 RESULTS
showed a very homogeneous nuclear pattern and no accumulation at all, Tet1∆1-389
showed a slightly (p=0.1823) and Tet1∆566-833 a significantly (p=0.002756) increased
accumulation compared to full-length Tet1 (Figure 11B). In regard to this finding, I set
out to investigate the spatio-temporal dynamics of the CxxC-lacking Tet1∆566-833 fusion-
protein during S-phase. For this, I transfected the respective EGFP-tagged construct
together with mRFP-PCNA and performed live-cell time lapse microscopy as described
earlier. Interestingly, in stark contrast to full-length Tet1 or Tet1s, strong focal accumulations
were observed already during early S-phase and persisted throughout the whole S-phase
and G2. The characteristic colocalization with PCNA at PHC in late S-phase was also
observed (Figure 11C).
Figure 11: The CxxC domain of Tet1 prevents PHC association during DNA replication. (A) Domain
organization of full-length Tet1. Indicated are the the locations of amino acids from N-terminal deletion
mutants, used in this study. (B) Representative confocal mid-Z-plane images of C2C12 mouse myoblasts
in late S-phase that were transfected with EGFP-tagged full-length Tet1, Tet1∆1-389, Tet1∆566-833 or the
Tet1-CxxC domain and mRFP-PCNA. The corresponding boxplot shows the relative accumulation of the
EGFP signal at PCNA marked DNA replication sites in pericentric heterochromatin. Tet1∆566-833 shows
a significant accumulation compared to full-length Tet1, while Tet1∆1-389 accumulation is only slightly
increased and the Tet1-CxxC does not show any accumulation (n-numbers: Tet1=10, Tet1∆1-389=11,
Tet1∆566-833=10, Tet1-CxxC=11). Statistical significance was tested with a paired two-samples Wilcoxon
test, using R-studio version 1.1.447. (C) Representative confocal mid-Z-sections of a C2C12 mouse myoblast
cell that was co-transfected with EGFP-Tet1∆566-833 and mRFP-PCNA and subjected to live-cell time lapse
microscopy 8 hours post transfection. Tet1∆566-833 shows a strong focal pattern in the nucleus throughout
the entire S-phase and in G2, but also colocalizes with PCNA during ongoing DNA replication in PHC in late
S-phase. Scale bars = 5 µm.
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5.1.3 DNA replication association of Tet1 is independent of its catalytic activity
Many studies, including our own that investigated the effects of Tet catalytic activity, used
not only the full-length Tet proteins, but also the respective C-terminal catalytic domains.
The catalytic domain of all Tet proteins comprises the cysteine-rich domain (CRD) and
the double-stranded beta helix (DSBH) that together are sufficient for Tet-mediated 5hmC
formation in vivo and also in vitro (Ludwig et al., 2017; Zhang et al., 2017b; Zhang et al.,
2017c; Zhang et al., 2017a). To investigate the cell cycle distribution of the catalytic
domain of Tet1 (Tet1CD), I transfected C2C12 mouse myoblasts with mcherry-Tet1CD,
miRFP-PCNA and EGFP-MaSat, imaged cells in S-phase and scored the accumulation in
late S-phase as described earlier (Figure 10C). Similar to the observation made for Tet1s,
no notewhorty nuclear Tet1CD-patterns were observed throughout early or mid S-phase
(not shown). However, in late S-phase Tet1CD showed a clear colocalization with PCNA
as also observed for Tet1s (Figure 12B, upper panel). This prompted me to further test,
whether single amino acid substitutions in the cofactor binding sites (H1652Y, D1654A,
(Figure 12A)) of Tet1CD can change the observed localization. These mutations render
Tet1 catalytically inactive but do not affect its DNA-binding affinity (Zhang et al., 2017b).
Figure 12: DNA replication association of Tet1 is independent of its catalytic activity. (A) Schematic
of the catalytic domain of Tet1. Stars indicate the location of cofactor binding site mutations that render it
catalytically inactive. (B) Representative pseudocolored mid-Z-sections of C2C12 mouse myoblasts in late
S-phase, transiently expressing fluorescently tagged Tet1CD or Tet1CDmut as well as PCNA and MaSat.
(B) Quantification result of the accumulation of Tet1CD and Tet1CDmut at late replicating PHC, marked by
PCNA (n-number for both = 15). For accumulation quantification, mean fluorescence intensities in three
circular regions, inside and outside of sites of ongoing DNA replication were measured and the average of
the ratio plotted. Statistical significance was tested with a paired two-samples Wilcoxon test, using R-studio
version 1.1.447. Scale bar = 5 µm.
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For this, I again transfected C2C12 myoblasts with miRFP-PCNA, EGFP-MaSat and the
mcherry-tagged catalytically inactive mutant of Tet1CD (Tet1CDmut). This mutant showed
the same nuclear localization pattern as previously observed for the short isoform of Tet1
or Tet1CD and the accumulation at replication sites in PHC was not significantly changed,
compared to Tet1CD. (Figure 12B, lower panel, C).
With respect to the finding that the catalytic domain of Tet1 is sufficient for its association
with DNA replication at PHC and the high sequence homology to the catalytic domains of
Tet2 and Tet3 (Bauer et al., 2015), I investigated also the S-phase distribution of full-length
Tet2 and Tet3 and their respective catalytic domains, employing the protein accumulation
assay (Figure 10C). With this approach, no accumulation throughout the whole S-phase,
including during the replication of pericentric heterochromatin in late S-phase was observed
for either the full-length proteins or the catalytic domains of Tet2 or Tet3 (Figure 13A, B).
Figure 13: Tet2 and Tet3 do not localize to pericentric heterochromatin during late DNA replication.
(A) Representative pseudocolored confocal mid-Z-sections of C2C12 mouse myoblasts in late S-phase
transiently transfected with fluorescently tagged PCNA and Tet2 and Tet3 full-length proteins and respective
catalytic domains. (B) Boxplots show the relative accumulation of Tet2 and Tet3 or their respective catalytic
domains in PCNA marked chromocenters. Statistical significance was tested with a paired two-samples
Wilcoxon test, using R-studio version 1.1.447. Scale bar = 5 µm.
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5.1.4 The cysteine-rich domain of Tet1 is essential for its S-phase association and
catalytic activity
The minimal domain that is needed for the dioxygenase activity of the Tet proteins, is
their C-terminal catalytic domain, which comprises the CRD and the DSBH. While these
domains together are sufficient for catalytic activity and localization to PHC during ongoing
DNA replication, I was interested to test, whether either of the two domains alone can
localize to late-replicating DNA or at least still be catalytically active. I therefore first
tested the localization of these two domains during ongoing DNA replication in PHC. For
this purpose, I co-transfected C2C12 cells with mRFP-tagged PCNA and EGFP-tagged
CRD or DSBH and acquired confocal Z-stacks of cells with a late S-phase PCNA pattern
approximately eight hours post transfection and quantified their accumulation.
In this way, I found no cells, which overexpressed the DSBH, to show focal patterns
that resembled those of PCNA. Cells that were co-transfected with EGFP-CRD, however,
occasionally showed weak accumulations of CRD at PCNA marked PHC. When I quantified
the accumulation of the CRD and the DSBH at late-replicating PHC, values close to 1 were
measured, indicating almost no accumulation. However, the CRD, for which occasional
accumulations were observed, showed a significantly increased accumulation compared
to the DSBH (Figure 14A, B). To test, whether either of the domains can increase global
5hmC levels, C2C12 cells were transfected with EGFP-Tet1CD, EGFP-CRD or EGFP-
DSBH and 24 hours later fixed and immunostained against 5hmC and counterstained
with DAPI. Stained cells were imaged with a wide-field high content screening microscope
and the sum and mean nuclear values of DAPI, EGFP and Alexa-594-labelled 5hmC
measured. Sum nuclear 5hmC levels were normalized to the sum DAPI intensity and
grouped according to their mean EGFP fluorescence as an indicator for Tet1-X expression
levels. While both, CRD and DSBH, failed to increase global 5hmC levels compared to
control EGFP-transfected cells, Tet1CD significantly (p for all groups = 2.2x10-16) increased
5hmC levels independent of its respective expression levels, compared to EGFP, EGFP-
CRD or EGFP-DSBH transfected cells (Figure 14C).
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Figure 14: The cysteine-rich domain of Tet1 colocalizes with PCNA during PHC replication but is
catalytically inert. (A) Representative confocal mid-Z-sections of C2C12 mouse myoblasts, co-transfected
with plasmids, encoding fluorescently tagged PCNA and Tet1-CRD or Tet1-DSBH. (B) Schematic of the
accumulation quantification of Tet1-CRD or Tet1-DSBH in PCNA marked PHC replication sites and the
corresponding boxplot that summarizes the quantification results (n-numbers: CRD=14, DSBH=13) (C)
Boxplot showing the normalized sum nuclear 5hmC levels in C2C12 mouse myoblasts that were transfected
with Tet1CD, Tet1-CRD or Tet1-DSBH and 24 hours later immunostained against 5hmC. 5hmC levels were
normalized to background fluorescence levels and the sum nuclear DAPI levels. Cells were grouped in low
(<50-100 AU), mid (<100-500 AU) and high (<500-1000 AU) expressing cells according to their mean nuclear
EGFP fluorescence (n-numbers: CD=15893, CRD=15835, DSBH=8121). Three stars indicate a p-value >
2.2x10-16. Statistical significance was tested with a paired two-samples Wilcoxon test, using R-studio version
1.1.447 Scale bar = 5 µm.
The very weak, but focal accumulation that was occasionally observed for Tet1-CRD,
prompted me to delete the CRD from Tet1s and investigate the effects that the deletion
of this domain has on S-phase Tet1 localization, as well as global 5hmC production. I
generated an EGFP-tagged Tet1s∆CRD-construct and transfected it into C2C12 mouse
myoblasts together with mRFP-PCNA, to perform live-cell time lapse microscopy. In stark
contrast to the localization of Tet1s that showed a clear accumulation in late S-phase
at PCNA marked chromocenters, no accumulation at PCNA marked replication foci was
observed throughout S-phase. Investigating the global 5hmC levels of C2C12 cells that
overexpressed EGFP-Tet1s∆CRD gave a similar picture as observed before for the CRD
or DSBH alone. No 5hmC increase was found for either low, mid or high Tet1s∆CRD
overexpressing cells, while Tet1s overexpression significantly increased global 5hmC levels
compared to EGFP-control transfected cells.
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Figure 15: The CRD of Tet1s is required for its catalytic activity and S-phase localization. (A) Rep-
resentative confocal mid-Z-section images of a C2C12 mouse myoblast cell that was co-transfected with
EGFP-Tet1s∆CRD and mRFP-PCNA and subjected to live-cell time lapse microscopy. (B) Schematic of the
experimental procedure and respective boxplots. Mouse myoblasts were transfected with EGFP, EGFP-Tet1s
or EGFP-Tet1s∆CRD and 24 hours later stained against 5hmC. Sum nuclear 5hmC were normalized to the
5hmC levels in the lowest expressing cells and the sum nuclear DAPI intensity and grouped, according to their
mean nuclear EGFP fluorescence intensity in low (<50-100 AU), mid (<100-500 AU) and high (<500-1000
AU) expressing (n-numbers: GFP=6255, Tet1s=5960, Tet1s∆CRD=2070). Experiments were performed
at least in triplicate and statistical significance was tested with a paired two-samples Wilcoxon test, using
R-studio version 1.1.447. Three stars indicate a p-value > 2.2x10-16. Scale bar = 5 µm.
Many proteins that associate with sites of ongoing DNA replication, do so via the interaction
with the clamp loader protein PCNA. Dnmt1, for example, harbours a so-called PCNA
binding domain (PBD), a short peptide with a conserved sequence motif that facilitates
this interaction. The consensus sequence of classical PBDs is characterized by an initial
glutamine (Q), followed by two variable amino acids, a hydrophobic amino acid, like
leucine (L) or isoleucine (I), two variable residues and finally two aromatic amino acids, like
phenylalanine (F), tryptophan (W), tyrosine (Y) or histidine (H). This consensus sequence
is often followed by basic residues like arginine (R) or lysine (K) (Easwaran, Leonhardt, and
Cardoso, 2007) (Figure 16A). Interestingly, PCNA was found to be a strong interactor of
Tet1 and to regulate its dioxygenase activity throughout the cell cycle and thereby protect
cells from aberrant DNA methylation (Cartron et al., 2013). To identify a putative PBD in
Tet1, but also Tet2 and Tet3, the respective amino acids sequences were searched for
a glutamine followed by five variable amino acids and finally two aromatic amino acids
with the pattern finder tool from www.bioinformatics.org. While I did not get any hit in the
respective protein sequences of Tet2 or Tet3, a short peptide that harbours the desired
sequence was identified in the CRD of Tet1. The major difference of the putative PBD of
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Tet1 and the consensus sequence, is the hydrophobic middle amino acid. The putative
PBD of Tet1 harbours a hydrophilic lysine residue, instead of a hydrophobic leucine or
isoleucine (Figure 16A). To test, whether the PBD-like sequence of Tet1 can nevertheless
associate with PCNA and consequently the DNA replication machinery, I performed
oligo-cloning to obtain a EGFP-tagged Tet1-"PBD". This construct was transfected into
C2C12 mouse myoblasts together with mRFP-PCNA and confocal Z-stacks were acquired
approximately 8 hours post transfection and cells in different S-phase substages, defined
by their respective PCNA pattern. Strikingly, Tet1-"PBD" showed a distribution throughout
the cell with a strong nuclear signal. This distribution was attributed to the fact that
the flanking sequences of the Tet1-"PBD" contain many arginines that are also found in
nuclear localization sequences (Kalderon et al., 1984). Despite the strong nuclear signal,
no accumulation of Tet1-"PBD" at PCNA labelled sites of ongoing DNA replication was
observed in either of the S-phase substages, which was also confirmed by line-profile
analysis (Figure 16B).
Figure 16: The CRD of Tet1 harbours an inert putative PBD. (A) Domain organization of the short isoform
of Tet1 with the location of the putative PCNA binding domain (PBD) identified in the N-terminal region of its
cysteine-rich domain (CRD). The putative PBD sequence is aligned to known PBDs from different proteins,
associated with DNA replication and repair, with their respective accession numbers. The consensus
PBD sequence consisting of a glutamine followed by two variable amino acids, a hydrophobic amino acid,
two variable amino acids and two aromatic amino acid residues, is given at the bottom. (B) Exemplary
confocal mid-Z-sections of C2C12 mouse myoblasts in different S-phase substages co-transfected with the
EGFP-tagged putative PBD of Tet1 and mRFP-tagged PCNA. Line profiles of the indicated arrows are shown
next to the respective images. Scale bar = 5 µm.
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5.1.5 A conserved lysine in Tet1s CRD is crucial for its S-phase localization and
targeted catalytic activity
In addition to the non-functional putative PBD of Tet1 just described, two recent studies
independently identified a conserved lysine residue within the CRD of all Tet proteins.
Monoubiquitination of this lysine was found to modulate Tet catalytic activity and to be
important during oocyte development and for Tet2 chromatin binding (Yu et al., 2013;
Nakagawa et al., 2015). The lysine itself resides within a peptide that is conserved
between all three Tet protein family members and also between human and mouse Tet
(Figure 17A). This short amino acid stretch was shown to stabilize the DNA around
the modified cytosine target, by interacting with the phosphate backbone (Figure 17B).
Furthermore, mutations of the conserved lysine residue to a glutamate resulted in loss of
Tet2 catalytic activity, indicating its importance for the correct function of Tet proteins. (Hu
et al., 2013).
I therefore mutated lysine (K) 852 in Tet1s to a glutamate (E) or an arginine (R) to invert
or keep the respective charge and abrogate a putative ubiquitination. I continued to
investigate the DNA replication association capability of the respective constructs and the
effect of their overexpression on global 5hmC generation.
To test, whether the lysine mutations affect the accumulation during DNA replication in
PHC, EGFP-tagged Tet1s-constructs that harbour the K852R or K852E mutation were
co-transfected with mRFP-PCNA into C2C12 mouse myoblasts. Confocal Z-stacks were
acquired approximately eight hours later and the accumulation of the respective constructs
in late replicating DNA, marked by PCNA, was assessed as described earlier (Figure
10C). With this approach, no accumulation was found for either of the two Tet1s-mutants
during late S-phase, indicating that the respective lysine residue is indeed crucial for Tet1s
recruitment during DNA replication (Figure 17C, D).
To further test, whether the lost DNA replication association of Tet1s-K852R and Tet1s-
K852E (Figure 17A) affects global 5hmC levels, C2C12 myoblasts were transfected
with the respective EGFP-tagged constructs and immunostained against 5hmC 24 hours
later (Figure 18A). Tet1s, Tet1s-K852R, Tet1s-K582E all increased global 5hmC levels
significantly, compared to EGFP-control transfected cells (Figure 18B). However, while a
clear and significant increase of global 5hmC levels in Tet1s and Tet1s-K852R transfected
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cells was observed with increasing EGFP levels and hence Tet1s levels, increasing Tet1s-
K852E levels failed to further increase global 5hmC levels (Figure 18B).
Figure 17: A conserved lysine in Tet1s CRD is crucial for its S-phase localization. (A) Localization
within Tet1s and sequence alignment of a peptide from human and mouse Tet1, Tet2 and Tet3 surrounding
a conserved lysine residue that was shown to be monoubiquitination and thereby modulate Tet chromatin
binding and catalytic activity. The accession numbers are given next to the respective sequences. (B) Crystal
structure of human Tet2 bound to a 12 base pair long stretch of methylated DNA at a resolution of 2.03 Å
(PDB 4NM6) (Hu et al., 2013). The CRD is shown as faint red tube worms, with the conserved lysine 1492
shown in pink, and the DSBH as faint yellow tube worms. The bound DNA is depicted as blue and brown stick
representation helix with the methylated cytosine flipped out of the double helix shown in green. Zinc and iron
atoms are shown as grey and red spheres, respectively. The 2-oxoglutarate analog, N-oxalylglycine is shown
in stick representation. The model was visualized with Cn3D (Wang et al., 2000). (C) Representative confocal
mid-Z-sections of mouse myoblasts transiently expressing mRFP-PCNA together with EGFP-tagged Tet1s,
Tet1s-K852R or Tet1s-K852E. (D) Boxplots showing the relative accumulation of Tet1s and its lysine mutants
at PCNA marked DNA replication foci in C2C12 mouse myoblasts. The accumulation of the respective
Tet1s-constructs was quantified by measuring the mean fluorescence intensity levels of Tet1s or its lysine
mutants in PCNA marked PHC and dividing it by the mean levels in nucleoplasmic regions (n-numbers:
Tet1s=13 Tet1s-K852R=18, Tet1s-K852E=21). Scale bar = 5 µm.
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Figure 18: Tet1s lysine 852 mutations affect global 5hmC levels. (A) Schematic rationale of the ex-
periment. C2C12 mouse myoblasts were transfected with EGFP, EGFP-Tet1s, EGFP-Tet1s-K852R or
EGFP-Tet1s-K852E and 24 hours later immunostained against 5hmC and the DNA counterstained with DAPI.
(B) Boxplots show the normalized sum nuclear 5hmC levels of C2C12 mouse myoblasts that transiently
overexpressed the indicated EGFP-tagged proteins. Sum nuclear 5hmC levels were normalized to the
averaged 5hmC averaged levels of lowest expressing cells and further against the sum nuclear DAPI intensity.
Cells were grouped acording to their respective mean EGFP fluorescence intensities in low (50-100 AU),
mid (100-500) and high (500-1000) expressing. Circles above boxes denote outliers. All experiments were
done at least in triplicate and respective p values are denoted in the plot and outliers are depicted as circles
above and below boxes (n-numbers: GFP=6255, Tet1s=5960, Tet1s-K852R=7482, Tet1s-K852E=16901).
Statistical significance was tested with a paired two-samples Wilcoxon test, using R-studio version 1.1.447.
The finding that Tet1s-K852R overexpression significantly increased global 5hmC levels,
compared to wildtype Tet1s overexpressing cells (Figure 18B) prompted me to examine the
nuclear 5hmC distribution in closer detail. For this purpose, I acquired high-magnification
confocal Z-stacks of randomly chosen cells that were previously imaged with the wide-field
high content screening system. To analyse the sub-nuclear 5hmC deposition upon Tet1s-
overexpression, a self-written, semiautomated ImageJ macro was used (Figure 19A). With
this analysis method, mean fluorescence intensity levels of 5hmC in chromocenters and
the surrounding nucleoplasm were measured and plotted. Similar to the observations,
made for global 5hmC levels (Figure 18B), I found that Tet1s, Tet1s-K852R and also Tet1s-
K852E showed significantly increased 5hmC levels in the nucleoplasm and chromocenters,
compared to EGFP control-transfected cells (Figure 19B, C). While Tet1s transfected
cells showed a significant increase of 5hmC in chromocenters, compared to Tet1s-K852E
transfected cells, no major difference was found in cells that overexpressed Tet1s-K852R.
In contrast to this, 5hmC levels in the nucleoplasm of cells that overexpressed Tet1s-K852R,
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were significantly higher than in cells that overexpressed wildtype Tet1s (Figure 19C).
Figure 19: Tet1s lysine 852 mutations affect local 5hmC levels. (A) Schematic of the ImageJ-based in
situ 5hmC analysis procedure. Maximum intensity projections of confocal Z-stacks were generated. Binary
nuclear and chromocenter masks were generated based on the thresholded DAPI signals and a binary
nucleoplasm mask was calculated from the DAPI and chromocenter masks. Mean fluorescence intensities
in the respective areas, were measured. (B) Representative confocal, pseudocoloured mid-Z-sections of
C2C12 cells that transiently overexpressed the indicated Tet1s variants or EGFP. (C) Boxplots show the
quantification results of (A), hence 5hmC levels in C2C12 mouse myoblasts in chromocenters (cyan) and
the surrounding nucleoplasm (purple), (n-numbers: GFP=19, S=50, K852R=39, K852E=33). Outliers are
depicted as circles above and below boxes, p-values are given in the plot directly and were calculated with a
paired two-samples Wilcoxon test, using R-studio version 1.1.447. Scale bar = 5 µm.
5.1.6 The CRL4(VprBP) complex might facilitate a crucial role in the S-phase as-
sociation of Tet1
VprBP/DCAF1 (Viral protein r Binding Protein/DDB1 And CUL4 Associated Factor 1) is a
threonine kinase that was shown to phosphorylate histone H3T120 (Kim et al., 2013), but
is most prominent for its role as an adapter protein for the DDB1-Cul4 E3 ubiquitin-ligase
complex (Angers et al., 2006). This complex and especially the E3 ubiquitin-ligases of
the CRL (CUL4-RING E3 ubiquitn-ligase) family have been implicated in the regulation of
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various cellular processes like DNA repair, but also replication. They were, for example,
shown to prevent DNA re-replication in C. elegans by restraining origin licensing (Jackson
and Xiong, 2009). Besides this role, recent studies found the proteins of the Tet dioxyge-
nase family to be a common substrate for the CRL4(VprBP)-complex. Monoubiquitination
of a conserved lysine residue in the CRD of all three Tet proteins, via the CRL4(VprBP)-
complex, was linked to increased catalytic activity and in the case of Tet2, also chromatin
loading (Yu et al., 2013; Nakagawa et al., 2015). Despite this, it was also found that the
CRL4(VprBP)-complex can polyubiquitinate Tet2 upon HIV-1 infection, which results in
proteasomal degradation of Tet2 and facilitates HIV-1 replication (Lv et al., 2018). Little
is known about the cell cycle- and in particular S-phase dynamics of the CRL4(VprBP)-
complex or VprBP in general.
I, therefore, addressed the S-phase localization of VprpBP, with respect to the previous
finding that mutations of the conserved lysine residue, known to be monoubiquitinated,
abrogate the S-phase localization of Tet1s (Figure 17C, D). To this end, C2C12 mouse
myoblasts were co-transfected with EGFP-Tet1, mcherry-VprBP and miRFP-PCNA en-
coding plasmids and subjected to live cell time-lapse microscopy. Cells in early S-phase
were chosen, according to their respective PCNA pattern and followed over time while
acquiring confocal Z-stacks every 20 minutes. Although VprBP showed a pancellular
distribution, a slight cytoplasmic-to-nuclear translocation was observed from early to late
S-phase (Figure 20A, B). The translocation was quantified by calculating the ratio of the
mean nuclear to the mean cytoplasmic VprBP fluorescence intensity. In addition to this,
line profile analysis of a late S-phase replication focus, showed that the VprBP signal




Figure 20: The CRL4-adapter protein VprBP colocalizes with Tet1s during late S-phase. (A) Repre-
sentative mid-Z-plane images of C2C12 mouse myoblasts that were transiently transfected with EGFP-Tet1s,
miRFP-PCNA and mRFP-VprBP and subjected to live-cell time lapse microscopy. Snapshots of the re-
spective channels during early, mid and late S-phase are shown. (B) Bar graphs represent the ratio of the
mean nuclear to mean cytoplasmic fluorescence intensity of mRFP-VprBP. (C) Pseudocoloured, detailed
examination of the late S-phase cell shown in (A). A chromocenter that was marked by PCNA and Tet1s was
examined in detail by line-profile analysis. Scale bars = 5 µm, except scale bar in blow-up in (C) = 2 µm.
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5.2 Uhrf1 is crucial for Tet1s replication association
5.2.1 Loss of Uhrf1 but not Dnmt1 affects Tet1s localization
As the catalytic inactive mutant of Tet1 still localizes to DNA replication sites and therefore
seems to be dispensable for its association with sites of ongoing DNA replication during
late S-phase, I set out to test whether loss of the Tet substrate 5mC can affect the
observed localization. For this purpose I made use of cells that are deficient for either the
maintenance methyltransferase Dnmt1 or its facilitating factor Uhrf1, which both colocalize
or even associate with PCNA, during DNA replication in pericentric heterochromatin.
Mouse embryonic fibroblasts deficient for Dnmt1 were also deficient for p53 (MEF-PM),
as primary fibroblasts from Dnmt1 negative and p53 proficient embryos proved non-
viable (Lande-Diner et al., 2007). As loss of Uhrf1 is eventually lethal during embryonic
development and differentiation, the effects of Uhrf1 deficiency were tested in mouse
embryonic stem cells (Bostick et al., 2007; Sharif et al., 2007). Cells deficient for Dnmt1
and cells deficient for Uhrf1 are characterized by global hypomethylation and exhibit only
residual genomic 5mC levels and are therefore suitable models to study the effects of 5mC
depletion on Tet1s localization during the cell cycle. Dnmt1-deficient cells are characterized
by decondensed pericentric heterochromatin and therefore often morphologically distorted
chromocenters (Casas-Delucchi et al., 2012a). For this reason, I co-transfected MEF-PM
and MEF control cells that are only deficient for p53, with mcherry-Tet1s, miRFP-PCNA and
EGFP-MaSat, to mark pericentric heterochromatin and imaged the cells live approximately
eight hours later, to qualitatively assess the localization of Tet1s during late S-phase.
The p53 deficient cells, and also the cells deficient for p53 and Dnmt1, showed a clear
accumulation of Tet1s at PCNA labelled chromocenters (Figure 21A), indicating that
neither the loss of the maintenance DNA methyltransferase Dnmt1 nor the accompanied
global loss of DNA methylation does affect the association of Tet1s with sites of ongoing
DNA replication in chromocenters.
The multi-domain protein Uhrf1 is mostly implicated in serving as a facilitating factor for
Dnmt1 mediated DNA methylation maintenance. This is achieved by interpreting the
combined information of the DNA methylation status and different histone modifications in
the vicinity of hemimethylated CpGs during ongoing DNA replication. This triggers the E3
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ubiquitin-ligase activity of Uhrf1 towards lysines in the histone H3 tail, which recruits the
TS of Dnmt1 (Hashimoto et al., 2009; Qin et al., 2015). The loss of Uhrf is accompanied
by severe global hypomethylation, similar to the loss of Dnmt1. To qualitatively address
the effect of Uhrf1 loss, I co-transfected wildtype and Uhrf1-deficient embryonic stem cells
with mcherry-Tet1s, miRFP-PCNA and EGFP-MaSat and imaged them live approximately
10 hours later. While E14 wildtype cells showed a clear colocalization of Tet1s, PCNA
and MaSat, no accumulation of Tet1s was observed in Uhrf1-deficient E14 cells, at PCNA
marked chromocenters (Figure 21B).
Figure 21: Loss of Uhrf1 prevents Tet1s accumulation at replicating PHC. (A) Representative mid-Z-
plane sections of mouse embryonic fibroblasts deficient for p53 (MEF-P; upper panel) or p53 and Dnmt1
(MEF-PM; lower panel) transiently expressing mcherry-Tet1s, miRFP-PCNA and EGFP-MaSat. (B) Repre-
sentative mid-Z-plane sections of wild type E14 mouse embryonic stem cells (upper panel) or E14 mouse
embryonic stem cells deficient for Uhrf1 (E14-Uhrf1-/-; lower panel) transiently expressing mcherry-Tet1s,
miRFP-PCNA and EGFP-MaSat. Scale bars = 5 µm.
5.2.2 Uhrf1 physically interacts with Tet1 and can rescue the S-phase localization
of its short isoform
Based on the finding that Tet1s accumulation is lost in Uhrf1-deficient cells, I was interested
to see, whether Tet1 and Uhrf1 can physically interact. The putative protein-protein
interaction was tested by co-immunoprecipitation experiments with single-domain deletions
of Uhrf1 and the minimal catalytically active domain of Tet1, Tet1CD that still localizes
to sites of ongoing DNA replication in PHC. For this purpose, HEK-293 cells were co-
transfected with mcherry-tagged Tet1CD and EGFP-tagged single-domain deletion mutants
of Uhrf1 and harvested approximately 36 hours after transfection. Cell extracts were
prepared and incubated with GFP-binding nanobody immobilized on sepharose beads.
The input fraction and the bound fraction were separated by SDS-PAGE and transferred to
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nitrocellulose membranes. The fusion proteins were detected with monoclonal antibodies
against GFP and red fluorescent proteins, respectively. While full-length Uhrf1 as well as
all of its single-domain deletion mutants could pull down mcherry-Tet1CD, EGFP alone
failed to so (Figure 22).
Figure 22: Uhrf1 physically interacts with Tet1. EGFP or EGFP-tagged Uhrf1 constructs were ectopically
overexpressed in HEK-293 cells together with mcherry-Tet1CD and cell extracts were analysed by im-
munoprecipitation using an immobilized GFP-binding nanobody followed by western blotting with antibodies
against GFP and red fluorescent proteins. Schematic protein structures of the used fusion-proteins are
depicted on the left. The cut-outs on the right show the bound GFP-fractions and the input and bound
mcherry fractions.
As no Tet1s-recruitment to replication foci in PHC was observed in Uhrf1-deficient E14
ESCs, I was prompted to test if Tet1s localization can be rescued by ectopically reintro-
ducing Uhrf1. Besides this, I also tested, whether its highly similar homologue Uhrf2 can
substitute Uhrf1 in Tet1s recruitment. Uhrf2 was shown to specifically bind 5hmC but was
not implicated in DNA methylation maintenance due to a different chromatin modification
readout (Vaughan et al., 2018). Besides this, Uhrf2 is mostly absent from embryonic stem
cells and found to be upregulated in somatic tissues (Pichler et al., 2011). The effects of
ectopic re-expression of Uhrf1 or Uhrf2 were tested by co-transfecting E14-Uhrf1-/- ESCs
with miRFP-PCNA, mcherry-Tet1s and either EGFP, EGFP-Uhrf1 or EGFP-Uhrf2. After
approximately 12 hours confocal Z-stacks were acquired and the accumulation of Tet1s in
large PCNA foci that were assumed to represent ongoing PHC replication, assessed with
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ImageJ as described earlier (Figure 23B). Cells that co-expressed EGFP-Uhrf1 showed a
clear colocalization between Tet1s and PCNA and the relative accumulation was similar to
the one that was measured in E14 wildtype cells, miRFP-PCNA, mcherry-Tet1s and Uhrf1.
In contrast to this finding, EGFP and Uhrf2 failed to restore the accumulation of Tet1s in a
Uhrf1-deficient background (Figure 23A, C).
Figure 23: Uhrf1 but not Uhrf2 is required for Tet1s S-phase localization. (A) Representative pseudo-
coloured confocal mid-Z-sections of E14 and E14-/- co-transfected with fluorescently tagged PCNA, Tet1s and
either Uhrf1, Uhrf2 or EGFP. (B) Rational of the Tet1s accumulation quantification. Relative mcherry-Tet1s
fluorescence intensity in PCNA marked chromocenters and surrounding nucleoplasm was quantified by
measuring three areas each and putting them into relation. (C) Boxplots depict the quantification results of
the accumulation measurements of E14 wildtype and E14-Uhrf1-/- co-transfected with fluorescently tagged
PCNA, Tet1s and either Uhrf1, Uhrf2 or EGFP (n-numbers: E14+EGFP-Uhrf1=9, E14-Uhrf1-/-+EGFP=12,
E14-Uhrf1-/-+EGFP-Uhrf1=10, E14-Uhrf1-/-+EGFP-Uhrf2=23). Outliers are depicted as circles above boxes.
P-values are given in the plot directly and were calculated with a paired two-samples Wilcoxon test in RStudio
version 1.1.447. Scale bar = 5 µm.
From the co-immunoprecipitation experiments (Figure 22), I deduced that at least two
domains of Uhrf1 can facilitate the interaction with Tet1, as the protein-protein interaction
was observed with full-length Uhrf1, but also all of its single domain deletion mutants.
This finding and my previous finding that lysine 852 of Tet1s, which was shown to be
monoubiquitinated (Nakagawa et al., 2015), is crucial for its S-phase localization (Figure
17C, D), led me to investigate, which effect the deletion of the UBL or the RING domains
of Uhrf1 have on Tet1s S-phase localization. These two domains have been shown to
concomitantly act on different protein targets, like the histone H3-tail, by forming a stable
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E2-E3 complex during ubiquitin-ligation (Foster et al., 2018). To test whether UBL- or
RING-deletion mutants can rescue Tet1s recruitment, Uhrf1-deficient E14 cells were co-
transfected with plasmids, encoding fluorescently tagged PCNA and Tet1s in combination
with Uhrf1-∆UBL or Uhrf1-∆RING. Confocal Z-stacks were acquired approximately 12
hours later and analysed for Tet1s acumulation in PCNA foci in PHC, as described earlier
(Figure 23B). Uhrf1-∆UBL failed to significantly increase the accumulation of Tet1s in
replicating PHC over the levels observed in EGFP control transfected Uhrf1 knock-out
cells. In contrast, a significant increase in Tet1s accumulation was observed upon co-
overexpression of Uhrf1-∆RING in comparison to E14-Uhrf1-/- co-transfected with EGFP or
EGFP-Uhrf1-∆UBL encoding plasmids (Figure 24B). In regard to the finding that deletion of
the E3 ubiqutin-ligase mediating RING domain failed to rescue the S-phase localization of
Tet1s and the fact that lysine 852 in Tet1s was shown to be monoubiquitinated, I performed
a CoIP of Uhrf1 with Tet1s or its respective lysine mutants. For this, HEK-293 cells were
co-transfected with mcherry-tagged Uhrf1 and EGFP or EGFP-tagged Tet1CD, Tet1CD-
K171R or Tet1CD-K171E mutants and protein lysates were prepared approximately 36
hours later. Cell extracts were incubated with an antibody against multiple red fluorescent
proteins coupled to sepharose beads. The input and bound fractions were seperated
by SDS-PAGE and transferred to nitrocellulose membranes. The fusion proteins were
detected with monoclonal antibodies against GFP and red fluorescent proteins. While
mcherry-Uhrf1 could not pull down GFP alone, EGFP-tagged wildtype Tet1CD as well as
Tet1CD-K171R and Tet1CD-K171E could all be pulled down by Uhrf1 (Figure 24C).
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Figure 24: The UBL-domain of Uhrf1 is requiered for Tet1s S-phase association. (A) Schematic of
full-length Uhrf1 indicating domain architecture. (B) Relative mcherry-Tet1s fluorescence intensity in PCNA
marked chromocenters and surrounding nucleoplasm was quantified by measuring three areas each and
putting them into relation. Boxplots depict the quantification results of the accumulation measurements of
E14 wildtype and E14-/- co-transfected with fluorescently tagged PCNA, Tet1s and either Uhrf1 or EGFP (n-
numbers: E14+EGFP=12, E14-/-+EGFP=12, E14-/-+EGFP-Uhrf1∆UBL=21, E14-/-+EGFP-Uhrf1∆RING=21).
Outliers are depicted as circles above boxes. P-values are given in the plot directly and were calculated
with a paired two-samples Wilcoxon test in RStudio version 1.1.447. (C) EGFP or EGFP-tagged Tet1CD,
Tet1CD-KtoR or Tet1CD-KtoE were ectopically overexpressed in HEK-293 cells together with mcherry-Uhrf1.
Cell extracts were analysed by immunoprecipitation using an immobilized antibody against multiple red
fluorescent proteins followed by western blotting with antibodies against GFP and red fluorescent proteins.
5.2.3 Tet1s localization is S-phase substage-dependent and independent
of ligase1
Besides its binding to hemimethylated DNA, Uhrf1 was shown to recognize and bind
trimethylated lysine 9 in the histone H3 tail (H3K9me3) (Liu et al., 2013b). This modification
was, however, shown to be dispensable for Uhrf1 recruitment to pericentric heterochro-
matin during ongoing DNA replication and subsequent DNA methylation maintenance by
Dnmt1 (Lu et al., 2015). I tested whether Tet1s recruitment is affected by the deficiency
of the histone methyltransferase Suv39, which is responsible for di- and trimethylation of
H3K9 (Peters et al., 2002; Lehnertz et al., 2003).
To address, whether Tet1s is still recruited during late S-phase in Suv39-deficient mouse
embryonic fibroblasts (MEF), I first tested whether Uhrf1 can still be recruited. For this,
I transfected wildtype MEF-W8 cells and Suv39-deficient MEF-D15 cells with fluores-
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cently tagged Uhrf1, PCNA and MaSat encoding plasmids and imaged the cells live,
approximately 8 hours later. In the wildtype as well as the Suv39-deficient cells, a clear
colocalization of Uhrf1 and PCNA at chromocenters was observed (Figure 25A), as it was
also published (Lu et al., 2015). To further address the binding of Tet1s in these cells, they
were again co-transfected with plasmids encoding fluorescently tagged PCNA, Uhrf1 and
Tet1s and imaged live after about 8 hours. Again, a clear colocalization between PCNA,
Uhrf1 and also Tet1s was observed (Figure 25B).
Figure 25: Tet1s localization in late S-phase is independent of the H3K9 methylation status. (A)
Representative, pseudocoloured confocal mid-Z-sections of wildtype MEF-W8 and Suv39-deficient MEF-
D15, cotransfected with fluorescently tagged PCNA, MaSat and Uhrf1. (B) Representative, pseudocoloured
confocal mid-Z-sections of wildtype MEF-W8 cells and Suv39-deficient MEF-D15 cells, cotransfected with
fluorescently tagged PCNA, Uhrf1 and Tet1s. Scale bars = 5 µm.
As I found Tet1s recruitment to sites of late DNA replication to be unaffected by DNA
hypomethylation and abscence of the H3K9 methylation marks, I deemed replication
association to be more important than general heterochromatin binding. To further address
this, I made use of a fluorescent three hybrid (F3H) assay, using the MEF-PM cells that are
deficient for Dnmt1 and, hence, retain only residual levels of 5mC within their major satellite
repeats (Casas-Delucchi et al., 2012a). I first assessed the Uhrf1 S-phase distribution in
MEF-PM cells, by transfecting the cells with EGFP-Uhrf1 and mRFP-PCNA. While in early
or mid S-phase only very few focal, if at all, Uhrf1 accumulations were observed, a clear,
chromocenter-like, pattern was observed in late S-phase (Figure 26A). For the MEF-PM
based F3H assay, the major satellite recognizing zinc-finger protein MaSat, fused to a
GFP-binding nanobody (GBP-MaSat) (Casas-Delucchi et al., 2012b)was co-transfected
with a EGFP fusion protein as bait and a different fluorescently tagged protein as prey.
EGFP or EGFP-fusion proteins are tethered to chromocenters via the GBP-MaSat and,
thus, independent of the DNA methylation status and a colocalization with the prey protein
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is observed in case of protein-protein interactions. If cell-cycle independent interactions are
observed, this colocalization persists throughout the different S-phase and non-S-phase
substages as we found for example, for Tet1 and the methyl-CpG-binding domain protein
Mbd1 (Zhang et al., 2017c).
To monitor the cell cycle stage, I co-transfected miRFP-PCNA together with the minimal
Uhrf1-interacting Tet1 domain and EGFP or EGFP-Uhrf1 with or without GBP-MaSat
in MEF-PM cells. Cells were imaged live 8 hours post transfection and all cells that
showed EGFP-labelled chromocenter-like patterns were counted. Interestingly, around
50% of all cells with an EGFP-labelled chromocenter pattern showed a colocalization of
mcherry-Tet1CD with the EGFP signal, independent of whether EGFP or EGFP-Uhrf1 were
co-transfected. In contrast, almost 90% of cells without GBP-MaSat co-transfection but
EGFP-Uhrf1 foci showed a colocalization between the mcherry-Tet1CD and EGFP-Uhrf1
signals (Figure 26B). When I analysed the respective PCNA patterns in these cells, it
was observed that non-targeted cells with a clear colocalization between Tet1 and Uhrf1
showed a PCNA late S-phase pattern in most of the cases. However, cells co-expressing
GBP-MaSat that showed a clear EGFP-Uhrf1 chromocenter localization, but no mcherry-
Tet1CD accumulation were found to also be in early or mid S-phase or non-S-phase (not
shown). Taken together, this in situ interaction assay emphasizes an S-phase substage
dependent interaction between Tet1 and Uhrf1.
Tethering Uhrf1 to chromocenters could not provoke a premature Tet1CD recruitment,
before late S-phase (Figure 26B). This furthermore hinted to a replication-dependent
recruitment mechanism for Tet1s. A recent study proposed that Uhrf1 recruitment during
DNA replication-coupled methylation maintenance, is achieved by binding to a H3K9me3-
mimicking peptide in DNA ligase1. It was found that Uhrf1 recruitment, as well as global
5mC levels are severly decreased, upon mutating the respective peptide (Ferry et al.,
2017). Based on this finding, I was interested to test, whether abscence of ligase1 would
affect the recruitment of Tet1s. For this, I made use of recently published ligase1-deficient
E14 mouse ESCs and corresponding wildtype cells (Ferry et al., 2017) and validated the
ligase1 knockout by immunostaining against ligase1 (Figure 27A). To adress, whether
Tet1s can still be recruited to DNA replication sites in PHC, I cotransfected the cells with
plasmids that encode fluorescently tagged PCNA, Tet1s and MaSat and acquired confocal
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Figure 26: Tet1 localization to pericentric heterochromatin is restricted to late S-phase. (A) Confocal
mid-Z-sections of MEF-PM cells, transiently expressing EGFP-Uhrf1 and mRFP-PCNA. Cells were imaged
live approximately eight hours post transfection. Shown are cells in representative S-phase substages. (B)
Schematic of the MEF-PM based F3H-assay. MEF-PM cells were transfected with mcherry-Tet1CD and
EGFP or EGFP-Uhrf1 with or without GBP-MaSat. Approximately eight hours post transfection, cells with
EGFP-labelled chromocenters were imaged live. The bargraph depicts the percentage of cells that showed
a colocalization between EGFP-labelled chromocenters and mcherry-Tet1CD (n-numbers: EGFP-Uhrf1=17,
GBP-MaSat+EGFP=20, GBP-MaSat+EGFP-Uhrf1=32). Scale bar = 5 µm.
Z-stacks live, approximately ten hours later. The accumulation of Tet1s in PCNA marked
pericentric heterochromatin was assessed as previously described (Figure 23B). I found




Figure 27: Tet1 localization to pericentric heterochromatin is not affected by the loss of DNA ligase1.
(A) Confocal mid-Z-sections of E14 wildtype and E14-ligase1-/- mouse embryonic stem cells, immunostained
against PCNA, ligase1 and counterstained with DAPI. (B) Boxplots depict the quantification results of the
accumulation measurements in E14 wildtype and E14-ligase1-/- co-transfected with fluorescently tagged
PCNA, Tet1s and MaSat (n-numbers: E14=12, E14-ligase1-/-=8). (C) Pseudocolored, representative mid
Z-section of a E14-ligase1-/- ESC, co-transfected with fluorescently tagged PCNA, Tet1s and MaSat. Scale
bars = 5 µm.
5.3 Tet1s overexpressing cells show aberrant cytosine modification
levels
5.3.1 Tet1s localization is conserved between mouse and human
The short isoform of Tet1 was identified to be expressed predominantly in somatic cells
(Zhang et al., 2016b) and was furthermore found to be overexpressed in different cancer
cells (Good et al., 2017). A hallmark of most cancer types are aberrant cytosine modifi-
cation levels. On one hand, a global hypomethylation is observed in most cancers, while
local hypermethylation is often found in the context of promoter and coding regions of
tumour suppressor genes that are usually hypomethylated in normal tissues (Vidal et al.,
2017). In addition, many cancers also show a global loss of genomic 5hmC (Yang et al.,
2013). Interestingly, the canonical Tet1 promoter is found to become hypermethylated in
cancer cells (Li et al., 2016), which leads to the use of an alternate promoter and TSS and
consequently the expression of a N-terminally truncated, but catalytically active isoform of
Tet1, Tet1s (Good et al., 2017). I therefore wanted to address the localization of Tet1s in
human cancer cells.
MCF7 breast cancer cells were shown to overexpress Tet1s (Good et al., 2017). As I
performed all my previous experiments in murine cells, I first tested whether the described
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S-phase localization pattern of Tet1s (Figure 10B) is conserved between mouse and
human. For this, MCF7 breast cancer cells and MCF10a mammary gland cells that serve
as non-tumorigenic control cells, were co-transfected with EGFP-Tet1s and mRFP-PCNA
encoding plasmids and the localization of Tet1s analyzed. Cells in early, mid and late
S-phase, identified by the respective PCNA pattern, were imaged live approximately 12
hours after transfection. In the MCF10a control cells, as well as the MCF7 breast cancer
cells, a clear Tet1s accumulation at PCNA foci during late S-phase was observed, while no
accumulation was found in early and mid S-phase cells (Figure 28A). As it was published
that the MCF7 cells overexpress Tet1s (Good et al., 2017) (Figure 28B), I immunostained
them with a Tet1 specific antibody, which is directed against the unstructured C-terminal
region that splits the DSBH and therefore can detect full-length Tet1 and also Tet1s. Sur-
prisingly, a nuclear, focal Tet1 pattern was observed which, however, did not colocalize with
PCNA and was, moreover, found in nuclear regions with a weak DAPI-staining (Figure
28C).
Figure 28: Tet1s is expressed in MCF7 breast cancer cells. (A) Shown are mid-Z sections of non-
tumorigenic MCF10a breast epithelial cells and MCF7 breast cancer cells that were transfected with
EGFP-Tet1s and mRFP-PCNA. Cells were imaged live approximately 12 hours post transfection and confocal
Z-stacks were acquired. (B) Representative western blot of MCF10a and MCF7 cells probed with an antibody
against Tet1. Cutouts show the respective Tet1 bands at approximately 235 kDa (Tet1) and 165 kDa (Tet1s).
A cutout from the Ponceau stained membrane is shown as loading control. (C) Confocal mid-Z-section image
of the nucleus of a MCF7 breast cancer cell that was immunostained against PCNA and Tet1 and the DNA
counterstained with DAPI. Scale bars = 5 µm.
5.3.2 Cancer cells that overexpress Tet1s show aberrant cytosine
modification levels
Many cancer cells are characterized by aberrant cytosine modification levels. In regard to
the finding that the short isoform of Tet1 can also localize to late replication chromatin in
cancer cells (Figure 28A), I was interested to see, whether global 5mC and 5hmC levels
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are altered between MCF7 breast cancer cells and the non-tumorigenic MCF10a mammary
gland cells. To test this, cells were seeded on glass coverslips and simultaneously
immunostained against 5mC and 5hmC and counterstained with DAPI. Immunostained
cells were imaged with a wide-field high content screening microscope and the respective
sum nuclear fluorescence levels were quantified. To control, for the potential of the two
antibodies blocking each others epitope access, I also performed single stainings for either
5mC or 5hmC. I found no intensity differences compared to double stained cells and
therefore continued to analyse the fluorescence intensities of DAPI, Alexa-488 labelled
5mC and Alexa-594 labelled 5hmC in double-stained cells. For the analysis the sum
nuclear 5mC and 5hmC levels were normalized to the averaged sum
Figure 29: MCF7 breast cancer cells show aberrant cytosine modification levels. (A) Scheme of the
experimental procedure. MCF10a and MCF7 cells were seeded on glass coverslips and the next day fixed and
immunostained against 5mC and 5hmC and counterstained with DAPI. Cells were imaged with a wide-field
high content screening microscope and sum nuclear fluorescence levels were quantified. (B) Representative
confocal mid-Z-sections of 5mC and DAPI stained nuclei of MCF10a and MCF7 cells and corresponding
boxplots showing the normalized sum nuclear 5mC intensity. Nuclear 5mC levels were normalized to the
sum DAPI signal and the averaged fluorescence intensity signal of cells that were only incubated with the
respective secondary antibody (n-numbers: MCF10a=9635, MCF7=32715). (C) Representative confocal
mid-Z-sections of 5hmC and DAPI stained nuclei of MCF10a and MCF7 cells and corresponding boxplots
showing the normalized sum nuclear 5hmC intensity. Nuclear 5hmC levels were normalized as just described
(n-numbers: MCF10a=9635, MCF7=32715). Statistical significance was tested with paired two-samples
Wilcoxon test in RStudio version 1.1.447. Scale bars = 5 µm.
nuclear Alexa-488 and Alexa594 fluorescence of cells that were only incubated with the
secondary antibodies, but not the primary ones, to exclude background fluorescence
from the analysis. To furthermore compensate for cell cycle effects and differences in
DNA content, the signal was normalized to the sum nuclear DAPI intensity. Analysing
the respective sum nuclear fluorescence levels in this way, I found that the MCF7 breast
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cancer cells show significantly reduced global levels of 5mC and also 5hmC in contrast to
the non-tumorigenic MCF10a cells. (Figure 29B, C).
5.3.3 Pericentric heterochromatin is depleted of 5mC and 5hmC in cancer cells
I have shown in this work that the S-phase recruitment of Tet1s to chromocenters in mouse
myoblasts is accompanied by a massive 5hmC increase in pericentric heterochromatin
(Figure 19C). Based on this finding and the reduction of global 5mC and 5hmC levels in
MCF7 breast cancer cells (Figure 29A, B), I set out to quantify the respective cytosine
modification levels in heterochromatic regions of MCF7 and MCF10a cells. In contrast to
the acrocentric chromosomes of mice that all harbour a large pericentric heterochromatin
domain (Guenatri et al., 2004), large clusters of highly methylated pericentric heterochro-
matin in humans are predominantly found in chromosomes 1, 9, 16 and in male cells
also the Y chromosome (Miller et al., 1974). Hence, human cells show fewer and smaller
heterochromatic subnuclear domains.
To address the levels of 5mC and 5hmC in situ, confocal Z-stack images were acquired
of MCF10a and MCF7 cells that were simultaneously immunostained against 5mC and
5hmC and counterstained with DAPI. For the analysis of the 5mC and 5hmC levels in DAPI
dense regions, maximum intensity Z-projections were generated and a circular region
of interest with a radius of 5 pixels was chosen and the respective mean fluorescence
intensities measured (Figure 30A). The mean levels of 5mC and 5hmC were normalized
to the respective DAPI levels and plotted. Similar to the observations made for global
5mC and 5hmC levels, MCF7 cells showed a significant reduction of both modifications
compared to MCF10a cells (Figure 30C, D), with a major decrease in 5mC levels. This is
also reflected in the respective ratios of 5hmC to 5mC levels in the measured regions that
almost doubled in MCF7 cells, compared to MCF10a cells (Figure 30B).
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Figure 30: Levels of 5mC and 5hmC in heterochromatin-rich regions in breast cancer cells. (A)
Rational of the experimental procedure. MCF10a and MCF7 cells were seeded on glass cover slips and
the next day fixed and immunostained against 5mC and 5hmC and counterstained with DAPI. Confocal
Z-stacks were acquired and analysed with ImageJ. Maximum intensity Z-projections were generated and
the mean nuclear levels of 5mC and 5hmC in DAPI dense focal regions that represent heterochromatin-rich
regions, measured in a ROI with a radius of 5 pixels and normalized to the respective DAPI signal. (B) The
ratio of mean 5mC and 5hmC in DAPI-dense regions of MCF10a and MCF7 cells was plotted. (C) Mean
fluorescence intensity of 5mC in DAPI-dense focal regions in MCF10a and MCF7 cell nuclei (n-numbers:
MCF10a=32, MCF7=38). (D) Mean fluorescence intensity of 5hmC in DAPI-dense focal regions in MCF10a
and MCF7 cell nuclei (n-numbers: MCF10a=32, MCF7=38). Statistical significance was tested with paired
two-samples Wilcoxon test in RStudio version 1.1.447. Scale bars = 5 µm.
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6 Discussion & Perspective
The main objective of the present study was to elucidate, whether Tet proteins can be
recruited during ongoing DNA replication, which would emphasize a role in the mainte-
nance of 5mC oxidation products during the cell cycle and in particular during S-phase.
I therefore addressed the nuclear localization of the different Tet proteins and found a
late S-phase recruitment of the short isoform of Tet1, but not for full-length Tet1, Tet2
or Tet3, during ongoing DNA replication in pericentric heterochromatin. I continued to
investigate the domains of Tet1s that mediate S-phase recruitment and found that the
cysteine-rich domain within the catalytic domain of Tet1 is needed not only for catalytic
activity but also for the association with ongoing DNA replication in late S-phase. Based
on this finding, I further dissected the CRD and found a conserved lysine to be crucial
for the observed S-phase localization of Tet1s. S-phase localization was abrogated upon
mutating the said lysine to arginine (Tet1s-K852R). However, global 5hmC levels were
significantly increased in cells that transiently overexpressed Tet1s-K852R, compared to
wildtype Tet1s overexpressing cells. This observation was explained by analysing 5hmC
levels in situ and I found that Tet1s-mediated 5hmC formation was mostly restricted to
pericentric heterochromatin, whereas Tet1s-K852R overexpression increased 5hmC levels
on a more global scale. (Section 5.1, 6.1)
I could moreover show that Tet1s recruitment to PHC during DNA replication is indepen-
dent of its catalytic activity and was also not affected by a strong decrease of global DNA
methylation levels or the absence of the maintenance DNA methyltransferase Dnmt1. In
contrast, I found that Uhrf1, an important facilitating factor of Dnmt1, physically interacts
with Tet1. Besides this, I could show that Tet1s recruitment to DNA replication in peri-
centric heterochromatin is lost in Uhrf1-deficient cells, but can be rescued by ectopically
reintroducing Uhrf1. (Section 5.2, 6.2)
Finally, I found the described S-phase localization of Tet1s to be conserved also in cancer
cells that are known to overexpress Tet1s. I could show that these cancer cells, in compari-
son to non-tumorigenic cells, are characterized by a significant decrease of global 5mC
and 5hmC levels globally and also in pericentric heterochromatin, whereby especially 5mC
is depleted in heterochromatic domains of breast cancer cells. (Section 5.3, 6.3)
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6.1 The short isoform of Tet1 localizes to pericentric heterochro-
matin during ongoing DNA replication
The proteins of the Tet dioxygenase family, Tet1, Tet2 and Tet3, have all been shown to
oxidise the repressive DNA modification 5mC to create 5hmC, 5fC and 5caC and thereby
diversify the epigenetic information in eukaryotic cells (Tahiliani et al., 2009; Ito et al.,
2011; Pfaffeneder et al., 2011). Similar to 5mC, the Tet-mediated oxidation products were
shown to be stable DNA modifications throughout the cell cycle, which is in line with their
specific signalling functions (Bachman et al., 2014; Bachman et al., 2015). Recently, a
short isoform of Tet1, the founding member of the Tet protein family, was identified and
shown to be overexpressed in cancer cells, which show loss of non-modified euchromatic
regions, due to aberrant DNA methylation spreading (Good et al., 2017). This observation
was in part attributed to the N-terminal, chromatin-binding BC- and CxxC-domains of Tet1
that are not present in its short isoform, which therefore shows a significantly reduced
chromatin-association (Zhang et al., 2016b). The chromatin-binding ability of full-length
Tet1 has before been implicated in the maintenance of euchromatin integrity by preventing
DNA methylation spreading into non-methylated CpG-islands in somatic cells (Jin et al.,
2014).
Despite these findings, little is known on how the 5mC oxidation products are maintained
throughout the cell cycle. This prompted me to investigate the cell cycle localization of
the putative maintenance dioxygenase Tet1 (Jin et al., 2014) and its short isoform, but
also of Tet2 and Tet3. By addressing the spatio-temporal nuclear localization of Tet1 and
Tet1s with live-cell time lapse microscopy, I observed a significant accumulation of Tet1s
at sites of ongoing DNA replication in pericentric heterochromatin during late S-phase
(Figure 10B, C). Full-length Tet1 on the other hand, did not show any focal accumulations
during ongoing DNA replication in either of the S-phase substages. These difference in
localization can be explained by the retention of full-length Tet1 in euchromatic regions
via its CxxC- and BC-domains, which have both been shown to concomitantly facilitate
the strong Tet1 chromatin association. Tet1s, on the other hand, which lacks both of these
domains (Figure 10A), was shown to be found predominantly in the soluble fraction in
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cellular fractionation experiments and furthermore to be highly susceptible to detergent
extraction (Zhang et al., 2016b). These findings in part also explain my observation that
the late S-phase association of Tet1s can not be fixed, necessitating to address this
localization in live-cell microscopy experiments. To further dissect the role of Tet1 and
Tet1s in the nucleus during different S-phase stages and in different nuclear regions, FRAP
(fluorescence recovery after photobleaching) experiments could provide insight into binding
kinetics. Fast binding kinetics of Tet1s in chromocenters during DNA replication would
further explain, why it could not be fixed. For full-length Tet1 on the other hand, a strong
euchromatic binding is to be expected, while its kinetics in PHC are likely faster, due to its
different mode of chromatin binding via the N-terminus.
In this line, FRAP experiments could also be used to further elucidate the role of the
N-terminal BC- and CxxC-domains. The observation that the deletion of the CxxC-domain
was sufficient to target the respective Tet1 deletion mutant to replicating chromocenters,
hints to the CxxC-domain as major facilitator of the full-length Tet1 euchromatin localization
(Figure 11), as it was also speculated before (Jin et al., 2014). The observed premature
heterochromatin association of the Tet1 CxxC deletion mutant, in comparison to Tet1s
(Figure 11B), hints to a general chromatin association via the BC-domain, with a potential
bias for methylated DNA. This could be addressed by testing the binding affinities of
respective N-terminal deletion-mutants to differentially modified DNA substrates in vitro.
Interestingly, Tet1s overexpression markedly increased global 5hmC levels in comparison
to cells that overexpressed full-length Tet1 (Figure 10D. In line with this finding, we could
previously show that ectopic overexpression of the catalytic domain of Tet1, which shows
the same S-phase localization as Tet1s (Figure 12 A), significantly increases global
5hmC levels. The significantly increased 5hmC levels, upon Tet1CD overexpression, were
accompanied by increased reexpression and reactivation of major satellite repeats and
LINE1 retrotransposable elements in mouse and human cells (Ludwig et al., 2017; Zhang
et al., 2017b). Fittingly, a previous study found that overexpression of full-length Tet1
resulted only in minor transcriptional changes, whereas Tet1s overexpression resulted in
fatal transcription defects during development (Zhang et al., 2016b).
The observation that Tet1CD is sufficient for late S-phase localization, led me to investigate
also the S-phase localization of the structurally, highly similar (Figure 5A) (Bauer et al.,
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2015) catalytic domains of Tet2 and Te3, but also the respective full-length proteins. For
neither of the variants of Tet2 or Tet3, S-phase accumulations, similar to those observed
for Tet1s or Tet1CD, were found (Figure 13). This observation hints to a distinct biological
role for the short isoform of Tet1. Accordingly, although all three Tet proteins share the
same catalytic activity, distinct roles in development have been implicated (Santiago et al.,
2014).
Based on the finding that its catalytic domain is sufficient for the observed Tet1s-localization
in late S-phase, I further dissected Tet1CD and tested whether its main domains, the CRD
and the DSBH, can individually localize to late replicating DNA or be catalytically active.
Both domains alone failed to increase global 5hmC levels, in stark contrast to Tet1CD
(Figure 14C), which fits to structural studies on the catalytic domain of Tet2. This study
found that a peptide within the CRD, which is conserved between all three Tet proteins, is
needed to stabilize the DNA around the substrate base, in the catalytic center. The actual
substrate and cofactor binding and the accompanied flipping of the substrate base are
facilitated by the DSBH (Hu et al., 2013). These findings underline that neither the CRD,
nor the DSBH can act on 5mC or its oxidative derivatives by themselves.
When I addressed the respective late S-phase localization of the CRD and the DSBH, I
found only a minor accumulation for the CRD, while the DSBH did not accumulate at all
(Figure 14A). Fittingly, a Tet1s-mutant that lacks the CRD also failed to increase 5hmC
levels and to localize to sites of ongoing DNA replication in PHC (Figure 15).
With regard to the observation that the deletion of the CRD renders Tet1s catalytically
inactive and abrogates its S-phase localization, it would be interesting to see whether the
fusion protein that results from the eponymous MLL-Tet1 genomic translocation (Ono, Taki,
and Taketani, 2002; Lorsbach et al., 2003) is catalytically active or shows any noteworthy
S-phase localization patterns. The genomic breakpoint in intron 8 of Tet1 results in a
fusion protein where the N-terminus of MLL/KMT2 that harbours a DNA-binding AT-hook
and a CxxC-domain, is fused to the C-terminal part of the catalytic domain of Tet1, hence
its DSBH without the CRD (Allen et al., 2006; Hamidi, Singh, and Chen, 2015). As
demonstrated in this work and known from structural work on Tet2 (Hu et al., 2013), the
CRD of Tet proteins is essential for their catalytic activity and in the case of Tet1s also for
the S-phase recruitment. Hence, the CxxC-domain and/or the AT-hook of MLL could either
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replace the CRD and its chromatin-binding ability in the MLL-Tet1 fusion protein or it would
be rendered catalytically inert by the underlying genomic translocation.
As the CRD was identified as the domain that mediates late S-phase association of Tet1s,
I examined it for motifs that could facilitate this accumulation. A previous study found Tet1
to interact with the replication-associated clamp loader protein PCNA, which was shown
to mediate Tet1 activity (Cartron et al., 2013). In regard to this finding, I screened the
proteinsequences of full-length Tet1, Tet2 and Tet3 for a PCNA binding domain (PBD) that
is characterized by a conserved consensus sequence. I found a highly similar sequence
in the CRD of Tet1 (Figure 16A) but not Tet2 or Tet3 and proceeded to test its PCNA
association capability. The major difference between the putative PBD of Tet1 and the
PBD-consensus sequence, is a hydrophilic lysine that replaces the central hydrophobic
amino acid residue in canonical PBDs and the putative PBD of Tet1 did to not colocalize
with PCNA during ongoing DNA replication (Figure 16B). This finding can most likely be
explained with the just described central amino acid substitution and it would be interesting
to see, whether the putative PBD of Tet1 could be rendered active by exchanging the lysine
to a leucine or isoleucine. A successful reactivation of the putative PBD, hence a restored
interaction with PCNA, would hint to an initial function that was lost during evolution or
replaced by a different mode of recruitment, respectively.
The before described conserved peptide in the CRD of all Tet proteins that stabilizes
the DNA around the substrate was found to harbour a central lysine (K852), whose
CRL4(VprBP)-mediated monoubiquitination was linked to the modulation of the catalytic
activity in all three Tet proteins (Figure 17A, B) (Yu et al., 2013; Nakagawa et al., 2015).
Mutating this conserved lysine in Tet1s to arginine or glutamate abrogated replication
association during late S-phase completely (Figure 17C, D), emphasizing that it indeed
plays a crucial role during Tet1s replication association. Surprisingly, global 5hmC levels in
cells that overexpressed Tet1s-K852R were significantly increased compared to cells that
overexpressed wildtype Tet1s or Tet1s-K852E (Figure 18). Overexpression of Tet1s-K852E
resulted only in a very minor 5hmC increase, which can be explained by the DNA-binding
role of the surrounding peptide (Hu et al., 2013). Whereas the positively charged lysine or
arginine can stabilize the negatively charged phosphate backbone of the DNA, substitution
to a negatively charged glutamate could significantly distort this interaction and only a
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residual catalytic activity is retained. To further examine the markedly increased 5hmC
levels in Tet1s-K852R overexpressing cells, I addressed the nuclear 5hmC distribution in
situ (Figure 19A). In the course of this experiment, I found that Tet1s overexpressing cells
showed a significant 5hmC increase in chromocenters, hence, pericentric heterochromatin
(Figure 19B, C). In contrast to this, 5hmC levels in cells that overexpressed Tet1s-K852R
were also significantly increased in the nucleoplasm, outside of chromocenters, compared
to Tet1s overexpressing cells. This hints to a targeted mode of Tet1s catalytic activity,
which could be further addressed by investigating cells that overexpress lower levels of
Tet1s or Tet1s-K852R. On the other hand, the respective mutants could be introduced into
the endogenous Tet1 locus to observe the effects of physiological expression levels on
5hmC production. This would of course also necessitate to ensure the expression of only
the short isoform of Tet1s. The expression of only the short isoform could be achieved
by either deleting exon 1 from the endogenous locus or render the canonical promoter
inactive, to trigger expression of only the short isoform.
On the basis of these findings, I was interested in the cell cycle localization of the proteins
of the CRL4(VprBP)-complex that were found to be responsible for the monoubiquitination
of the conserved lysine (Figure 17A) in all Tet proteins (Yu et al., 2013; Nakagawa et al.,
2015). Although, the proteins of the CRL4(VprBP)-complex have been implicated in various
cellular processes, like DNA replication or repair (Angers et al., 2006; Jackson and Xiong,
2009), little is known about their subcellular dynamics. The histone H3 directed kinase
VprBP serves as the central adapter molecule in the CRL4(VprBP)-complex, bringing
together the E2 ubiquitin-conjugating enzymes, the E3 ubiquitin-ligases and their respective
targets (Angers et al., 2006). Examining the localization of VprBP throughout S-phase
by live-cell time lapse microscopy, showed a cytoplasmatic to nuclear translocation with
S-phase progression, besides its pancellular localization (Figure 20A, B). Interestingly,
when late S-phase DNA replication foci in cells that co-overexpressed fluorescently tagged
PCNA, Tet1s and VprBP were examined in close detail, a colocalization of the three
proteins was discovered. The observed cytoplasmatic to nuclear translocation of VprBP,
as well as the replication foci association in late S-phase is in line with previous findings.
It was demonstrated that the chromatin association of VprBP, but also its associated E3
ubiquitn ligase Cul4A, which targets Tet proteins (Yu et al., 2013; Nakagawa et al., 2015),
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increases throughout S-phase and is strongest during late S-phase and G2 (McCall et al.,
2008). Considering that VprBP bridges the interaction between Tet proteins and the CUL4
E3 ubiquitn-ligases, it is very likely that Tet1s ubiquitination by the CRL4(VprBP) complex
takes place during late S-phase. This would eventually recruit Tet1s to sites of ongoing
DNA replication for targeted catalytic activity in pericentric heterochromatin. Mutations of
the conserved lysine residue (Figure 17C, D) resulted in the loss of S-phase recruitment
of Tet1s and furthermore support this idea. Consistently, knockdown of Cul4A, Cul4B or
VprBP was shown to negatively affect the catalytic activity of Tet proteins (Yu et al., 2013;
Nakagawa et al., 2015).
However, it still needs to be tested, whether depleting cells of Cul4A, Cul4B or VprBP
also abrogates the observed S-phase localization of Tet1s. In order to address this
question, lentiviral knockdowns of different components of the CRL4(VprBP) complex
are being established, to test the effect of depletion of the respective proteins. If the
monoubiquitantion of lysine 852 in Tet1s plays a role in its late S-phase recruitment, this
pattern might be lost upon knockdown of the respective E3-ligases. If the ubiquitination
of lysine 852 is also required for targeted catalytic activity, depletion of the Tet1s-K852
monoubiquitination facilitators might result in a similar nuclear 5hmC pattern, as it was
observed for the Tet1s-K852R mutant that also lost its S-phase localization (Figure 17C,
D, 19).
Taken together, I found that the short isoform of Tet1 is recruited to sites of ongoing DNA
replication in pericentric heterochromatin, which is accompanied by a massive increase
of 5hmC levels in chromocenters. Full-length Tet1 recruitment to these sites, is likely
prevented by its binding to non-modified euchromatin via its N-terminal CxxC-domain in
interplay with the adjacent BC-domain (Figure 31).
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Figure 31: Summary of S-phase behaviour and catalytic activity of different Tet proteins and sub-
domains. (A) Schematic protein structure of Tet1. Lines above the protein structure denote different
constructs that were used in this study. (B) Table summarizing the association capability of different ectopi-
cally expressed Tet1, Tet2 and Tet3 constructs at PCNA marked late replicating pericentric heterochromatin.
Furthermore the effect on global 5hmC levels, upon overexpression is summarized (n.d.=not determined
in this study. Catalytic activity of Tet2CD and Tet3CD was addressed previously (Zhang et al., 2017c).)
(C) Schematic summary of the key findings of (Section 5.1). Tet1s is recruited to sites of ongoing DNA
replication in late S-phase, which is accompanied by an increased 5mC oxidation. This recruitment depends
on a conserved lysine within the CRD of Tet1. Full-length Tet1 is not recruited during DNA replication and is
known to bind to non-modified DNA in euchromatic regions via its N-terminal BC- and CxxC-domain (Zhang
et al., 2016b).
6.2 Uhrf1 is crucial for Tet1s replication association
Uhrf1 has been implicated as a crucial factor in DNA methylation maintenance, as it
recognizes and binds hemimethylated DNA and interacts with the histone H3-tail in the
vicinity of hemimethylated CpGs (Hashimoto et al., 2008; Qin et al., 2015). This multimodal
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chromatin interaction recruits Dnmt1 for methylation maintenance during DNA replication.
Loss of Dnmt1 or Uhrf1 results in severe phenotypes (Section 2.5.5), underlining their
crucial role in cellular homeostasis. As cells that lack Dnmt1 or Uhrf1 are characterized
by global DNA hypomethylation (Lande-Diner et al., 2007; Sharif et al., 2007), I was
interested to see, whether loss of either of these two proteins or the consequent loss of
DNA methylation could affect the observed Tet1s localization during late S-phase.
While qualitatively assessing the localization of Tet1s in Dnmt1 and Uhrf1 deficient cells,
I found that Tet1s recruitment to ongoing DNA replication in pericentric heterochromatin
is unaffected by the loss of Dnmt1 and the drastically reduced 5mC levels (Figure 21A).
The qualitative assessment of Tet1s localization during ongoing DNA replication in PHC in
Uhrf1-deficient mouse embryonic stem cells, on the other hand, showed no accumulation,
while a clear Tet1s recruitment in the corresponding wildtype cells was observed (Figure
21B, Figure 23).
Tet1s was previously shown not to be expressed in ESCs, but only in somatic cells upon
differentiation (Zhang et al., 2016b). Hence, this indicates that the general recruitment
mechanism that underlies the S-phase localization of Tet1s is not restricted to somatic
cells, but also active in ESCs and therefore independent of the differentiation status of the
cell.
In many of the live-cell experiments, I made use of a triple transfection with fluorescently
tagged Tet1s, PCNA and also a major-satellite repeat recognizing polydactyl zinc-finger
protein (Lindhout et al., 2007), to mark pericentric heterochromatin in addition to DNA
replication sites (Figure 21, 12). Interestingly, we could show in a previous publication that
Tet1CD mediated 5hmC formation in pericentric heterochromatin is counteracted by block-
ing DNA access through sequence-specific DNA-binding proteins, like said major-satellite
recognizing zinc-finger (Ludwig et al., 2017). Despite this finding, co-overexpression with
this zinc-finger protein did not prevent Tet1s or Tet1CD localization to sites of ongoing DNA
replication in PHC (Figure 21, 12). This hints to a protein-protein interaction mediated
replication association, via players, whose chromatin-association is unaffected by the
occupancy of binding sites in major satellite repeat-containing heterochromatic DNA by
another protein. With respect to the multimodal heterochromatin association of Uhrf1
during ongoing DNA replication and the observed absence of Tet1s from DNA replication
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sites in PHC in Uhrf1-deficient cells, this underlines the importance for Uhrf1 in Tet1s
replication association.
Prompted by the finding that Uhrf1-deficiency abrogated Tet1s replication association,
I tested, whether Uhrf1 and Tet1 can physically interact. For this purpose, I performed
co-immunoprecipitation experiments with Tet1CD, hence the minimal domain of Tet1 that
still colocalizes with ongoing DNA replication and is also still catalytically active (Figure
12A, 14C) and full-length Uhrf1 as well as different single-domain deletion mutants. With
this approach I found that immobilized full-length Uhrf1, as well as, all of its single domain
deletion mutants were able to pull down Tet1CD (Figure 22).
The findings that Uhrf1-deficiency abrogates Tet1s recruitment to DNA replication sites
in PHC and that Uhrf1 and Tet1 physically interact, led me to test, whether the absent
Tet1s recruitment in Uhrf1-deficient cells can be rescued by reintroducing Uhrf1. With this
approach, I found that ectopic overexpression of Uhrf1 in Uhrf1-deficient cells could restore
the accumulation of Tet1s to similar levels as observed in wildtype ESCs (Figure 23A,
C). I have shown initially that Tet1s accumulation was not affected by Dnmt1-deficiency
(Figure 21A) or the accompanied, severely decreased DNA methylation levels (Lande-
Diner et al., 2007). It can, therefore, be assumed that potentially changing DNA methylation
levels, upon Uhrf1 reintroduction, did not play a role in the restored Tet1s accumulation.
Interestingly, the structurally highly similar Uhrf1 homologue, Uhrf2 failed to rescue the
Tet1s accumulation phenotype. Uhrf2 was identified to specifically recognize and bind
5hmC in neuronal progenitor cells (NPCs) via its SRA domain (Spruijt et al., 2013b; Zhou
et al., 2014). The failure to restore Tet1s localization in an Uhrf1-deficient background,
despite its affinity for 5hmC, can likely be explained by the different chromatin readout
in comparison to Uhrf1 (Vaughan et al., 2018). The findings that the E3 ubiquitin-ligase
activity of Uhrf2 towards histone H3 is promoted by hydroxymethylated DNA (Vaughan
et al., 2018) however pose an interesting starting point, to further investigate, how 5hmC is
maintained in general during the cell cycle in somatic cells, where Uhrf2 is predominantely
expressed (Pichler et al., 2011).
From the findings in the co-immunoprecipitation experiments that all single-domain deletion
mutants of Uhrf1 can physically interact with Tet1, I deduced that at least two domains
of Uhrf1 are responsible for this interaction. In the present work, I could show that a
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conserved lysine within the CRD of Tet1s that is known to be monoubiquitinated, is needed
for the association of Tet1s with ongoing DNA replication in PHC (Figure 17C, D). In
regard to my finding and the previously described monoubiquitination of this lysine (Yu
et al., 2013; Nakagawa et al., 2015), I reasoned that the UBL and the RING domain of
Uhrf1 are most likely the domains responsible for the protein-protein interaction with Tet1.
The interplay of the UBL and the RING domain of Uhrf1 was recently shown to be crucial
during the maintenance of DNA methylation in DNA replication (Foster et al., 2018). This
study found that the UBL of Uhrf1 connects the E2 ubiquitin-conjugating enzyme UbcH5a
with the RING-domain of Uhrf1 to facilitate histone H3-tail monoubiquitination, which in
turn results in faithful DNA methylation maintenance via Dnmt1 (Qin et al., 2015).
When I tried to ectopically rescue the localization of Tet1s in Uhrf1-deficient cells with
either a UBL- or a RING-domain deficient Uhrf1 construct, I found that deletion of the
UBL failed to restore Tet1s localization. Deletion of the RING domain, on the other hand,
resulted in a significantly increased Tet1s accumulation compared to control-transfected
Uhrf1-deficient ESCs (Figure 24B). This observation hints to the UBL of Uhrf1 as the major
Tet1s interacting domain. I furthermore tested whether the interaction of Uhrf1 and Tet1 is
mediated via the conserved lysine residue of the CRD of Tet1 by co-immunoprecipitation
experiments. However, immobilized Uhrf1 could successfully bind to wildtype Tet1CD
and also its respective KtoR or KtoE mutants (Figure 24C). Taken together these results
indicate that the UBL of Uhrf1 plays a crucial role in Tet1s recruitment during ongoing DNA
replication, but does not bind to Tet1 via the conserved lysine in its CRD.
Prompted by the physical interaction between Tet1 and Uhrf1, I tested whether Tet1s can
be recruited to chromocenters outside of DNA replication, by tethering Uhrf1 to major-
satellite repeats (Figure 26B). With this approach I could show that the in situ interaction
of Tet1 and Uhrf1 is S-phase substage dependent, as Uhrf1 tethering could not increase
the number of cells with Tet1-Uhrf1 co-localization compared to EGFP-control transfected
cells. A recent study could show that pericentric heterochromatin can be re-localized
and tethered to the nuclear periphery. This was shown to affect the histone-modification
pattern, but also to change replication timing of pericentric heterochromatin to a more
mid S-phase like state (Heinz et al., 2018). On the basis of the finding that tethering
Uhrf1 to chromocenters could not localize Tet1s to pericentric heterochromatin outside
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of late S-phase, it would be interesting to see, whether Tet1s is recruited to re-localized
chromocenters at the nuclear lamina already during mid S-phase. This would indicate
that not only pericentric DNA and associated histones are being localized to the nuclear
lamina, but also that this re-localization dramatically changes the signalling cascade that is
responsible for Tet1s recruitment during late S-phase.
The S-phase localization and activity of Uhrf1 was recently shown to depend not only
on different chromatin modifications, but also on the binding to a H3K9me3-mimicking
peptide in ligase1 (Ferry et al., 2017). However, testing Tet1s accumulation capabilities
in ligase1 deficient mouse ESCs showed no difference compared to wildtype cells. This
could be explained by a putative backup pathway via ligase3 (Le Chalony et al., 2012).
Accordingly, cells that are deficient for ligase1 show no DNA methylation defects, while
cells that express ligase1 mutants that lack the H3K9me3-mimic, show a massive loss of
global DNA methylation levels (Ferry et al., 2017). In the future it will therefore be tested,
if cells that only express H3K9-mimic deficient mutants of ligase1 show the same Tet1s
accumulation pattern as ligase1-deficient or wildtype ESCs.
Taken together, I found Uhrf1 to be crucial for Tet1s recruitment during ongoing DNA
replication in pericentric heterochromatin. I furthermore found that the UBL-domain is
crucial for Tet1s localization and that the interaction between Tet1 and Uhrf1 is indepen-
dent of a conserved lysine that is known to be monoubiquitinated and to modulate Tet
dioxygenase activity. It was recently found that the UBL of Uhrf1 serves as a stabilizing
factor that brings together E2 ubiquitin-conjugating enzymes and the E3 ubiquitin-ligase
RING domain of Uhrf1, as well as the respective substrate (Foster et al., 2018). Moreover, I
found that Uhrf1 tethering to chromocenters can not induce a premature Tet1s recruitment
outside of late S-phase. These recent findings on the role of the UBL of Uhrf1 and my
own observations prompt me to speculate that the Uhrf1 UBL domain fulfils a stabilizing
task also in the monoubiquitination of Tet1s by bringing it together with the CRL4(VprBP)-
complex. The main components of this complex, VprBP, undergoes a cytoplasmatic to
nuclear translocation with progressing S-phase, which indicates a nuclear activity mostly
during late S-phase and G2. This would also explain, why Uhrf1 tethering failed to re-
cruit Tet1s outside of late S-phase, as the physical interaction might be disrupted upon
failure to monoubiquitinate Tet1s. The final recruitment of monoubiquitinated Tet1s dur-
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ing DNA replication is likely facilitated by a factor that still needs to be identified (Figure 32).
Figure 32: Potential mode of Tet1s recruitment during DNA replication. (A) Different members of
the CRL4(VprBP)-complex, like DDB1 or VprBP itself, undergo a cytoplasmatic to nuclear translocation
during progressing S-phase and the CRL4(VprBP)-complex is eventually assembled in the nucleus. (B)
Schematic model of Tet1s recruitment incorporating the findings from the present study and literature
data that were discussed here. Uhrf1 binds to Tet1s via its UBL-domain and recruits it to the assembled
CRL4(VprBP)-complex. The UBL of Uhrf1 stabilizes Tet1s, while a monoubiquitnation of lysine 852 takes
place. Monoubiquitinated Tet1s is recruited to sites of ongoing DNA replication via a yet unknown factor.
Tet1s binds methylated cytosine in the context of pericentric heterochromatin and oxidizes it to 5hmC. (C)
Schematic overview of the different proteins that are involved in the hypothesized Tet1s recruitment during
DNA replication.
6.3 Tet1s-overexpressing cells show aberrant cytosine modification
levels
Global DNA hypomethylation is a characteristic epigenetic alteration in cancer cells (Gaudet
et al., 2003). However, despite the strong reduction of global 5mC levels, local hypermethy-
lation events are frequently observed in the context of promoters or coding sequences of
tumour suppressor genes, which results in their transcriptional silencing (Baylin and Jones,
2011). It has been speculated, whether this feature of malignant neoplasms arises from
a stochastic de novo deposition of aberrant DNA methylation marks or in fact represents
a tumour-specific epigenetic code, which would hint to an instructive model for de novo
DNA methylation in cancer (Struhl, 2014). It could, for example, be shown that genomically
adjacent regions and functionally related genes are often found to be novo methylated in a
mode that opposes a stochastic model (Keshet et al., 2006; Serra et al., 2014).
Interestingly, also the canonical Tet1 promoter is found to become hypermethylated in
cancer cells (Li et al., 2016), which leads to the use of an alternative promoter and a
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thereby targeted alternative transcription start site (Figure 10A). This eventually results in
a N-terminally truncated, but catalytically active short isoform of Tet1 (Good et al., 2017),
whose biological relevance I characterized in the present work.
The S-phase localization of Tet1s that I characterized in murine cells (Figure 10B), is
conserved also in human cells and even in cancer cells (Figure 28A). This finding hints
to a conserved molecular mechanism for the Tet1s recruitment that is not affected by the
malignant transformation in breast cancer cells.
Interestingly, no colocalization of the Tet1 signal and the PCNA signal was found in late
S-phase, when the localization of endogenous Tet1 was addressed by immunostaining Tet1
in MCF7 breast cancer cells that overexpress Tet1s (Good et al., 2017). This observation
might be attributed to the fact that the short isoform of Tet1 lacks the N-terminal BC- and
CxxC-domains, which together contribute to chromatin binding in hypomethylated, euchro-
matic regions (Zhang et al., 2016b). The loss of these domains and the thereby increased
kinetics and decreased fixability of Tet1s could again be addressed by FRAP experiments,
as discussed before (Section 6.1). The overexpression of Tet1s in cancer cells was found
to be accompanied by a failure to prevent DNA methylation- and hence heterochromatin
spreading into euchromatic domains (Good et al., 2017). However, cancer cells are in
general found to be hypomethylated (Gaudet et al., 2003). Besides my finding that MCF7
breast cancer cells show a strong global reduction of 5mC and also 5hmC levels, compared
to non-tumorigenic mammary gland cells (Figure 29B, C), it has previously been published
that these cells overexpress the short isoform of Tet1s, which I could confirm (Figure 28B).
Non-tumorigenic MCF10a mammary gland cells, on the other hand, expressed only minor
levels of Tet1s. Considering my initial findings on the localization and the targeted catalytic
activity of Tet1s in pericentric heterochromatin (Figure 10B, 19B, C), the global 5mC and
5hmC reduction in MCF7 cells could be accounted for by the massive Tet1s overexpression.
By further addressing, differences in 5mC and 5hmC levels in situ in heterochromatic
regions of MCF10a and MCF7 cells, I again found significant differences between the non-
tumorigenic and the breast cancer cell lines (Figure 30C, D). However, while normalized
5mC levels in pericentric heterochromatin regions of MCF7 cells were reduced by almost
50% in comparison to non-tumorigenic MCF10a cells, 5hmC levels showed only a small,
but still significant, reduction in MCF7 cells. This minor decrease in 5hmC, compared to
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the strong loss of 5mC is also underlined by the ratio of 5hmC to 5mC levels in PHC. The
5hmC/5mC ratio is significantly increased in MCF7 cells compared to MCF10a cells, which
is mostly due to the massive 5mC decrease (Figure 30B). Furthermore, the comparatively
minor changes of the 5hmC levels could, besides the cancer phenotype, also be attributed
to normal DNA modification fluctuations between different individuals, as the MCF7 and
MCF10a cells were obtained from two different donors (Palumbo et al., 2018). In regard
to the estimate that about 5% of all cytosines in the human genome are methylated of
which a large number is found in a heterochromatic CpG-context (Smith and Meissner,
2013), a decrease of about 50% in methylation levels accounts for a considerable number
of cytosines that can not be considered as normal variation between individuals. Overall,
the observed 5mC reduction, especially in heterochromatin, supports my initial findings
from murine cells that Tet1s overexpression and its targeted catalytic activity in pericentric
heterochromatin, results in a significant 5mC oxidation, hence 5hmC production (Figure
10D, Figure 19).
Interestingly, Uhrf1 has been found to contribute to global hypomethylation in the cancer
context, despite its crucial role in DNA methylation maintenance. Accordingly, it was
shown that the DNA de novo methyltransferase Dnmt3A is targeted for ubiquitin-dependent
proteasomal degradation by Uhrf1, which was found to be frequently overexpressed in
various cancers (Jia et al., 2016). In line with these findings, Uhrf1 overexpression in
different cancer types like squamous cell carcinoma or gastric cancer was found to be
correlated with poor prognosis for affected patients. Moreover and again in stark contrast
to the role of Uhrf1 in DNA methylation maintenance, decreased DNA methylation levels
in LINE1 and its accompanied reactivation, are found to be inversely correlated to Uhrf1
expression in these cancers (Nakamura et al., 2016; Hong et al., 2018).
We have shown before that Tet1CD mediated 5mC oxidation can reactivate LINE1 retro-
transposition in human cells (Zhang et al., 2017b). Besides this, we found that loss of the
crucial 5mC binding protein MeCP2, also results in the lost protection of PHC against 5mC
oxidation by Tet1. This results in significantly increased 5hmC levels and accompanied
increased reexpression of major satellite repeats in mouse brain (Ludwig et al., 2017).
The reexpression of LINE1 and satellite repeats is a commonly observed feature of many
epithelial cancer types (Ting et al., 2011). Moreover, genomic insertions upon LINE1
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reactivation are found to be disruptive to genes, where they are newly inserted and in
this way can render tumour suppressor genes inactive. Besides this, the LINE1 encoded
proteins, ORF1p and ORF2p, have also been implicated in the activation of oncogenic
transcription factors (Xiao-Jie et al., 2016).
Taken together, my findings allow me to speculate on the involvement of Tet1s and also
Uhrf1 in an expanded instructive model for a cancer-specific epigenetic code. Aberrant
de novo DNA methylation in cancer cells is thought to be deposited, in part, in a directed
mode to eventually silence tumour suppressor genes (Serra et al., 2014). The role for
Uhrf1 in Tet1s recruitment for DNA replication association in highly methylated PHC and
the accompanied increase of 5mC oxidation in those regions hints to a secondary mech-
anism, besides aberrant local de novo hypermethylation. As discussed, we have shown
that the catalytic activity of Tet1CD in highly methylated heterochromatic regions is ac-
companied by the reactivation of retrotransposable elements that are also reactivated in
Uhrf1-overexpressing cells. The finding that Tet1s is overexpressed in many cancer types
(Good et al., 2017) makes a co-overexpression of Uhrf1 and Tet1s a likely scenario, which
would, based on my findings, result in a targeted loss of DNA methylation in pericentric
heterochromatin.
Figure 33: Potential role of Tet1s in an instructive cancer epigenetics model. (A) Stochastic model for
DNA methylation in cancer. De novo DNA methylation is deposited by a DNA methyltransferase randomly
across the genome, eventually silencing a tumour suppressor gene (TSG). (B) Instructive model for DNA
methylation in cancer. A DNA methyltransferase is recruited to the genomic locus of a tumour suppressor
gene (TSG) for de novo DNA methylation, by a sequence specific protein (X). This eventually silences
the tumour suppressor gene. (C) Putative instructive model for the role of Tet1s in cancer epigenetics.
Highly methylated heterochromatin that contains LINE1 is targeted by the Uhrf1-Tet1s axis. This results
in the oxidation of the methylated DNA and eventually the reexpression of LINE1. Random or directed
retrotransposition in loci of tumour suppressor genes (TSG), disrupts their expression. White circles:
non-modified cytosine, black circles: methylated cytosine, black squares: hydroxymethylated cytosine.
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6.4 Conclusion & Outlook
The proteins of the Tet dioxygenase family have been implicated in crucial developmental
processes and in this line also in various diseases and recurringly in different cancer types
Section 2.5. In my study, I could show that the cancer-associated short isoform of Tet1s
can be recruited to ongoing DNA replication in an Uhrf1-dependent manner (Figure 23),
which is very likely also dependent on the proteins of the CRL4(VrpBP) E3 ubiquitin-ligase
complex, given my finding of the the subcellular dynamics of the central protein VprBP
(Figure 20). To further address this, knockdowns of the different components of the
CRL4(VprBP)-complex will be used to dissect the interplay of this complex, Uhrf1 and also
the conserved lysine residue 852 within the CRD of Tet1s, during Tet1s recruitment. The
interplay of Uhrf1 and the catalytic domain of Tet1 poses another interesting question, as
mutations of the conserved lysine residue did not affect the interaction of the two proteins.
Structural data hint to the low-complexity insert within the DSBH of Tet1 as a protein-protein
interaction scaffold, which will be further addressed (Hu et al., 2013) (Section 6.1, 6.2).
Similar to the previously discussed FRAP experiments that can be used to examine the
nuclear kinetics of Tet1 and Tet1s and address the role of different domains of Tet1, live
cell experiments with different inhibitors will be used to dissect the role of ubiquitination in
replication association of Tet1. First attempts to alter Tet1s recruitment during S-phase,
by treatment with the E1 ubiquitin-activating enzyme inhibitor PYR-41 (Yang et al., 2007)
proved also toxic to the progression of DNA replication in general. Therefore, a more
directed mode for abrogation of Tet1s ubiquitination would be the use of a specific inhibitor
for Cul4 E3 ubiquitin-ligases, assesing if they are responsible for lysine 852 monoubiquiti-
nation (Lan et al., 2016).
The overexpression of Tet1s in cancer cells was found to be accompanied by a failure
to prevent DNA methylation and hence heterochromatin spreading into euchromatic do-
mains (Good et al., 2017). Moreover, I could show that Tet1s is recruited to, normally
highly methylated heterochromatic domains in murine cells during DNA replication, which
resulted in a major increase of 5hmC levels in these domains. This observation led me to
speculate on the involvement of Tet1s in an instructive cancer epigenetics model. (Section
6.3) This hypothesis could be addressed by disrupting the canonical Tet1 promoter in
non-transformed cells, which would result in the use of the alternative promoter and sole
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expression of Tet1s. By investigating the resulting transcriptional changes and epigenetic
alterations, a first idea of the Tet1s potential in malignant transformation could be gained.
Finally, as described earlier, it was striking that the S-phase localization of Tet1s was lost
upon fixation. Consequently, no colocalization of Tet1 and PCNA was found, when the
localization of endogenous Tet1 was addressed by immunostaining Tet1 in MCF7 breast
cancer cells that are known to overexpress the short isoform of Tet1 (Figure 28C) (Good
et al., 2017). This observation might be attributed to the fact that the short isoform lacks
the N-terminal BC- and CxxC-domains, which together contribute to chromatin binding
in hypomethylated, euchromatic regions (Zhang and Xu, 2017), thereby increasing ki-
netics and decreasing fixability. However, a portion of endogenous Tet1 could be fixed
and showed focal patterns in immunostainings. Interestingly, these patterns were found
to be anti-correlated with DAPI-dense regions and in follow-up experiments, I found a
colocalization of the fixable fraction of Tet1 and the splicing factor SC-35/SFRS2 (Splicing
factor, arginine/serine-rich 2). In this line, I could moreover show that this colocalization
persists throughout different developmental stages, from mouse embryonic stem cells to
adult mouse fibroblasts and is susceptible to RNase treatment. These observations are in
line with a previous finding in Drosophila, where a Tet homologue was shown to oxidise
5mC in RNA and, thereby, positively affected translation efficiency (Delatte et al., 2016).
Ectopic overexpression of Tet proteins was furthermore found to increase the levels of
5hmC in RNA from HEK cells (Fu et al., 2014). Taken together, published data and my
observations on the nuclear whereabouts of Tet ptoteins, hint to a dual mode of gene






Agarwal, Noopur, Tanja Hardt, Alessandro Brero, Danny Nowak, Ulrich Rothbauer, Annette Becker, Heinrich Leonhardt, and M.
Cristina Cardoso (2007). “MeCP2 interacts with HP1 and modulates its heterochromatin association during myogenic differ-
entiation”. In: Nucleic Acids Research 35.16, pp. 5402–5408.
Allen, Mark D., Charles G. Grummitt, Christine Hilcenko, Sandra Young Min, Louise M. Tonkin, Christopher M. Johnson, Stefan
M. Freund, Mark Bycroft, and Alan J. Warren (2006). “Solution structure of the nonmethyl-CpG-binding CXXC domain of the
leukaemia-associated MLL histone methyltransferase”. In: EMBO Journal 25.19, pp. 4503–4512.
Angers, Stephane, Ti Li, Xianhua Yi, Michael J MacCoss, Randall T Moon, and Ning Zheng (2006). “Molecular architecture and
assembly of the DDB1-CUL4A ubiquitin ligase machinery.” In: Nature 443.7111, pp. 590–3.
Arita, Kyohei, Mariko Ariyoshi, Hidehito Tochio, Yusuke Nakamura, and Masahiro Shirakawa (2008). “Recognition of hemi-methylated
DNA by the SRA protein UHRF1 by a base-flipping mechanism”. In: Nature 455.7214, pp. 818–821.
Arita, Kyohei, Shin Isogai, Takashi Oda, Motoko Unoki, Kazuya Sugita, Naotaka Sekiyama, Keiko Kuwata, R. Hamamoto, H. Tochio,
M. Sato, M. Ariyoshi, and M. Shirakawa (2012). “Recognition of modification status on a histone H3 tail by linked histone reader
modules of the epigenetic regulator UHRF1”. In: Proceedings of the National Academy of Sciences of the United States of
America 109.32, pp. 12950–12955.
Avvakumov, George V., John R. Walker, Sheng Xue, Yanjun Li, Shili Duan, Christian Bronner, Cheryl H. Arrowsmith, and Sirano Dhe-
Paganon (2008). “Structural basis for recognition of hemi-methylated DNA by the SRA domain of human UHRF1”. In: Nature
455.7214, pp. 822–825.
Bachman, Martin, Santiago Uribe-Lewis, Xiaoping Yang, Michael Williams, Adele Murrell, and Shankar Balasubramanian (2014). “5-
Hydroxymethylcytosine is a predominantly stable DNA modification”. en. In: Nature Chemistry 6.12, pp. 1049–1055.
Bachman, Martin, Santiago Uribe-Lewis, Xiaoping Yang, Heather E Burgess, Mario Iurlaro, Wolf Reik, Adele Murrell, and Shankar
Balasubramanian (2015). “5-Formylcytosine can be a stable DNA modification in mammals”. In: Nature Chemical Biology 11.8,
pp. 555–557.
Bannister, Andrew J. and Tony Kouzarides (2011). “Regulation of chromatin by histone modifications”. In: Cell Research 21.3, pp. 381–
395.
Barau, Joan, Aurélie Teissandier, Natasha Zamudio, Stéphanie Roy, Valérie Nalesso, Yann Hérault, Florian Guillou, and Déborah
Bourc’his (2016). “The DNA methyltransferase DNMT3C protects male germ cells from transposon activity”. In: Science 354.6314,
pp. 909–912.
Bashtrykov, Pavel, Gytis Jankevicius, Renata Z Jurkowska, Sergey Ragozin, and Albert Jeltsch (2013). “The Uhrf1 protein stimulates
the activity and specificity of the maintenance DNA methyltransferase Dnmt1 by an allosteric mechanism.” In: The Journal of
biological chemistry, pp. 0–18.
Bauer, Christina, Klaus Göbel, Nagarjuna Nagaraj, Christian Colantuoni, Mengxi Wang, Udo Müller, Elisabeth Kremmer, Andrea
Rottach, and Heinrich Leonhardt (2015). “Phosphorylation of TET Proteins Is Regulated via O -GlcNAcylation by the O -Linked
N -Acetylglucosamine Transferase (OGT)”. In: Journal of Biological Chemistry 290.8, pp. 4801–4812.
Baumbusch, L O, T Thorstensen, V Krauss, A Fischer, K Naumann, R Assalkhou, I Schulz, G Reuter, and R B Aalen (2001). “The
Arabidopsis thaliana genome contains at least 29 active genes encoding SET domain proteins that can be assigned to four
evolutionarily conserved classes.” In: Nucleic acids research 29.21, pp. 4319–33.
Baylin, Stephen B. and Peter A. Jones (2011). “A decade of exploring the cancer epigenome — biological and translational implica-
tions”. In: Nature Reviews Cancer 11.10, pp. 726–734.
Becker, Annette, Peng Zhang, Lena Allmann, Daniela Meilinger, Bianca Bertulat, Daniel Eck, Maria Hofstaetter, Giody Bartolomei,
Michael O. Hottiger, Valérie Schreiber, Heinrich Leonhardt, and M. Cristina Cardoso (2016). “Poly(ADP-ribosyl)ation of methyl
CpG binding domain protein 2 regulates chromatin structure”. In: Journal of Biological Chemistry 291.10, pp. 4873–4881.
Berkyurek, Ahmet Can, Isao Suetake, Kyohei Arita, Kohei Takeshita, Atsushi Nakagawa, Masahiro Shirakawa, and Shoji Tajima (2014).
“The DNA Methyltransferase Dnmt1 Directly Interacts with the SET and RING Finger-associated (SRA) Domain of the Multi-
functional Protein Uhrf1 to Facilitate Accession of the Catalytic Center to Hemi-methylated DNA.” In: The Journal of biological
chemistry 289.1, pp. 379–86.
91
7 BIBLIOGRAPHY
Bird, A. (2002). “DNA methylation patterns and epigenetic memory”. In: Genes & Development 16.1, pp. 6–21.
Bird, Adrian P. (1986). “CpG-rich islands and the function of DNA methylation”. In: Nature 321, pp. 209–213.
Blau, Helen M, Grace K Pavlath, Edna C Hardeman, Choy-Pik Chiu, Laura Silberstein, Steven G Webster, Steven C Miller, and Cecelia
Webster (1985). “Plasticity of the differentiated state.” In: Science (New York, N.Y.) 230.4727, pp. 758–66.
Blow, J Julian and Anindya Dutta (2005). “Preventing re-replication of chromosomal DNA”. In: Nature Reviews Molecular Cell Biology
6.6, pp. 476–486.
Bostick, Magnolia, Jong Kyong Kim, Pierre-olivier Estève, Amander Clark, Sriharsa Pradhan, Steven E. Jacobsen, P.-O. Esteve,
Amander Clark, Sriharsa Pradhan, and Steven E. Jacobsen (2007). “UHRF1 Plays a Role in Maintaining DNA Methylation in
Mammalian Cells”. In: Science 317.August, pp. 1760–1764.
Boyarchuk, Ekaterina, Rocío Montes de Oca, and Geneviève Almouzni (2011). “Cell cycle dynamics of histone variants at the cen-
tromere, a model for chromosomal landmarks”. In: Current Opinion in Cell Biology 23.3, pp. 266–276.
Boyarchuk, Ekaterina, Dan Filipescu, Isabelle Vassias, Sylvain Cantaloube, and Geneviève Almouzni (2014). “The histone variant
composition of centromeres is controlled by the pericentric heterochromatin state during the cell cycle.” In: Journal of cell science
127.Pt 15, pp. 3347–59.
Brero, Alessandro, Hariharan P. Easwaran, Danny Nowak, Ingrid Grunewald, Thomas Cremer, Heinrich Leonhardt, and M. Cristina
Cardoso (2005). “Methyl CpG-binding proteins induce large-scale chromatin reorganization during terminal differentiation.” In:
The Journal of cell biology 169.5, pp. 733–43.
Bronner, Christian, Mayada Achour, Yoshimi Arima, Thierry Chataigneau, Hideyuki Saya, and Valérie B Schini-Kerth (2007). “The
UHRF family: oncogenes that are drugable targets for cancer therapy in the near future?” In: Pharmacology & therapeutics 115.3,
pp. 419–34.
Campos, Eric I., James M. Stafford, and Danny Reinberg (2014). “Epigenetic inheritance: Histone bookmarks across generations”. In:
Trends in Cell Biology 24.11, pp. 664–674.
Capuano, Floriana, Michael Mülleder, Robert Kok, Henk J Blom, and Markus Ralser (2014). “Cytosine DNA Methylation Is Found in
Drosophila melanogaster but Absent in Saccharomyces cerevisiae, Schizosaccharomyces pombe , and Other Yeast Species”. In:
Analytical Chemistry 86.8, pp. 3697–3702.
Cardoso, M C and H Leonhardt (1999). “DNA methyltransferase is actively retained in the cytoplasm during early development.” In:
The Journal of cell biology 147.1, pp. 25–32.
Cartron, Pierre-François, Arulraj Nadaradjane, Fiona Lepape, Lisenn Lalier, Betty Gardie, and François M Vallette (2013). “Identifica-
tion of TET1 Partners That Control Its DNA-Demethylating Function.” In: Genes & cancer 4.5-6, pp. 235–41.
Casas-Delucchi, Corella S., Alessandro Brero, Hans-Peter Rahn, Irina Solovei, Anton Wutz, Thomas Cremer, Heinrich Leonhardt,
and M. Cristina Cardoso (2011). “Histone acetylation controls the inactive X chromosome replication dynamics.” In: Nature
communications 2, p. 222.
Casas-Delucchi, Corella S., Joke G. van Bemmel, Sebastian Haase, Henry D. Herce, Danny Nowak, Daniela Meilinger, Jeffrey H.
Stear, Heinrich Leonhardt, and M. Cristina Cardoso (2012a). “Histone hypoacetylation is required to maintain late replication
timing of constitutive heterochromatin.” In: Nucleic acids research 40.1, pp. 159–69.
Casas-Delucchi, Corella S., Annette Becker, Janine J. Bolius, and M. Cristina Cardoso (2012b). “Targeted manipulation of heterochro-
matin rescues MeCP2 Rett mutants and re-establishes higher order chromatin organization”. In: Nucleic Acids Research 40.22.
Chagin, Vadim O., Jeffrey H. Stear, and M. Cristina Cardoso (2010). “Organization of DNA replication.” In: Cold Spring Harbor per-
spectives in biology 2.4, a000737.
Chedin, Frederic, Michael R Lieber, and Chih-Lin Hsieh (2002). “The DNA methyltransferase-like protein DNMT3L stimulates de novo
methylation by Dnmt3a.” In: Proceedings of the National Academy of Sciences of the United States of America 99.26, pp. 16916–
21.
Cheng, Jingdong, Yi Yang, Jian Fang, Jianxiong Xiao, Tingting Zhu, Fei Chen, Ping Wang, Ze Li, Huirong Yang, and Yanhui Xu (2013).
“Structural insight into coordinated recognition of trimethylated histone H3 lysine 9 (H3K9me3) by the plant homeodomain (PHD)
and tandem tudor domain (TTD) of UHRF1 (ubiquitin-like, containing PHD and RING finger domains, 1) protein.” In: The Journal
of biological chemistry 288.2, pp. 1329–39.
92
7 BIBLIOGRAPHY
Citterio, Elisabetta, Roberto Papait, and Francesco Nicassio (2004). “Np95 is a histone-binding protein endowed with ubiquitin ligase
activity”. In: . . . and cellular biology 24.6, pp. 2526–2535.
Clapier, Cedric R., Janet Iwasa, Bradley R. Cairns, and Craig L. Peterson (2017). “Mechanisms of action and regulation of ATP-
dependent chromatin-remodelling complexes”. In: Nature Reviews Molecular Cell Biology 18.7, pp. 407–422.
Costantini, M. and G. Bernardi (2008). “Replication timing, chromosomal bands, and isochores”. In: Proceedings of the National
Academy of Sciences 105.9, pp. 3433–3437.
Dawlaty, Meelad M., Kibibi Ganz, Benjamin E. Powell, Yueh-Chiang Hu, Styliani Markoulaki, Albert W. Cheng, Qing Gao, Jongpil Kim,
Sang-Woon Choi, David C. Page, and Rudolf Jaenisch (2011). “Tet1 Is Dispensable for Maintaining Pluripotency and Its Loss Is
Compatible with Embryonic and Postnatal Development”. In: Cell Stem Cell 9.2, pp. 166–175.
Dawlaty, Meelad M, Achim Breiling, Thuc Le, M Inmaculada Barrasa, Günter Raddatz, Qing Gao, Benjamin E Powell, Albert W Cheng,
Kym F Faull, Frank Lyko, and Rudolf Jaenisch (2014). “Loss of Tet enzymes compromises proper differentiation of embryonic
stem cells.” In: Developmental cell 29.1, pp. 102–11.
Delatte, Benjamin, Fei Wang, Long Vo Ngoc, Evelyne Collignon, Elise Bonvin, Rachel Deplus, Emilie Calonne, Bouchra Hassabi,
Pascale Putmans, Stephan Awe, Collin Wetzel, Judith Kreher, Romuald Soin, Catherine Creppe, Patrick A. Limbach, Cyril Guey-
dan, Véronique Kruys, Alexander Brehm, Svetlana Minakhina, Matthieu Defrance, Ruth Steward, and François Fuks (2016).
“Transcriptome-wide distribution and function of RNA hydroxymethylcytosine”. In: Science 351.6270, pp. 282–285.
Easwaran, Hariharan P, Heinrich Leonhardt, and M Cristina Cardoso (2007). “Distribution of DNA replication proteins in Drosophila
cells.” In: BMC cell biology 8, p. 42.
Easwaran, Hariharan P, Lothar Schermelleh, Heinrich Leonhardt, and M Cristina Cardoso (2004). “Replication-independent chromatin
loading of Dnmt1 during G2 and M phases.” In: EMBO reports 5.12, pp. 1181–6.
Fang, Jian, Jingdong Cheng, Jiaolong Wang, Qiao Zhang, Mengjie Liu, Rui Gong, Ping Wang, Xiaodan Zhang, Yangyang Feng,
Wenxian Lan, Zhou Gong, Chun Tang, Jiemin Wong, Huirong Yang, Chunyang Cao, and Yanhui Xu (2016). “Hemi-methylated
DNA opens a closed conformation of UHRF1 to facilitate its histone recognition”. en. In: Nature Communications 7, p. 11197.
Ferry, Laure, Alexandra Fournier, Takeshi Tsusaka, Guillaume Adelmant, Tadahiro Shimazu, Shohei Matano, Olivier Kirsh, Rachel
Amouroux, Naoshi Dohmae, Takehiro Suzuki, Guillaume J. Filion, Wen Deng, Maud de Dieuleveult, Lauriane Fritsch, Srikanth
Kudithipudi, Albert Jeltsch, Heinrich Leonhardt, Petra Hajkova, Jarrod A. Marto, Kyohei Arita, Yoichi Shinkai, and Pierre-Antoine
Antoine Defossez (2017). “Methylation of DNA Ligase 1 by G9a/GLP Recruits UHRF1 to Replicating DNA and Regulates DNA
Methylation”. In: Molecular Cell 67.4, 550–565.e5.
Foster, Benjamin M, Paul Stolz, Christopher B Mulholland, Alex Montoya, Holger Kramer, Sebastian Bultmann, Till Bartke Correspon-
dence, and Till Bartke (2018). “Critical Role of the UBL Domain in Stimulating the E3 Ubiquitin Ligase Activity of UHRF1 toward
Chromatin”. In: Molecular Cell 72, pp. 1–14.
Frauer, Carina, Andrea Rottach, Daniela Meilinger, Sebastian Bultmann, Karin Fellinger, Stefan Hasenöder, Mengxi Wang, Weihua
Qin, Johannes Söding, Fabio Spada, and Heinrich Leonhardt (2011a). “Different binding properties and function of CXXC zinc
finger domains in Dnmt1 and Tet1.” In: PloS one 6.2, e16627.
Frauer, Carina, Thomas Hoffmann, Sebastian Bultmann, Valentina Casa, M. Cristina Cardoso, Iris Antes, and Heinrich Leonhardt
(2011b). “Recognition of 5-hydroxymethylcytosine by the Uhrf1 SRA domain.” In: PloS one 6.6, e21306.
Fu, Lijuan, Candace R Guerrero, Na Zhong, Nicholas J Amato, Yunhua Liu, Shuo Liu, Qian Cai, Seung-Gi Jin, Debin Ji, Laura J
Niedernhofer, Gerd P Pfeifer, Guo-Liang Xu, Yinsheng Wang, Seung-Gi Jin, Laura J Niedernhofer, Gerd P Pfeifer, Guo-Liang Xu,
and Yinsheng Wang (2014). “Tet-mediated Formation of 5-Hydroxymethylcytosine in RNA.” In: Journal of the American Chemical
Society 136.33, pp. 11582–11585.
Fujimori, Akira, Yoichi Matsuda, Yoshihiro Takemoto, Yasuhiro Hashimoto, Eiko Kubo, Ryoko Araki, Ryutaro Fukumura, Kazuei Mita,
Kouichi Tatsumi, and Masahiro Muto (1998). “Cloning and mapping of Np95 gene which encodes a novel nuclear protein associ-
ated with cell proliferation”. In: Mammalian Genome 9.12, pp. 1032–1035.
Gaudet, François, J Graeme Hodgson, Amir Eden, Laurie Jackson-Grusby, Jessica Dausman, Joe W Gray, Heinrich Leonhardt,




Globisch, Daniel, Martin Münzel, Markus Müller, Stylianos Michalakis, Mirko Wagner, Susanne Koch, Tobias Brückl, Martin Biel, and
Thomas Carell (2010). “Tissue distribution of 5-hydroxymethylcytosine and search for active demethylation intermediates.” In:
PloS one 5.12, e15367.
Goll, Mary Grace, Finn Kirpekar, Keith A. Maggert, Jeffrey A. Yoder, Chih Lin Hsieh, Xiaoyu Zhang, Kent G. Golic, Steven E. Jacobsen,
and Timothy H. Bestor (2006). “Methylation of tRNAAsp by the DNA methyltransferase homolog Dnmt2”. In: Science 311.5759,
pp. 395–398.
Good, Charly R., Jozef Madzo, Bela Patel, Shinji Maegawa, Nora Engel, Jaroslav Jelinek, and Jean-Pierre J. Issa (2017). “A novel
isoform of TET1 that lacks a CXXC domain is overexpressed in cancer”. In: Nucleic Acids Research 45.14, pp. 8269–8281.
Gu, Tian-Peng, Fan Guo, Hui Yang, Hai-Ping Wu, Gui-Fang Xu, Wei Liu, Zhi-Guo Xie, Linyu Shi, Xinyi He, Seung-gi Jin, Khursheed
Iqbal, Yujiang Geno Shi, Zixin Deng, Piroska E Szabó, Gerd P Pfeifer, Jinsong Li, and Guo-Liang Xu (2011). “The role of Tet3
DNA dioxygenase in epigenetic reprogramming by oocytes”. In: Nature 477.7366, pp. 606–610.
Guenatri, Mounia, Delphine Bailly, Christèle Maison, and Geneviève Almouzni (2004). “Mouse centric and pericentric satellite repeats
form distinct functional heterochromatin”. In: Journal of Cell Biology 166.4, pp. 493–505.
Hamidi, Tewfik, Anup Kumar Singh, and Taiping Chen (2015). “Genetic alterations of DNA methylation”. In: 7, pp. 247–265.
Han, Pei, Wei Li, Chiou-Hong Lin, Jin Yang, Ching Shang, Sylvia T. Nurnberg, Kevin Kai Jin, Weihong Xu, Chieh-Yu Lin, Chien-jung
Lin, Yiqin Xiong, Huan-Chieh Chien, Bin Zhou, Euan Ashley, Daniel Bernstein, Peng-Sheng Chen, Huei-Sheng Vincent Chen,
Thomas Quertermous, and Ching-pin Chang (2014). “A long noncoding RNA protects the heart from pathological hypertrophy”.
In: Nature 514.7520, pp. 102–106.
Harrison, Joseph S, Evan M Cornett, Dennis Goldfarb, Paul A DaRosa, Zimeng M Li, Feng Yan, Bradley M Dickson, Angela H Guo,
Daniel V Cantu, Lilia Kaustov, Peter J Brown, Cheryl H Arrowsmith, Dorothy A Erie, Michael B Major, Rachel E Klevit, Krzysztof
Krajewski, Brian Kuhlman, Brian D Strahl, and Scott B Rothbart (2016). “Hemi-methylated DNA regulates DNA methylation
inheritance through allosteric activation of H3 ubiquitylation by UHRF1”. In: eLife 5, pp. 818–821.
Hashimoto, Hideharu, John R. Horton, Xing Zhang, Magnolia Bostick, Steven E. Jacobsen, and Xiaodong Cheng (2008). “The SRA
domain of UHRF1 flips 5-methylcytosine out of the DNA helix.” In: Nature 455.7214, pp. 826–9.
Hashimoto, Hideharu, John R. Horton, Xing Zhang, and Xiaodong Cheng (2009). “UHRF1, a modular multi-domain protein, regulates
replication-coupled crosstalk between DNA methylation and histone modifications”. In: Epigenetics 4.1, pp. 8–14.
Hata, Kenichiro, Masaki Okano, Hong Lei, and En Li (2002). “Dnmt3L cooperates with the Dnmt3 family of de novo DNA methyl-
transferases to establish maternal imprints in mice.” In: Journal of embryology and experimental morphology 129.8, pp. 1983–
1993.
Heinz, Kathrin S., Corella S. Casas-Delucchi, Timea Török, Dusan Cmarko, Alexander Rapp, Ivan Raska, and M. Cristina Cardoso
(2018). “Peripheral re-localization of constitutive heterochromatin advances its replication timing and impairs maintenance of
silencing marks”. In: Nucleic Acids Research 46.12, pp. 6112–6128.
Hergeth, S. P. and R. Schneider (2015). “The H1 linker histones: multifunctional proteins beyond the nucleosomal core particle”. In:
EMBO reports 16.11, pp. 1439–1453.
Hervouet, Eric, Lisenn Lalier, Emilie Debien, Mathilde Cheray, Audrey Geairon, Hélène Rogniaux, Delphine Loussouarn, and Stéphane
Cartron (2010). “Disruption of Dnmt1 / PCNA / UHRF1 Interactions Promotes Tumorigenesis from Human and Mice Glial Cells”.
In: PloS one 5.6, e11333.
Ho, Steffan N., Henry D. Hunt, Robert M. Horton, Jeffrey K. Pullen, and Larry R. Pease (1989). “Site-directed mutagenesis by overlap
extension using the polymerase chain reaction”. In: Gene 77.1, pp. 51–59.
Hong, Jang Hee, Eun Heui Jin, Soyeon Kim, Kyu Sang Song, and Jae Kyu Sung (2018). “LINE-1 hypomethylation is inversely corre-
lated with UHRF1 overexpression in gastric cancer”. In: Oncology Letters 15.5, pp. 6666–6670.
Hopfner, Raphaël, Marc Mousli, JM Jeltsch, and A Voulgaris (2000). “ICBP90, a novel human CCAAT binding protein, involved in the
regulation of topoisomerase IIα expression”. In: Cancer research, pp. 121–128.
Hotchkiss, Rollin D (1948). “The Quantitative Separation of Purines, Pyrimidines, and Nucleosides by Paper Chromatography”. In: J.
Biol. Chem. 175, pp. 315–332.
Hu, Lulu, Ze Li, Jingdong Cheng, Qinhui Rao, Wei Gong, Mengjie Liu, Yujiang Geno Shi, Jiayu Zhu, Ping Wang, and Yanhui Xu (2013).
“Crystal Structure of TET2-DNA Complex: Insight into TET-Mediated 5mC Oxidation.” In: Cell, pp. 1–11.
94
7 BIBLIOGRAPHY
Hübner, Michael R. and David L. Spector (2010). “Chromatin Dynamics”. In: Annual Review of Biophysics 39.1, pp. 471–489.
Ito, Shinsuke, Li Shen, Qing Dai, Susan C Wu, Leonard B Collins, James a Swenberg, Chuan He, and Yi Zhang (2011). “Tet proteins
can convert 5-methylcytosine to 5-formylcytosine and 5-carboxylcytosine.” In: Science (New York, N.Y.) 333.6047, pp. 1300–3.
Iwata, Atsushi, Yu Nagashima, Lumine Matsumoto, Takahiro Suzuki, Tomoyuki Yamanaka, Hidetoshi Date, Ken Deoka, Nobuyuki
Nukina, and Shoji Tsuji (2009). “Intranuclear Degradation of Polyglutamine Aggregates by the Ubiquitin-Proteasome System”. In:
Journal of Biological Chemistry 284.15, pp. 9796–9803.
Jackson, Sarah and Yue Xiong (2009). “CRL4s: the CUL4-RING E3 ubiquitin ligases”. In: Trends in Biochemical Sciences 34.11,
pp. 562–570.
Jenuwein, Thomas and C David Allis (2001). “Translating the Histone Code \r10.1126/science.1063127 ”. In: Science 293.August,
pp. 1074–1081.
Jeong, Jae Yeon, Hyung Soon Yim, Ji Young Ryu, Hyun Sook Lee, Jung Hyun Lee, Dong Seung Seen, and Sung Gyun Kang (2012).
“One-step sequence-and ligation-independent cloning as a rapid and versatile cloning method for functional genomics Studies”.
In: Applied and Environmental Microbiology 78.15, pp. 5440–5443.
Jia, Yuanhui, Pishun Li, Lan Fang, Haijun Zhu, Liangliang Xu, Hao Cheng, Junying Zhang, Fei Li, Yan Feng, Yan Li, Jialun Jiwen Jialun
Li, Ruiping Wang, James X Du, Jialun Jiwen Jialun Li, Taiping Chen, Hongbin Ji, Jackie Han, Wenqiang Yu, Qihan Wu, and Jiemin
Wong (2016). “Negative regulation of DNMT3A de novo DNA methylation by frequently overexpressed UHRF family proteins as
a mechanism for widespread DNA hypomethylation in cancer”. en. In: Cell Discovery 2.1, p. 16007.
Jin, Chunlei, Yue Lu, Jaroslav Jelinek, Shoudan Liang, Marcos R.H. H. Estecio, Michelle Craig Barton, and Jean-Pierre J. Issa (2014).
“TET1 is a maintenance DNA demethylase that prevents methylation spreading in differentiated cells”. In: Nucleic Acids Research
42.11, pp. 6956–6971.
Jin, Seung-Gi, Zhi-Min Zhang, Thomas L. L Dunwell, Matthew R. R Harter, Xiwei Wu, Jennifer Johnson, Zheng Li, Jiancheng Liu,
Piroska E. E Szabó, Qiang Lu, Guo-Liang Xu, Jikui Song, and Gerd P. P Pfeifer (2016). “Tet3 Reads 5-Carboxylcytosine through
Its CXXC Domain and Is a Potential Guardian against Neurodegeneration”. In: Cell Reports 14.3, pp. 493–505.
Joffe, Boris, Heinrich Leonhardt, and Irina Solovei (2010). “Differentiation and large scale spatial organization of the genome”. In:
Current Opinion in Genetics & Development 20.5, pp. 562–569.
Jones, Peter A. (2012). “Functions of DNA methylation: Islands, start sites, gene bodies and beyond”. In: Nature Reviews Genetics
13.7, pp. 484–492.
Jurkowska, Renata Zofia, Tomasz Piotr Jurkowski, and Albert Jeltsch (2011). “Structure and Function of Mammalian DNA Methyltrans-
ferases”. In: ChemBioChem 12.2, pp. 206–222.
Kalderon, Daniel, Bruce L. Roberts, William D. Richardson, and Alan E. Smith (1984). “A short amino acid sequence able to specify
nuclear location”. In: Cell 39.3 PART 2, pp. 499–509.
Kaneda, Masahiro, Masaki Okano, Kenichiro Hata, Takashi Sado, Naomi Tsujimoto, En Li, and Hiroyuki Sasaki (2004). “Essential role
for de novo DNA methyltransferase Dnmt3a in paternal and maternal imprinting”. In: Nature 429.6994, pp. 900–903.
Karagianni, Panagiota, Larbi Amazit, Jun Qin, and Jiemin Wong (2008). “ICBP90, a novel methyl K9 H3 binding protein linking protein
ubiquitination with heterochromatin formation.” In: Molecular and cellular biology 28.2, pp. 705–17.
Karlic, R., H.-R. Chung, J. Lasserre, K. Vlahovicek, and M. Vingron (2010). “Histone modification levels are predictive for gene expres-
sion”. In: Proceedings of the National Academy of Sciences 107.7, pp. 2926–2931.
Keshet, Ilana, Yeshayahu Schlesinger, Shlomit Farkash, Eyal Rand, Merav Hecht, Eran Segal, Eli Pikarski, Richard A. Young, Alain
Niveleau, Howard Cedar, and Itamar Simon (2006). “Evidence for an instructive mechanism of de novo methylation in cancer
cells”. In: Nature Genetics 38.2, pp. 149–153.
Kim, Kyunghwan, Jin-Man Kim, Joong-Sun Kim, Jongkyu Choi, Yong Suk Lee, Nouri Neamati, Jin Sook Song, Kyu Heo, and Woojin
An (2013). “VprBP Has Intrinsic Kinase Activity Targeting Histone H2A and Represses Gene Transcription”. In: Molecular Cell
52.3, pp. 459–467.
Klutstein, Michael, Deborah Nejman, Razi Greenfield, and Howard Cedar (2016). “DNA Methylation in Cancer and Aging”. In: Cancer
Research 76.12, pp. 3446–3450.
Ko, Myunggon, Hozefa S. Bandukwala, Jungeun An, Edward D. Lamperti, Elizabeth C. Thompson, Ryan Hastie, Angeliki Tsangaratou,
Klaus Rajewsky, Sergei B. Koralov, and Anjana Rao (2011). “Ten-Eleven-Translocation 2 (TET2) negatively regulates homeosta-
95
7 BIBLIOGRAPHY
sis and differentiation of hematopoietic stem cells in mice.” In: Proceedings of the National Academy of Sciences of the United
States of America 108.35, pp. 14566–71.
Ko, Myunggon, Jungeun An, Hozefa S Bandukwala, Lukas Chavez, Tarmo Äijö, William A Pastor, Matthew F Segal, Huiming Li,
Kian Peng Koh, Harri Lähdesmäki, Patrick G Hogan, L Aravind, and Anjana Rao (2013). “Modulation of TET2 expression and
5-methylcytosine oxidation by the CXXC domain protein IDAX”. In: Nature 497.7447, pp. 122–126.
Kouzarides, Tony (2007). “Chromatin modifications and their function.” In: Cell 128.4, pp. 693–705.
Kraushaar, Daniel C., Zuozhou Chen, Qingsong Tang, Kairong Cui, Junfang Zhang, and Keji Zhao (2018). “The gene repressor
complex NuRD interacts with the histone variant H3.3 at promoters of active genes”. In: Genome Research.
Kriaucionis, Skirmantas and Nathaniel Heintz (2009). “The Nuclear DNA Base 5-Hydroxymethylcytosine Is Present in Purkinje Neurons
and the Brain”. In: Science 324.5929, pp. 929–930.
Lan, Huiyin, Zaiming Tang, Hongchuan Jin, and Yi Sun (2016). “Neddylation inhibitor MLN4924 suppresses growth and migration of
human gastric cancer cells”. In: Scientific Reports 6, pp. 1–12.
Lande-Diner, Laura, Jianmin Zhang, Ittai Ben-Porath, Ninette Amariglio, Ilana Keshet, Merav Hecht, Veronique Azuara, Amanda G.
Fisher, Gideon Rechavi, and Howard Cedar (2007). “Role of DNA methylation in stable gene repression”. In: Journal of Biological
Chemistry 282.16, pp. 12194–12200.
Langemeijer, Saskia M C, Roland P Kuiper, Marieke Berends, Ruth Knops, Mariam G Aslanyan, Marion Massop, Ellen Stevens-
Linders, Patricia van Hoogen, Ad Geurts van Kessel, Reinier A P Raymakers, Eveline J Kamping, Gregor E Verhoef, Estelle
Verburgh, Anne Hagemeijer, Peter Vandenberghe, Theo de Witte, Bert A van der Reijden, and Joop H Jansen (2009). “Acquired
mutations in TET2 are common in myelodysplastic syndromes”. In: Nature Genetics 41, p. 838.
Le Chalony, Catherine, Françoise Hoffschir, Laurent R. Gauthier, Julia Gross, Denis S. Biard, François D. Boussin, and Vincent
Pennaneach (2012). “Partial complementation of a DNA ligase I deficiency by DNA ligase III and its impact on cell survival and
telomere stability in mammalian cells”. In: Cellular and Molecular Life Sciences 69.17, pp. 2933–2949.
Lehnertz, Bernhard, Yoshihide Ueda, Alwin A H A Derijck, Ulrich Braunschweig, Laura Perez-burgos, Stefan Kubicek, Taiping Chen,
En Li, Thomas Jenuwein, and Antoine H F M Peters (2003). “Suv39h -Mediated Histone H3 Lysine 9 Methylation Directs DNA
Methylation to Major Satellite Repeats at Pericentric Heterochromatin”. In: 13, pp. 1192–1200.
Leonhardt, Heinrich, Andrea W Page, Heinz-Ulrich Weier, and Timothy H Bestor (1992). “A targeting sequence directs DNA methyl-
transferase to sites of DNA replication in mammalian nuclei”. In: Cell 71.5, pp. 865–873.
Leonhardt, Heinrich, Hans-Peter Rahn, Peter Weinzierl, Anje Sporbert, Thomas Cremer, Daniele Zink, and M Cristina Cardoso (2000).
“Dynamics of DNA Replication Factories in Living Cells”. In: The Journal of Cell Biology 149.2, pp. 271–280.
Li, En, Timothy H Bestor, and Rudolf Jaenisch (1992). “Targeted Mutation of the DNA Methyltransferase Gene Results in Embryonic
Lethality”. In: Cell 69, pp. 915–926.
Li, Haitao, Serge Ilin, Wooikoon Wang, Elizabeth M Duncan, Joanna Wysocka, C David Allis, and Dinshaw J Patel (2006). “Molecular
basis for site-specific read-out of histone H3K4me3 by the BPTF PHD finger of NURF.” In: Nature 442.7098, pp. 91–5.
Li, Lili, Chen Li, Haitao Mao, Zhenfang Du, Wai Yee Chan, Paul Murray, Bing Luo, Anthony T.C. Chan, Tony S.K. Mok, Francis K.L.
Chan, Richard F. Ambinder, and Qian Tao (2016). “Epigenetic inactivation of the CpG demethylase TET1 as a DNA methylation
feedback loop in human cancers”. In: Scientific Reports 6.January, pp. 1–12.
Li, Tao, Linsheng Wang, Yongming Du, Si Xie, Xi Yang, Fuming Lian, Zhongjun Zhou, and Chengmin Qian (2018). “Structural and
mechanistic insights into UHRF1-mediated DNMT1 activation in the maintenance DNA methylation”. In: Nucleic Acids Research
46.6, pp. 3218–3231.
Li, Zhe, X. Cai, C.-L. Cai, Jiapeng Wang, Wenyong Zhang, Bruce E Petersen, F.-C. Yang, and Mingjiang Xu (2011). “Deletion of Tet2
in mice leads to dysregulated hematopoietic stem cells and subsequent development of myeloid malignancies”. In: Blood 118.17,
pp. 4509–4518.
Lindhout, Beatrice I., Paul Fransz, Federico Tessadori, Tobias Meckel, Paul J.J. Hooykaas, and Bert J. van der Zaal (2007). “Live cell
imaging of repetitive DNA sequences via GFP-tagged polydactyl zinc finger proteins”. In: Nucleic Acids Research 35.16.
Liu, Nan, Mengxi Wang, Wen Deng, Christine S Schmidt, Weihua Qin, Heinrich Leonhardt, and Fabio Spada (2013a). “Intrinsic and
extrinsic connections of Tet3 dioxygenase with CXXC zinc finger modules.” In: PloS one 8.5, e62755.
96
7 BIBLIOGRAPHY
Liu, Xiaoli, Qinqin Gao, Pishun Li, Qian Zhao, Jiqin Zhang, Jiwen Li, Haruhiko Koseki, and Jiemin Wong (2013b). “UHRF1 targets
DNMT1 for DNA methylation through cooperative binding of hemi-methylated DNA and methylated H3K9.” In: Nature communi-
cations 4.1, p. 1563.
Liu, Yidan, Bin Zhang, Xiaoyu Meng, Matthew J. Korn, Jack M. Parent, Lin-Yu Lu, and Xiaochun Yu (2017). “UHRF2 regulates local
5-methylcytosine and suppresses spontaneous seizures”. In: Epigenetics 12.7, pp. 551–560.
Lorsbach, R B, J Moore, S Mathew, S C Raimondi, S T Mukatira, and J R Downing (2003). “TET1, a member of a novel protein family,
is fused to MLL in acute myeloid leukemia containing the t(10;11)(q22;q23)”. In: Leukemia 17.3, pp. 637–641.
Lu, Lin-Yu, Henry Kuang, Gautam Korakavi, and Xiaochun Yu (2015). “Topoisomerase II Regulates the Maintenance of DNA Methyla-
tion”. In: Journal of Biological Chemistry 290.2, pp. 851–860.
Ludwig, Anne K., Peng Zhang, and M. C. Cardoso (2016). “Modifiers and Readers of DNA Modifications and Their Impact on Genome
Structure, Expression, and Stability in Disease”. In: Frontiers in Genetics 7.June, pp. 1–24.
Ludwig, Anne K., Peng Zhang, Florian D. Hastert, Stephanie Meyer, Cathia Rausch, Henry D. Herce, Udo Müller, Anne Lehmkuhl,
Ines Hellmann, Carina Trummer, Christian Storm, Heinrich Leonhardt, and M. Cristina Cardoso (2017). “Binding of MBD proteins
to DNA blocks Tet1 function thereby modulating transcriptional noise”. In: Nucleic Acids Research 45.5, pp. 2438–2457.
Luger, K and T J Richmond (1998). “DNA binding within the nucleosome core”. In: Curr Opin Struct Biol 8.1, pp. 33–40.
Luger, Karolin, Armin W Mäder, Robin K Richmond, David F Sargent, and Timothy J Richmond (1997). “Crystal structure of the
nucleosome resolution core particle at 2 . 8 A”. In: Nature 389, pp. 251–260.
Lv, Lei, Qi Wang, Yanping Xu, Li-Chung Chung Tsao, Tadashi Nakagawa, Haitao Guo, Lishan Su, and Yue Xiong (2018). “Vpr Targets
TET2 for Degradation by CRL4VprBPE3 Ligase to Sustain IL-6 Expression and Enhance HIV-1 Replication”. In: Molecular Cell
70.5, 961–970.e5.
Maenohara, Shoji, Motoko Unoki, Hidehiro Toh, Hiroaki Ohishi, Jafar Sharif, Haruhiko Koseki, and Hiroyuki Sasaki (2017). “Role of
UHRF1 in de novo DNA methylation in oocytes and maintenance methylation in preimplantation embryos”. In: PLOS Genetics
13.10. Ed. by Paula E. Cohen, e1007042.
Maiti, Atanu and Alexander C Drohat (2011). “Thymine DNA Glycosylase Can Rapidly Excise 5-Formylcytosine and 5-Carboxylcytosine”.
In: Journal of Biological Chemistry 286.41, pp. 35334–35338.
Margot, J B, a M Aguirre-Arteta, B V Di Giacco, S Pradhan, R J Roberts, M C Cardoso, and H Leonhardt (2000). “Structure and
function of the mouse DNA methyltransferase gene: Dnmt1 shows a tripartite structure.” In: Journal of molecular biology 297.2,
pp. 293–300.
Marina, Ryan J, David Sturgill, Marc A Bailly, Morgan Thenoz, Garima Varma, Maria F Prigge, Kyster K Nanan, Sanjeev Shukla, Naz-
mul Haque, and Shalini Oberdoerffer (2015). “TET-catalyzed oxidation of intragenic 5-methylcytosine regulates CTCF-dependent
alternative splicing.” In: The EMBO journal.
McCall, Chad M, Paula L Miliani de Marval, Paul D Chastain, Sarah C Jackson, Yizhou J He, Yojiro Kotake, Jeanette Gowen Cook,
and Yue Xiong (2008). “Human immunodeficiency virus type 1 Vpr-binding protein VprBP, a WD40 protein associated with the
DDB1-CUL4 E3 ubiquitin ligase, is essential for DNA replication and embryonic development.” In: Molecular and cellular biology
28.18, pp. 5621–33.
Miller, Orlando J, Wolfgang Schnedl, Julian Allen, and Bernard F Erlanger (1974). “5-Methylcytosine localised in mammalian constitu-
tive heterochromatin.” In: Nature 251.5476, pp. 636–7.
Moldovan, George Lucian, Boris Pfander, and Stefan Jentsch (2007). “PCNA, the Maestro of the Replication Fork”. In: Cell 129.4,
pp. 665–679.
Mori, Tsutomu, Yuanyuan Li, Hiroaki Hata, and Hideo Kochi (2004). “NIRF is a ubiquitin ligase that is capable of ubiquitinating PCNP,
a PEST-containing nuclear protein”. In: FEBS Letters 557.1-3, pp. 209–214.
Mortusewicz, Oliver, Lothar Schermelleh, Joachim Walter, M Cristina Cardoso, and Heinrich Leonhardt (2005). “Recruitment of DNA
methyltransferase I to DNA repair sites.” In: Proceedings of the National Academy of Sciences of the United States of America
102.25, pp. 8905–9.
Müller, Udo, Christina Bauer, Michael Siegl, Andrea Rottach, and Heinrich Leonhardt (2014). “TET-mediated oxidation of methylcyto-
sine causes TDG or NEIL glycosylase dependent gene reactivation.” In: Nucleic acids research 42.13, pp. 8592–604.
97
7 BIBLIOGRAPHY
Nakagawa, Tadashi, Lei Lv, Makiko Nakagawa, Yanbao Yu, Chao Yu, Ana C D’Alessio, Keiko Nakayama, Heng-Yu Fan, Xian Chen, Yue
Xiong, Ana C. D’Alessio, Keiko Nakayama, Heng-Yu Fan, Xian Chen, and Yue Xiong (2015). “CRL4VprBP E3 Ligase Promotes
Monoubiquitylation and Chromatin Binding of TET Dioxygenases”. In: Molecular Cell 57.2, pp. 247–260.
Nakamura, Kenichi, Yoshifumi Baba, Keisuke Kosumi, and Kazuto Harada (2016). “UHRF1 regulates global DNA hypomethylation and
is associated with poor prognosis in esophageal squamous cell carcinoma”. In: Oncotarget 7.36, pp. 57821–57831.
Neri, Francesco, Danny Incarnato, Anna Krepelova, Stefania Rapelli, Andrea Pagnani, Riccardo Zecchina, Caterina Parlato, and
Salvatore Oliviero (2013). “Genome-wide analysis identifies a functional association of Tet1 and Polycomb repressive complex 2
in mouse embryonic stem cells”. In: Genome Biology 14.8, R91.
Ngo, Thuy T.M., Jejoong Yoo, Qing Dai, Qiucen Zhang, Chuan He, Aleksei Aksimentiev, and Taekjip Ha (2016). “Effects of cytosine
modifications on DNA flexibility and nucleosome mechanical stability”. In: Nature Communications 7, pp. 1–9.
Okano, M, D W Bell, D a Haber, and E Li (1999). “DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation
and mammalian development.” In: Cell 99.3, pp. 247–57.
O’Leary, Valerie Bríd, Sarah Hain, Doris Maugg, Jan Smida, Omid Azimzadeh, Soile Tapio, Saak Victor Ovsepian, and Michael John
Atkinson (2017). “Long non-coding RNA PARTICLE bridges histone and DNA methylation”. In: Scientific Reports 7.1, p. 1790.
Ono, Ryoichi, Tomohiko Taki, and Takeshi Taketani (2002). “LCX , Leukemia-associated Protein with a CXXC Domain , Is Fused to
MLL in Acute Myeloid Leukemia with Trilineage Dysplasia Having t (10 ; 11)(q22 ; q23)”. In: Cancer research 62, pp. 4075–4080.
Ooi, Steen K. T., Chen Qiu, Emily Bernstein, Keqin Li, Da Jia, Zhe Yang, Hediye Erdjument-Bromage, Paul Tempst, Shau-Ping Lin,
C. David Allis, Xiaodong Cheng, and Timothy H. Bestor (2007). “DNMT3L connects unmethylated lysine 4 of histone H3 to de
novo methylation of DNA”. In: Nature 448.7154, pp. 714–717.
Palazzo, Alexander F. and Eliza S. Lee (2015). “Non-coding RNA: what is functional and what is junk?” In: Frontiers in Genetics 6.JAN,
pp. 1–11.
Palumbo, Domenico, Ornella Affinito, Antonella Monticelli, and Sergio Cocozza (2018). “DNA Methylation variability among individuals
is related to CpGs cluster density and evolutionary signatures”. In: BMC Genomics 19.1, pp. 1–9.
Pena, PV, RA Hom, T Hung, H Lin, AJ Kuo, RP Wong, OM Subach, KS Champagne, R Zhao, VV Verkhuscha, G Li, O Gozani, and TG
Kutateladze (2009). “Histone H3K4me3 binding is required for the DNA repair and apoptotic activities of ING1 tumor suppresor”.
In: J Mol Biol 380.2, pp. 303–312.
Penn, N W, R Suwalski, C O’Riley, K Bojanowski, and R Yura (1972). “The presence of 5-hydroxymethylcytosine in animal deoxyri-
bonucleic acid.” In: The Biochemical journal 126.4, pp. 781–90.
Peters, Antoine H F M, Dó Nal O ’carroll, Harry Scherthan, Karl Mechtler, Stephan Sauer, Christian Schö, Klara Weipoltsham-
mer, Michaela Pagani, Monika Lachner, Alexander Kohlmaier, Susanne Opravil, Michael Doyle, Maria Sibilia, O Carroll, Harry
Scherthan, Karl Mechtler, Stephan Sauer, Christian Scho, Klara Weipoltshammer, Michaela Pagani, Monika Lachner, Alexander
Kohlmaier, Susanne Opravil, Michael Doyle, Maria Sibilia, and Thomas Jenuwein (2001). “Loss of the Suv39h Histone Methyl-
transferases Impairs Mammalian Heterochromatin and Genome Stability”. In: Cell 107, pp. 323–337.
Peters, Antoine H F M, Jacqueline E Mermoud, Dónal O’Carroll, Michaela Pagani, Dieter Schweizer, Neil Brockdorff, and Thomas
Jenuwein (2002). “Histone H3 lysine 9 methylation is an epigenetic imprint of facultative heterochromatin.” In: Nature genetics
30.1, pp. 77–80.
Petryk, Nataliya, Maria Dalby, Alice Wenger, Caroline B. Stromme, Anne Strandsby, Robin Andersson, and Anja Groth (2018). “MCM2
promotes symmetric inheritance of modified histones during DNA replication”. In: Science 361.6409, pp. 1389–1392.
Pfaffeneder, Toni, Benjamin Hackner, Matthias Truss, Martin Münzel, Markus Müller, Christian a Deiml, Christian Hagemeier, and
Thomas Carell (2011). “The discovery of 5-formylcytosine in embryonic stem cell DNA.” In: Angewandte Chemie (International
ed. in English) 50.31, pp. 7008–12.
Pfaffeneder, Toni, Fabio Spada, Mirko Wagner, Caterina Brandmayr, Silvia K Laube, David Eisen, Matthias Truss, Jessica Steinbacher,
Benjamin Hackner, Olga Kotljarova, David Schuermann, Stylianos Michalakis, Olesea Kosmatchev, Stefan Schiesser, Barbara
Steigenberger, Nada Raddaoui, Gengo Kashiwazaki, Udo Müller, Cornelia G Spruijt, Michiel Vermeulen, Heinrich Leonhardt,
Primo Schär, Markus Müller, and Thomas Carell (2014). “Tet oxidizes thymine to 5-hydroxymethyluracil in mouse embryonic
stem cell DNA.” In: Nature chemical biology 10.7, pp. 574–81.
98
7 BIBLIOGRAPHY
Pichler, Garwin, Patricia Wolf, Christine S. Schmidt, Daniela Meilinger, Katrin Schneider, Carina Frauer, Karin Fellinger, Andrea Rot-
tach, and Heinrich Leonhardt (2011). “Cooperative DNA and histone binding by Uhrf2 links the two major repressive epigenetic
pathways”. In: Journal of Cellular Biochemistry 112.9, pp. 2585–2593.
Qin, Weihua, Heinrich Leonhardt, and Fabio Spada (2011). “Usp7 and Uhrf1 control ubiquitination and stability of the maintenance
DNA methyltransferase Dnmt1”. In: Journal of Cellular Biochemistry 112.2, pp. 439–444.
Qin, Weihua, Patricia Wolf, Nan Liu, Stephanie Link, Martha Smets, Federica La Mastra, Ignasi Forné, Garwin Pichler, David Hörl,
Karin Fellinger, Fabio Spada, Ian Marc Bonapace, Axel Imhof, Hartmann Harz, and Heinrich Leonhardt (2015). “DNA methylation
requires a DNMT1 ubiquitin interacting motif (UIM) and histone ubiquitination”. In: Cell Research 25.8, pp. 911–929.
Rajakumara, Eerappa, Zhentian Wang, Honghui Ma, Lulu Hu, Hao Chen, Yan Lin, Rui Guo, Feizhen Wu, Haitao Li, Fei Lan, Yu-
jiang Geno Geno Yang Shi, Yanhui Xu, Dinshaw J. J Patel, and Yujiang Geno Geno Yang Shi (2011). “PHD finger recognition of
unmodified histone H3R2 links UHRF1 to regulation of euchromatic gene expression.” In: Molecular cell 43.2, pp. 275–84.
Rajavelu, Arumugam, Cristiana Lungu, Max Emperle, Michael Dukatz, Alexander Bröhm, Julian Broche, Ines Hanelt, Edris Parsa,
Sarah Schiffers, Rahul Karnik, Alexander Meissner, Thomas Carell, Philipp Rathert, Renata Z Jurkowska, and Albert Jeltsch
(2018). “Chromatin-dependent allosteric regulation of DNMT3A activity by MeCP2”. In: Nucleic Acids Research 46.17, pp. 9044–
9056.
Ramesh, Vidya, Efil Bayam, Filippo M. Cernilogar, Ian M. Bonapace, Markus Schulze, Markus J. Riemenschneider, Gunnar Schotta,
and Magdalena Götz (2016). “Loss of Uhrf1 in neural stem cells leads to activation of retroviral elements and delayed neurode-
generation”. In: Genes & Development 30.19, pp. 2199–2212.
Rando, Oliver J. (2007). “Global patterns of histone modifications”. In: Current Opinion in Genetics and Development 17.2, pp. 94–99.
Rottach, Andrea, Elisabeth Kremmer, Danny Nowak, Heinrich Leonhardt, M Cristina Cardoso, Cardoso Mc, and M Cristina Cardoso
(2008). “Generation and characterization of a rat monoclonal antibody specific for multiple red fluorescent proteins.” In: Hybridoma
(2005) 27.5, pp. 337–43.
Rottach, Andrea, Carina Frauer, Garwin Pichler, Ian Marc Bonapace, Fabio Spada, and Heinrich Leonhardt (2010). “The multi-domain
protein Np95 connects DNA methylation and histone modification.” In: Nucleic acids research 38.6, pp. 1796–804.
Rudenko, Andrii, MeeladM Dawlaty, Jinsoo Seo, AlbertW Cheng, Jia Meng, Thuc Le, KymF Faull, Rudolf Jaenisch, and Li Huei Tsai
(2013). “Tet1 is critical for neuronal activity-regulated gene expression and memory extinction”. In: Neuron 79.6, pp. 1109–1122.
Saksouk, Nehmé, Elisabeth Simboeck, and Jérôme Déjardin (2015). “Constitutive heterochromatin formation and transcription in
mammals”. In: Epigenetics and Chromatin 8.1, pp. 1–17.
Sanchez-Mut, J. V., H. Heyn, E. Vidal, S. Moran, S. Sayols, R. Delgado-Morales, M. D. Schultz, B. Ansoleaga, P. Garcia-Esparcia, M.
Pons-Espinal, M. M. De Lagran, J. Dopazo, A. Rabano, J. Avila, M. Dierssen, I. Lott, I. Ferrer, J. R. Ecker, and M. Esteller (2016).
“Human DNA methylomes of neurodegenerative diseases show common epigenomic patterns”. In: Translational Psychiatry 6.1,
e718–8.
Santiago, Mafalda, Claudia Antunes, Marta Guedes, Nuno Sousa, and C. Joana Marques (2014). “TET enzymes and DNA hydrox-
ymethylation in neural development and function - How critical are they?” In: Genomics 104.5, pp. 334–340.
Satyanarayana, A. and P. Kaldis (2009). “Mammalian cell-cycle regulation: several Cdks, numerous cyclins and diverse compensatory
mechanisms.” In: Oncogene 28.33, pp. 2925–39.
Schaefer, Matthias, Tim Pollex, Katharina Hanna, Francesca Tuorto, Madeleine Meusburger, Mark Helm, and Frank Lyko (2010). “RNA
methylation by Dnmt2 protects transfer RNAs against stress-induced cleavage”. In: Genes & Development 24.15, pp. 1590–1595.
Serra, Ryan W., Minggang Fang, Sung Mi Park, Lloyd Hutchinson, and Michael R. Green (2014). “A KRAS-directed transcriptional
silencing pathway that mediates the CpG island methylator phenotype”. In: eLife 2014.3, pp. 1–22.
Sharif, Jafar, Masahiro Muto, Shin-ichiro Takebayashi, Isao Suetake, Akihiro Iwamatsu, Takaho A. Endo, Jun Shinga, Yoko Mizutani-
Koseki, Tetsuro Toyoda, Kunihiro Okamura, Shoji Tajima, Kohzoh Mitsuya, Masaki Okano, and Haruhiko Koseki (2007). “The SRA
protein Np95 mediates epigenetic inheritance by recruiting Dnmt1 to methylated DNA.” In: Nature 450.7171, pp. 908–12.
Shcherbakova, Daria M., Mikhail Baloban, Alexander V. Emelyanov, Michael Brenowitz, Peng Guo, and Vladislav V. Verkhusha (2016).




Shen, Li, Azusa Inoue, Jin He, Yuting Liu, Falong Lu, and Yi Zhang (2014). “Tet3 and DNA Replication Mediate Demethylation of Both
the Maternal and Paternal Genomes in Mouse Zygotes”. In: Cell Stem Cell 15.4, pp. 459–471.
Shi, Feng Tao, Hyeung Kim, Weisi Lu, Quanyuan He, Dan Liu, Margaret A. Goodell, Ma Wan, and Zhou Songyang (2013). “Ten-
eleven translocation 1 (Tet1) is regulated by o-linked n-acetylglucosamine transferase (ogt) for target gene repression in mouse
embryonic stem cells”. In: Journal of Biological Chemistry 288.29, pp. 20776–20784.
Shukla, Sanjeev, Ersen Kavak, Melissa Gregory, Masahiko Imashimizu, Bojan Shutinoski, Mikhail Kashlev, Philipp Oberdoerffer,
Rickard Sandberg, and Shalini Oberdoerffer (2011). “CTCF-promoted RNA polymerase II pausing links DNA methylation to
splicing.” In: Nature 479.7371, pp. 74–9.
Smets, Martha, Stephanie Link, Patricia Wolf, Katrin Schneider, Veronica Solis, Joel Ryan, Daniela Meilinger, Weihua Qin, and Hein-
rich Leonhardt (2017). “DNMT1 mutations found in HSANIE patients affect interaction with UHRF1 and neuronal differentiation”.
In: Human Molecular Genetics 26.8, pp. 1522–1534.
Smith, Zachary D. and Alexander Meissner (2013). “DNA methylation: roles in mammalian development.” In: Nature reviews. Genetics
14.3, pp. 204–20.
Song, Jikui, Olga Rechkoblit, Timothy H Bestor, and Dinshaw J Patel (2011). “Structure of DNMT1-DNA complex reveals a role for
autoinhibition in maintenance DNA methylation.” In: Science (New York, N.Y.) 331.6020, pp. 1036–40.
Song, Jikui, Marianna Teplova, Satoko Ishibe-Murakami, and Dinshaw J. Patel (2012). “Structure-based mechanistic insights into
DNMT1-mediated maintenance DNA methylation”. In: Science 335.6069, pp. 709–712.
Spada, Fabio, Andrea Haemmer, David Kuch, Ulrich Rothbauer, Lothar Schermelleh, Elisabeth Kremmer, Thomas Carell, Gernot
Längst, and Heinrich Leonhardt (2007). “DNMT1 but not its interaction with the replication machinery is required for maintenance
of DNA methylation in human cells”. In: The Journal of Cell Biology 176.5, pp. 565–571.
Sporbert, Anje, Petra Domaing, Heinrich Leonhardt, and M. Cristina Cardoso (2005). “PCNA acts as a stationary loading platform for
transiently interacting Okazaki fragment maturation proteins.” In: Nucleic acids research 33.11, pp. 3521–8.
Spruijt, Cornelia G, Felix Gnerlich, Arne H Smits, Toni Pfaffeneder, Pascal W T C Jansen, Christina Bauer, Mirko Wagner, Markus Mu,
Fariha Khan, H Christian Eberl, Anneloes Mensinga, Rolf Boelens, Hugo Van Ingen, Heinrich Leonhardt, Arie B Brinkman, Kon-
stantin Lephikov, Udo Mu, Thomas Carell, and Michiel Vermeulen (2013a). “Dynamic Readers for 5- ( Hydroxy ) Methylcytosine
and Its Oxidized Derivatives”. In: Cell, pp. 1–14.
Spruijt, Cornelia G., Felix Gnerlich, Arne H. Smits, Toni Pfaffeneder, Pascal W.T.C. Jansen, Christina Bauer, Martin Münzel, Mirko
Wagner, Markus Müller, Fariha Khan, H. Christian Eberl, Anneloes Mensinga, Arie B. Brinkman, Konstantin Lephikov, Udo Müller,
Jörn Walter, Rolf Boelens, Hugo van Ingen, Heinrich Leonhardt, Thomas Carell, and Michiel Vermeulen (2013b). “Dynamic
Readers for 5-(Hydroxy)Methylcytosine and Its Oxidized Derivatives”. In: Cell 152.5, pp. 1146–1159.
Strahl, Brian D and C David Allis (2000). “The language of covalent histone modifications”. In: Nature 403.6765, pp. 41–45.
Struhl, Kevin (2014). “Is DNA methylation of tumour suppressor genes epigenetic?” In: eLife 3.3, pp. 1–3.
Tahiliani, Mamta, Kian Peng KP Koh, Yinghua Shen, William a Pastor, Hozefa Bandukwala, Yevgeny Brudno, Suneet Agarwal, Laksh-
minarayan M Iyer, David R Liu, L Aravind, and Anjana Rao (2009). “Conversion of 5-methylcytosine to 5-hydroxymethylcytosine
in mammalian DNA by MLL partner TET1.” In: Science 324.5929, pp. 930–935.
Ting, David T, Doron Lipson, Suchismita Paul, Brian W Brannigan, S. Akhavanfard, Erik J Coffman, Gianmarco Contino, Vikram
Deshpande, A. J. Iafrate, Stan Letovsky, Miguel N Rivera, Nabeel Bardeesy, Shyamala Maheswaran, and Daniel A Haber (2011).
“Aberrant Overexpression of Satellite Repeats in Pancreatic and Other Epithelial Cancers”. In: Science 331.6017, pp. 593–596.
Tsai, Miao-Chih, Ohad Manor, Yue Wan, Nima Mosammaparast, Jordon K Wang, Fei Lan, Yang Shi, Eran Segal, and Howard Y Chang
(2010). “Long noncoding RNA as modular scaffold of histone modification complexes.” In: Science (New York, N.Y.) 329.5992,
pp. 689–93.
Tsukada, Yu-ichi, Tomohiko Akiyama, and Keiichi I. Nakayama (2015). “Maternal TET3 is dispensable for embryonic development but
is required for neonatal growth”. In: Scientific Reports 5.1, p. 15876.
Ueda, Yoshihide (2006). “Roles for Dnmt3b in mammalian development: a mouse model for the ICF syndrome”. In: Development
133.6, pp. 1183–1192.
Unoki, Motoko, Toshihiko Nishidate, and Yusuke Nakamura (2004). “ICBP90, an E2F-1 target, recruits HDAC1 and binds to methyl-
CpG through its SRA domain.” In: Oncogene 23.46, pp. 7601–10.
100
7 BIBLIOGRAPHY
Vaughan, Robert M, Bradley M Dickson, Evan M Cornett, Joseph S Harrison, Brian Kuhlman, and Scott B Rothbart (2018). “Com-
parative biochemical analysis of UHRF proteins reveals molecular mechanisms that uncouple UHRF2 from DNA methylation
maintenance”. In: Nucleic Acids Research 46.9, pp. 4405–4416.
Vidal, E., S. Sayols, S. Moran, A. Guillaumet-Adkins, M. P. Schroeder, R. Royo, M. Orozco, M Gut, I. Gut, N. Lopez-Bigas, H. Heyn,
and M. Esteller (2017). “A DNA methylation map of human cancer at single base-pair resolution”. In: Oncogene 36.40, pp. 5648–
5657.
Waddington, Conrad H. (1942). “The Epigenotype”. In: Endeavor 1.1, pp. 18–20.
Wade, Paul A, Anne Gegonne, Peter L Jones, Esteban Ballestar, Florence Aubry, and Alan P Wolffe (1999). “Mi-2 complex couples
DNA methylation to chromatin remodelling and histone deacetylation”. In: 23.september, pp. 1–5.
Wang, Fei, Svetlana Minakhina, Hiep Tran, Neha Changela, Joseph Kramer, and Ruth Steward (2018). “Tet protein function during
Drosophila development”. In: PLOS ONE 13.1. Ed. by Sriharsa Pradhan, e0190367.
Wang, Yanli, Lewis Y. Geer, Colombe Chappey, Jonathan A. Kans, and Stephen H. Bryant (2000). “Cn3D: Sequence and structure
views for Entrez”. In: Trends in Biochemical Sciences 25.6, pp. 300–302.
Wang, Yu and Yi Zhang (2014). “Regulation of TET protein stability by calpains.” In: Cell reports 6.2, pp. 278–84.
Wang, Zhibin, Chongzhi Zang, Jeffrey a Rosenfeld, Dustin E Schones, Artem Barski, Suresh Cuddapah, Kairong Cui, Tae-young Roh,
Weiqun Peng, Michael Q Zhang, and Keji Zhao (2008). “Combinatorial patterns of histone acetylations and methylations in the
human genome”. In: Nature Genetics 40.7, pp. 897–903.
Watson, James D and Francis HC Crick (1953). “Molecular Structure of Nucleic Acids: A Structure for Deoxyribose Nucleic Acid”. In:
Nature 171.4356, pp. 737–738.
Williams, Kristine, Jesper Christensen, MT Marianne Terndrup Pedersen, Jens V. Johansen, Paul A. C. Cloos, Juri Rappsilber, and Kris-
tian Helin (2011). “TET1 and hydroxymethylcytosine in transcription and DNA methylation fidelity”. In: Nature 473.7347, pp. 343–
348.
Wysocka, Joanna, Tomek Swigut, Hua Xiao, Thomas a Milne, So Yeon Kwon, Joe Landry, Monika Kauer, Alan J Tackett, Brian T
Chait, Paul Badenhorst, Carl Wu, and C David Allis (2006). “A PHD finger of NURF couples histone H3 lysine 4 trimethylation
with chromatin remodelling.” In: Nature 442.7098, pp. 86–90.
Xiao-Jie, Lu, Xue Hui-Ying, Xiaolong Qi, Xu Jiang, and Ma Shi-Jie (2016). “LINE-1 in cancer: Multifaceted functions and potential
clinical implications”. In: Genetics in Medicine 18.5, pp. 431–439.
Xu, Chao, Ke Liu, Ming Lei, Ally Yang, Yanjun Li, Timothy R. Hughes, and Jinrong Min (2018). “DNA Sequence Recognition of Human
CXXC Domains and Their Structural Determinants”. In: Structure 26.1, 85–95.e3.
Xu, Guo-Liang, Timothy H. Bestor, Déborah Bourc’his, Chih-Lin Hsieh, Niels Tommerup, Merete Bugge, Maj Hulten, Xiaoyan Qu,
James J. Russo, and Evani Viegas-Péquignot (1999). “Chromosome instability and immunodeficiency syndrome caused by mu-
tations in a DNA methyltransferase gene”. In: Nature 402.6758, pp. 187–191.
Yang, H, Y Liu, F Bai, J-Y Zhang, S-H Ma, J Liu, Z-D Xu, H-G Zhu, Z-Q Ling, D Ye, K-L Guan, and Y Xiong (2013). “Tumor development
is associated with decrease of TET gene expression and 5-methylcytosine hydroxylation”. In: Oncogene 32.5, pp. 663–669.
Yang, Yili, Jirouta Kitagaki, Ren Ming Dai, Che Tsai Yien, Kevin L. Lorick, Robert L. Ludwig, Shervon A. Pierre, Jane P. Jensen,
Ilia V. Davydov, Pankaj Oberoi, Chou Chi H Li, John H. Kenten, John A. Beutler, Karen H. Vousden, and Allan M. Weissman
(2007). “Inhibitors of ubiquitin-activating enzyme (E1), a new class of potential cancer therapeutics”. In: Cancer Research 67.19,
pp. 9472–9481.
Yu, Chao, Yin-Li Li Zhang, Wei-Wei Wei Pan, Xiao-Meng Meng Li, Zhong-Wei Wei Wang, Zhao-Jia Jia Ge, Jian-Jie Jie Zhou, Yong
Cang, Chao Tong, Qing-Yuan Yuan Sun, and Heng-Yu Yu Fan (2013). “CRL4 complex regulates mammalian oocyte survival and
reprogramming by activation of TET proteins.” In: Science (New York, N.Y.) 342.6165, pp. 1518–21.
Zhang, Hao-Ying, Jun Xiong, Bao-Ling Qi, Y.-Q. Yu-Qi Feng, and Bi-Feng Yuan (2016a). “The existence of 5-hydroxymethylcytosine
and 5-formylcytosine in both DNA and RNA in mammals”. en. In: Chem. Commun. 52.4, pp. 737–740.
Zhang, Jiqin, Qinqin Gao, Pishun Li, Xiaoli Liu, Yuanhui Jia, Weicheng Wu, Jiwen Li, Shuo Dong, Haruhiko Koseki, and Jiemin Wong
(2011). “S phase-dependent interaction with DNMT1 dictates the role of UHRF1 but not UHRF2 in DNA methylation maintenance.”
In: Cell research 21.12, pp. 1723–39.
101
7 BIBLIOGRAPHY
Zhang, Peng, Florian D. Hastert, Anne K. Ludwig, Kai Breitwieser, Maria Hofstätter, and M. Cristina Cardoso (2017a). “DNA base
flipping analytical pipeline”. In: Biology Methods and Protocols 2.1, pp. 1–12.
Zhang, Peng, Anne K. Ludwig, Florian D. Hastert, Cathia Rausch, Anne Lehmkuhl, Ines Hellmann, Martha Smets, Heinrich Leonhardt,
and M. Cristina Cardoso (2017b). “L1 retrotransposition is activated by Ten-eleven-translocation protein 1 and repressed by
methyl-CpG binding proteins”. In: Nucleus 1034.May, pp. 1–15.
Zhang, Peng, Cathia Rausch, Florian D. Hastert, Boyana Boneva, Alina Filatova, Sujit J. Patil, Ulrike A. Nuber, Yu Gao, Xinyu Zhao,
and M. Cristina Cardoso (2017c). “Methyl-CpG binding domain protein 1 regulates localization and activity of Tet1 in a CXXC3
domain-dependent manner”. In: Nucleic Acids Research 45.12, pp. 7118–7136.
Zhang, Run Rui, Qing Yan Cui, Kiyohito Murai, Yen Ching Lim, Zachary D. Smith, Shengnan Jin, Peng Ye, Luis Rosa, Yew Kok Lee,
Hai Ping Wu, Wei Liu, Zhi Mei Xu, Lu Yang, Yu Qiang Ding, Fuchou Tang, Alexander Meissner, Chunming Ding, Yanhong Shi,
and Guo Liang Xu (2013). “Tet1 regulates adult hippocampal neurogenesis and cognition”. In: Cell Stem Cell 13.2, pp. 237–245.
Zhang, Wenhao, Weikun Xia, Qiujun Wang, Aaron J. Towers, Jiayu Chen, Rui Gao, Yu Zhang, Chia-an Yen, Ah Young Lee, Yuanyuan
Li, Chen Zhou, Kaili Liu, Jing Zhang, Tian-Peng Gu, Xiuqi Chen, Zai Chang, Danny Leung, Shaorong Gao, Yong-hui Jiang, and
Wei Xie (2016b). “Isoform Switch of TET1 Regulates DNA Demethylation and Mouse Development”. In: Molecular Cell 64.6,
pp. 1062–1073.
Zhang, Wu and Jie Xu (2017). “DNA methyltransferases and their roles in tumorigenesis”. In: Biomarker Research 5.1, p. 1.
Zhong, Xia, Qian-Qian Wang, Jian-Wei Li, Yu-Mei Zhang, Xiao-Rong An, and Jian Hou (2017). “Ten-Eleven Translocation-2 (Tet2) Is
Involved in Myogenic Differentiation of Skeletal Myoblast Cells in Vitro”. In: Scientific Reports 7, p. 43539.
Zhou, Ting, Jun Xiong, Mingzhu Wang, Na Yang, Jiemin Wong, Bing Zhu, and Rui-Ming Xu (2014). “Structural basis for hydroxymethyl-




8.1 Honorary Declaration - Ehrenwörtliche Erklärung
Ehrenwörtliche Erklärung:
Ich erkläre hiermit ehrenwörtlich, dass ich die vorliegende Arbeit entsprechend den Regeln
guter wissenschaftlicher Praxis selbstständig und ohne unzulässige Hilfe Dritter angefertigt
habe.
Sämtliche aus fremden Quellen direkt oder indirekt übernommenen Gedanken sowie
sämtliche von Anderen direkt oder indirekt übernommenen Daten, Techniken und Ma-
terialien sind als solche kenntlich gemacht. Die Arbeit wurde bisher bei keiner anderen
Hochschule zu Prüfungszwecken eingereicht.
Darmstadt, den 28. November 2018
Florian Dieter Hastert
8.2 Own and external contributions
All experiments were conceived and performed by me, except for the following:
Susanne Zimbelmann cloned the Tet1s-K852R plasmid and performed the CoIP in Figure
22 during an internship under my direct supervision. Plasmids encoding EGFP-tagged
Tet1-CRD, Tet1-DSBH, Tet1-∆1-389, Tet1-∆566-833 and mRFP-tagged VprBP were kind





Name: Florian Dieter Hastert
Date of birth: 10.06.1986
Place of birth: Eberbach
Nationality: German




PhD student, TU Darmstadt, Cardoso Group since 11/2013
MSc Technical Biology, TU Darmstadt 10/2011-09/2013
BSc Biology, TU Darmstadt 10/2008-09/2011
& GSI Helmholtz Center for Heavy Ion Research
Secondary school, Gymnasium Michelstadt 07/2007
Abitur / high school diploma
Teaching positions
Instructor in basic and advanced practical courses:
Stem cell biology & epigenetics (MTB101) 2013, 2016, 2017
Methods in molecular cell biology (BB33) 2012, 2014
Methods in cell biology (BB02) 2012, 2013
Animal biodiversity (BB03) 2010
Advisor of undergraduate and graduate theses:
Bachelor’s thesis, Susanne Zimbelmann 08/2016-10/2016
Master’s thesis, Jasmin Weber 11/2015-05/2016
Bachelor’s thesis, Jasmin Weber 06/2014-08/2014
104
8 ANNEX
8.4 Publications and Conference contributions
8.4.1 Journal articles
Zhang P, Hastert FD, Ludwig AK, Breitwieser K, Hofstätter M, Cardoso MC (2017). "DNA base
flipping analytical pipeline". Biology Methods & Protocols. Volume 2, Issue 1, 1 January 2017,
bpx010. doi: 10.1093/biomethods/bpx010.
Zhang P, Ludwig AK, Hastert FD, Rausch C, Lehmkuhl A, Hellmann I, Smets M, Leonhardt H,
Cardoso MC (2017). "L1 retrotransposition is activated by Ten-eleven-translocation protein 1 and re-
pressed by methyl-CpG binding proteins". Nucleus. 2017 May 19:0. doi: 10.1080/19491034.2017.1330238.
Zhang P, Rausch C, Hastert FD, Boneva B, Filatova A, Patil SJ, Nuber UA, Gao Y, Zhao X, Cardoso
MC (2017). "Methyl-CpG binding domain protein 1 regulates localization and activity of Tet1 in a
CXXC3 domain-dependent manner". Nucleic Acids Res. 2017 Apr 25. doi: 10.1093/nar/gkx281.
Ludwig, AK, Zhang P, Hastert FD, Meyer S, Rausch C, Herce HD, Müller U, Lehmkuhl A, Hellmann
I, Trummer C, Storm C, Leonhardt H, Cardoso MC (2017). "Binding of MBD proteins to DNA
blocks Tet1 function thereby modulating transcriptional noise". Nucleic Acids Res. 2017 Mar
17;45(5):2438-2457. doi: 10.1093/nar/gkw1197.
Rajan M, Mortusewicz O, Rothbauer U, Hastert FD, Schmidthals K, Rapp A, Leonhardt H, Cardoso
MC (2015). "Generation of an alpaca-derived nanobody recognizing y-H2AX". FEBS Open Bio,
5(1), 779-788. doi: 10.1016/j.fob.2015.09.005.
8.4.2 Manuscripts in preparation
Hastert FD, Ludwig AK, Zimbelmann S, Cardoso MC. "Role and Regulation of Tet1 during DNA
replication".
Rausch C, Zhang P, Hastert FD, Cardoso MC. "Cytosine base interactions regulate DNA metabolism".
105
8 ANNEX
Weichmann F, Hett R, Flatley A, Slama K, Schepers A, Hastert FD, Cardoso MC, Dieterich
C, Helm M, Feederle R, Meister G. "Generation and validation of monoclonal antibodies specific to
modified nucleotides".
8.4.3 Talks and Posters
1st Symposium on Nucleic Acid Modifications
Poster: Methyl Magic - Magicians of Life.
Mainz, Germany, September 4-6, 2017
International Meeting of the German Society for Cell Biology: DGZ 2016
Flash presentation and Poster: A putative role for TET dioxygenases in RNA splicing regulation.
Munich, Germany, March 14-16, 2016
4th Munich Symposium of Chromatin Dynamics
Poster: A putative role for TET dioxygenases in RNA splicing regulation.
Munich, Germany, March 10-12, 2016
Graduate College 1657 - Radiation Biology Scientific Retreat
Short talk and Poster: Dynamic interplay of TET & UHRF proteins and their putative role in
cytosine modification maintenance.
Hirschegg, Austria, June 13-18, 2014 - awarded Poster prize
International Meeting of the German Society for Cell Biology: DGZ 2014
Poster: Dynamic interplay of TET & UHRF proteins and their putative role in cytosine modification
maintenance.












Aid Activation-induced cytidine deaminase
Alu Arthrobacter luteus
AML Acute myeloid leukemia
Apobec Apolipoprotein B mRNA Editing Enzyme Catalytic Polypeptide-Like
AU Arbitrary Units










CxxC CxxC-type zinc finger domain
DAPI 4’,6-diamidino-2-phenylindole
DCAF1 DDB1- and CUL4-associated factor 1
DDB1 DNA damage-binding protein 1
Dmap Dnmt1-associated protein









ESC Embryonic stem cell
FRAP Fluorescence recovery after photobleaching
Fe Iron
GBP GFP binding protein
GFP Green fluorescent protein
G-phase Gap-phase
H3K9me3 Tri-methylation of histone 3 at lysine 9
HDAC Histone deacetylase
HEK Human embryonic kidney
HRP Horseradish peroxidase
HSAN1E Hereditary Sensory and Autonomic Neuropathy Type 1E
ICBP90 Inverted CCAAT box binding protein of 90 kDa
ICF Immunodeficiency, chromosomal instability, and facial anomalies





LIF Leukemia inhibitory factor
LINE1 Long intersperesed nuclear element
MaSat Major Satellite
MCF7 Michigan Cancer Foundation 7
MCF10a Michigan Cancer Foundation 10a
Mbd1-6 Methyl-CpG binding domain proteins 1-6
Mecp2 Methyl-CpG binding protein 2
MLL Mixed lineage leukemia
Neil Nei-like
NIRF Np95/ICBP90-like RING finger protein
NuRD Nucleosome Remodeling Deacetylase
Oct4 Octamer-binding transcription factor 4
Paf15 PCNA associated factor 15
PBD PCNA binding domain
PBS Phosphate buffered saline
PCNA Proliferating cell nuclear antigen







mRFP Monomeric red fluorescent protein
RNA Ribonucleic acid
RING Really interesting new gene
RT-qPCR reverse transcription quantitative polymerase chain reaction
RTT Rett syndrome
Sin3a SIN3 transcription regulator family member A
SLIC Sequence and ligase independent cloning
Sox2 SRY (sex determining region Y)-box 2
SRA SET and RING finger associated
R Arginine
Tdg Thymine DNA glycosylase
Tet Ten eleven translocation
Tet1CD Catalytic domain of Tet1
Tet1CDmut Catalytic domain of Tet1
Tet1s short isoform of Tet1
TSS Transcription start site
TTD Tandem tudor domain
Ubi Ubiquitin
Ubl Ubiquitin-like domain
Uhrf1 Ubiquitin-like with plant homeodomain and ring finger domains 1
Uhrf2 Ubiquitin-like with plant homeodomain and ring finger domains 2
VPR Viral protein R
VPRBP Viral protein R binding protein





First, I have to thank Prof. Dr. M. Cristina Cardoso. From our very first encounter in the first semester in
Darmstadt, Cristina impacted my (scientific) life and should continue to do so in multiple ways. You may not
want to admit it, but the way you bring harmony to the lab is unparalleled and refreshing. Besides being the
best Doktormutter imaginable, you are definitely the best co-bandmanager one can ask for.
I am very thankful to Prof. Dr. Bodo Laube for being my second corrector and even more, for never
questioning my visits to his lab to clear my head by distracting his great people!
I would like to thank Prof. Dr. Beatrix Süß for taking over the role of being an examiner and always
being super friendly!
I am deeply indebted to Prof. Dr. Gisela Taucher-Scholz, who accompanied almost my whole academic life
and always had a couple of nice words and good advice to share!
Anne & Peng, to put it simply: This was very special!
Anne again, Cathia, Kathrin, Paddy, thanks for the laughs, the walks, the friendship!
My Bachelor-/Masterrettes Jasmin and Susi - I hope, I was half as good a supervisor, as you were students.
It was a pleasure to work, think & simply spend time with you!
Anne Lehmkuhl, there is definitely not enough chocolate in the world, to ever thank you for your incredible
support in so many ways!
Alex, what is there that you do not know? And thanks for all the Lilien games!
Bianca & Manu, thanks a lot for being something like big (lab)siblings.
Katrin, thank you so much for always dealing with my organizational chaos!
All the other current and past lab members, you made this odyssey something really special!
I want to say a big thank you to everybody in the Leonhardt lab in Munich for materials and expertise!
Thanks to everybody in the BiophoniX for the distraction. I still can not comprehend how big a stupid
idea in the Schlossgraben during the Heinerfest can become.
All the people outside the lab, who shared cold beers and open ears, big hearts and big smiles:
Pinky Starfish - Thanks Guys!, Daniel & Bayram - UupsiUupsi!, CS-VVK - you crazy, beautiful people!,
Papachristos-Family - Always there!, Tag&Nacht - Crew Love is True Love!
Kiki, thanks for calling me up for a beer one night, in the long term this definitely changed my life and
this thesis!
Daniel, I don’t know where to start or where to end, but I am forever grateful that you preferred beer
over breakfast!
Isi, thanks for always being there when I was in need of a sane person!
I am deeply indebted to the Kielenz family, who welcomed me like one of their own!
Anne, thanks for being my best friend, my partner in crime and a great tortoise mum! I am really looking
forward to all the leisure stress and baloney that is still to come!
Tobi & Moritz - I am ever more proud to call you family!
Mama & Papa, ich kann euch nicht oft genug dafür danken, dass ihr seit Tag eins allen Quatsch un-
terstützt, den ich und auch Tobi und Moritz in unserem Leben machen!
Die Schönheit der Chance, dass wir unser Leben lieben - So spät es auch ist.
Das ist nicht die Sonne die untergeht, sondern die Erde die sich dreht.
-Thees Uhlmann-
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